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ABSTRACT 
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Doctor of Philosophy 
A supported phosphorylation reagent for the synthesis of 
triphosphates and prodrugs 
By Cãrole Brückler 
A solid-supported phosphorylation reagent was developed, based on Ludwig-
Eckstein chemistry. Different resin supports were evaluated and microporous 
polystyrene with 1 % crosslinking was found to give the best results. The supported 
reagent was characterised by 31 P Gel-phase NMR and phosphorus content and 
applied to the synthesis of DNA triphosphates. The triphosphates were isolated in 
28-50 % yields, often without the need for ion exchange chromatography, using 
preparative UPLC for purification. Propargylamino linked triphosphates were also 
prepared using this approach. 
The reagent was successfully applied to the synthesis of a fluorescein labelled 
thymidine triphosphate. Using the supported reagent, complete phosphitylation of 
the alcohol could be demonstrated. The product was isolated by preparative HPLC 
and its identity proven by 31P NMR and mass spectrometry. 
Additionally, the reagent's potential as a handle to access different phosphorylated 
compounds, such as mono-H-phosphonate esters, phosphonate diesters, phosphate 
tnesters and diphosphoramidates was explored and its application to the synthesis 
of nucleoside prodrugs is discused. 
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A adenine, adenosine 
Ac acetyl 
Ahx 6-amino hexanoic acid 
AIDS Acquired immunodeficiency syndrome 
ATP adenosine triphosphate 
AZT 3'-azido-3'-deoxy-thymidine 
AZTIVIP 3'-azido-3'-deoxy-thymidine monophosphate 
aq aqueous 
Bn benzyl 




tB u tert-butyl 
Bz benzoyl 
°C degrees Celsius 
C cytosine, cytidine 
calcd calculated 
CPG Controlled Pore Glass 
Cy cyclohexyl 
chemical shift in ppm downfield from tetramethylsilane 
d doublet, days 
d4T 2' ,3 '-dideoxy-2' ,3 ' -didehydrothymidine 
dATP deoxyadenosine triphosphate 
DBU 1 ,8-diazabicyclo(5 .4.0)undec-7-ene 
dCTP deoxycytidine triphosphate 
DCC dicyclohexylcarbodiimide 
DEAE diethylaminoethyl 
ddATP dideoxyadenosine triphosphate 
ddNTP dideoxynucleoside triphosphate 
dGTP deoxyguanosine triphosphate 






DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
dNTP deoxynucleoside triphosphate 
Iv 
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dsDNA double-stranded DNA 
dTTP deoxythymidine triphosphate 
ELSD evaporative light scattering detector 
eq equivalent 
ES electrospray mass spectrometry 
Et ethyl 
fDNA functionalised DNA 
FISH Fluorescene in situ hybridisation 
Fmoc 9-fluorenylmethoxycarbonyl 
g grams 
G guanine, guanosine 
h hours 
HIV Human Immunodeficiency Virus 
HOBt 1-hydroxybenzotriazole 
FIRMS high resolution mass spectrometry 
Hz Hertz 
iC 5-methylisocytidine 
ICP Inductively coupled plasma 
iG isoguanosine 
'Pr isopropyl 
WA isopropyl alcohol 
IR infrared 
J coupling constant 
L litres 
wavelength 
m multiplet, metres 
M moles per litre 
MALDI-MS Matrix-assisted laser desorption ionisation mass spectrometry 




mp melting point 
mRNA messenger nbonucleic acid 
MS mass spectrometry 
mw molecular weight 
mlz mass to charge ratio 
n.d. not determined 
NDP nucleoside diphosphate 
NHS N-hydroxy succinimide 
NNRTI non-nucleoside reverse transcri ptase inhibitor 
NMP nucleoside monophosphate 
NMR nuclear magnetic resonance 
NRTI nucleoside reverse transcriptase inhibitor 
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NTP nucleoside triphosphate 
NOESY 	- nuclear Overhauser effect spectroscopy 
Nuc nucleoside 




ppm parts per million 
Pr propyl 
Proton sponge 1 ,8-bis(dimethy 1 amino)-naphthalene 
PS polystyrene 
PS-PEG polystyrene-pol yethyleneglycol copolymer 
q quartet 
Rf retention factor (movement of compound/solvent front) 
RNA ribonucleic acid 
RP-HPLC reverse-phase high performance liquid chromatography 
rRNA ribosomal ribonucleic acid 
rt room temperature 
RT reverse transcriptase 
s singlet, seconds 
SBS sequencing by synthesis 
SELEX systematic evolution of ligands by an exponential enrichment 
SM starting material 
SNP single nucleotide polymorphism 
ssDNA single-stranded DNA 
t triplet 
T thymine, thymidine 
TBA tetrabutyl ammonium 
TCA trichloroacetic acid 
TEA tnethylamine 
TEAB triethylammonium bicarbonate 
Tfa trifluoroacetate 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
tic thin layer chromatography 
tR elution time of compound on HPLC 
tRNA transfer ribonucleic acid 
U uracil, uridine 
UV ultraviolet 
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1.1 	Nucleic acids 
1.1.1 	Introduction 
Deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) belong to the group of 
biopolymers referred to as nucleic acids. DNA, located in the cell nucleus, is the 
permanent storage medium for genetic information, while various types of RNA 
are involved in the production of proteins. The DNA code is transcribed to 
messenger RNA (mRNA). Protein assembly is carried out by transfer RNAs 
(tRNA) and ribosomal RNA (rRNA) using mRNA as template. 
1.1.2 	General structure of a nucleotide 
A nucleoside consists of a ribose sugar and a base. When phosphorylated, it is 
referred to as a nucleotide, the general structure of which is shown below (Figure 
1.1). The accepted nomenclature for the ribose positions and the phosphate groups 
are illustrated below; the nomenclature for the bases is shown later (Figure 1.2). 
00 	 Base 
- 
	
OH R 	R=OHorH 
1 	f3 	a 	2 
Figure 1.1 Structure of an RNA nucleotide 
The major structural difference between RNA and DNA is located on the ribose 
sugar. RNA nucleosides have hydroxyl groups on the 2' and 3' positions, whereas 
DNA bases are 2' deoxygenated. The lack of the second hydroxyl group renders 
DNA more stable to backbone cleavage under basic conditions. If both 2' and 3' 
are deoxygenated, they are referred to as dideoxynucleotides, which have found 
applications in DNA sequencing.' 
Bases are classed into two groups of heterocycles: the pyrimidines, cytosine (C), 
uracil (U) and thymine (T), and the purines, which are pyrimidines fused to an 
imidazole, adenine (A) and guanine (G) (Figure 1.2). Here another difference is 
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observed between RNA and DNA: RNA incorporates uracil, whereas DNA uses 
thymine, which differs from it by a methyl substitution at C-5. 
NH2 	0 	 0 	 NH2 	 0 
41 
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NNH 
H 1 	H 	 H 	 H 	3 	
NNH2 
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C 	 U 	 T 	 A 	 G 
Figure 1.2 Structures of bases 
The 5' and 3' positions of the nucleotide can carry phosphate groups. The free 
hydroxyl group is joined to phosphate groups through successive kinase catalysed 
condensations. The first phosphate to be condensed is the a phosphate, subsequent 
ones are referred to as P and y  respectively. Mono-, di- and triphosphates play roles 
in various metabolic pathways. It is however the triphosphates which are of 
particular interest in this thesis, as the triphosphates are required for DNA 
polymerases in the synthesis of DNA. 
1.1.3 	Watson-Crick base pairing 
The 3D structure of DNA remained elusive until 1953, when Watson and Crick 
solved its structure based on X-ray pictures of hydrated DNA. They correctly 
proposed that it consists of two intertwining strands which form a double helix. 2 
The Watson-Crick model states that a purine base of one strand pairs with a 
pyrimidine base of the other strand. The complementary base pairs are GC and AT. 
Thymine forms two hydrogen bonds to adenine and cytosine forms three hydrogen 
bonds to guanine (Figure 1.3). 
H 
H, -H 	oY T 	 1-1 • 





Synthetic triphosphates have been coveted molecules ever since their potential for 
therapeutic and diagnostic applications was recognized and of particular 
importance are labelled dideoxynucleotide triphosphates (ddNTPs) as chain 
terminators for DNA sequencing." 3 Triphosphates of deoxynucleotides (dNTPs) 
are required for enzymatic DNA synthesis, 4 as they are essential building blocks 
for different biochemical applications, such as the Polymerase Chain Reaction 
(PCR)6 or fluorescence in situ hybridisation (FISH) . 7 This section describes the 
different applications and the varied modifications that are used on the 
triphosphates. 
1.2.1 	Enzymatic DNA synthesis 
1.2.1.1 Introduction 
DNA is synthesised enzymatically by providing a DNA polymerase with a 
template and all four dNTPs in a suitable buffer and at a suitable temperature. The 
template for DNA synthesis is annealed to a short, specific primer of usually 15-30 
nucleotides, complementary to the sequence on the template (Figure 1.4). 
primer 	enso'i 	3 
I 	I 	I I 	I I 
5 
temp'ate 
Figure 1.4 Template-dependent DNA synthesis 
If the template provided is DNA based, the enzyme is referred to as a DNA 
polymerase, if it is RNA based, as a reverse transcriptase. All polymerases 
synthesise DNA in the 5'—+3' direction, which means that incoming nucleotides 
are added to the 3' end of the previous nucleotide (Figure 1.4). 
In living cells, DNA polymerases also fulfil other functions, thus they proof-read 
and repair cellular DNA and correct errors during the replication process. Enzymes 
for use in the synthesis of modified DNA often have such exonuclease activity 
suppressed. Additionally, they should be able to accept synthetic triphosphates, not 
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dissociate from the strand at an appreciable rate and ideally be active at raised 
temperatures which disrupt secondary structures in the DNA template. Naturally 
occurring DNA polymerases have been modified accordingly through chemical 
modifications or genetic engineering. 8 
Either full or partial substitution of a dNTP is possible during enzymatic synthesis. 
Substituted dNTPs can have modifications on the base, the sugar ring or the 
triphosphate group. Replacement of more than one dNTP with a synthetic analogue 
during the enzymatic synthesis is also feasible. A few pertinent examples with 
applications are discussed below. 
1.2.1.2 Fluorescent labelling of DNA 
Labelling of DNA has been achieved by treating DNA with a nuclease which 
creates random nicks (cuts) in both DNA stands. DNA strands can be labelled by 
partially substituting dTTP, with a labelled ana1ogue 4 in an extension reaction, 
resulting in a tagged sequence (Figure 1.5). This is referred to as nick translation. 
5' 3' 





Figure 1.5 Nick translation: (a) Creation of nicks, (b) extension in the presence of a 
labelled dNTP 
The resulting DNA segments can be used in fluorescent in situ hybridisation 
(FISH) . 7  Prior to the development of fluorescent labels, radio-isotopes were used, 
but due to safety concerns and it not being possible to perform dual labelling, these 
have fallen out of favour. 
An alternative labelling approach involves indirect probes based on hapten 
molecules, which are detected in a separate step through a fluorogenically labelled 
secondary molecule, such as an antibody. Another example is the incorporation of 
biotin into DNA, which is visualised using labelled streptavidin. 
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FISH is a highly sensitive technique used to detect and localise DNA sequences on 
chromosomes. The applications include mapping of sequences to specific positions 
on a chromosome, identification of chromosomal abnormalities and chromosome 
painting. Chromosome painting is achieved by using a multitude of small probes 
and with one colour specific to each chromosome, this technique gives rise to an 
easily assigned spectral karyotype (Figure 1.6). 
Figure 1.6 Spectral Karvotvping, reproduced with permission 
1.2.1.3 Functionalization of DNA 
DNA is being studied for a range of applications, such as nanotechnology, material 
science, computing, and biotechnology. Widening the diversity of DNA by 
incorporating analogues for one, two or all four nucleotides is crucial to accessing 
wider chemical space. The incorporation of analogues with base modifications has 
been studied to see how tolerant polymerases are of these modifications and under 
which conditions the desired full-length products can be produced. Other studies 
have replaced the natural bases outright with unnatural analogues, such as 
benzimidazoles.' ° 
A recent study by Jager and Famulok demonstrated that enzymatic synthesis of 




long DNA strands (>100 base pairs) are produced chemically only with great 
difficulty. They showed that fDNA strands could be obtained from a natural DNA 
strand by substituting all natural dNTPs with triphosphates Al-Ti (Table 1.1).h1 
This iDNA strand could then be used as a template in the presence of a second set 
of triphosphates A2-T2 to give highly-functionalised double-stranded DNA 
(dsDNA)" or could be copied using natural dNTPs to give the original strand in 
high fidelity, as asserted by sequencing.' 2 
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In general, for enzymatic DNA synthesis, purines modified either at the 7 or 8 
positions appear to be accepted by polymerases. While punnes modified at the 8 
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position destabilise dsDNA secondary structure to cause a slight decrease in 
melting temperature, 7-modified-7-deazapurines are well accommodated in the 
major groove. 13 This has led to most research groups adopting the synthetically 
much more challenging 7-modified-7-deazapurines rather than commercial 8-
modified purines. 
Applied to fDNA synthesis, nucleotide triphosphates Cl, Gi, T2 in the presence of 
either A3 or A4 did not yield a full length product, due to lack of incorporation of 
the 8-modified purine analogues (Table 1.2). 13  The 7-analogue A2 however was 
incorporated successfully under the same conditions. 12 





NH2 	 0 NH2 
N 	 O 	NN 	 OH 
R 0 	 R 0 
1.2.1.4 DNA metallization 
DNA is being studied in nanoelectronics and metal ions need to be added to 
increase its conductivity for it to act as a molecular wire. To improve on current 
uniform metallization procedures, Burley et al. developed a procedure to introduce 
selectivity though aldehyde labelling of DNA (Scheme 1.1).' 
0 
HN 
0 N 	 N3 
444o 
HOLP 
I 	I 	I 	 HO-1 
_O _0 _0 OHOH 
(a) 	
OH 	1 	(b) 	2 
Scheme 1.1 Monomers for the synthesis of DNA susceptible to silver deposition: (a) 
alkynyl triphosphate, (b) galactose azide 
Alkynyl modified triphosphate 1 was incorporated by a DNA polymerase into 
DNA opposite adenine. The alkyne was reacted with galactose azide 2, a hemi- 
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acetal protected aldehyde, through Huisgen click chemistry and silver (U) was 
deposited on the DNA using Tollen reaction (a redox reaction between an aqueous 
diamine silver (I) complex and an aldehyde). 15 
1.2.1.5 DNA damage 
Death of cancer cells can be induced by provoking DNA damage through inter-
strand cross-links, which can subsequently lead to backbone cleavage. Examples of 
such agents which have been incorporated into DNA are seleno-modified 
thymidine triphosphate 3, which was found to sensitise DNA towards -y-irradiation 
at low radiation doses of 2-10 Gy by producing inter-strand cross-links.' 6 
Greenberg et al. postulated that the mechanism by which the y-rays provoke the 
cross-links proceeded via oxidation to the selenoxide 4, followed by a [2,3] 
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Scheme 1.2 Interstrand cross-link formation 
Another set of DNA fragmentation tools are photocleavable nucleosides, which, 
when inserted into the DNA, trigger DNA backbone cleavage upon irradiation 
which can lead to sequence-independent backbone cleavage (Scheme 1.3). The 
tnphosphate of 7-nitroindole 6 is one such nucleotide which can be inserted 













Scheme 1.3 Backbone cleavage of DNA following irradiation under alkaline conditions 
1.2.1.6 X-ray structure analysis of nucleic acids 
X-Ray crystallography is dogged by the difficulty of growing crystals of molecules 
of interest and of phasing problems. As the issue of phasing was addressed for 
proteins in 1990 by incorporating seleno-methionine into proteins, 18 an analogous 
approach for nucleic acids was developed. 
PSeIPO oligonucleotide chimeras showed that selenium atoms only needed to be 
included every 30 base pairs to improve crystallography. 19 Selenium could be 
incorporated instead of oxygen in most positions by appropriate synthesis of the 
nucleosides. One of the easiest sites for incorporation was on the cx position of the 
triphosphate (Figure 1.7). The Kienow fragment of DNA polymerase I could 
incorporate both diastereoisomers at phosphorus; 20 this is unlike for sulfur, where 
only Sp-diastereoisomers are recognised substrates. 
0 
NH 
0 0 Se JO 
 
OH 




1.2.2 	Polymerase Chain Reaction 
1.2.2.1 Introduction 
The polymerase chain reaction (PCR) is a technique to replicate DNA 
enzymatically in vitro. The quantity of DNA is amplified exponentially and as a 
result, PCR is commonplace in medical and biological research labs. 
	
5 	 3' 
3' 5' 
Denaturation 
5' 	 3' 
/ \Annealing  
: 	
Extension: 
5' 	 _3' 	
3' 	 5' 
/2nd cycle 
5 -- 3' 5' 
Figure 1.8 Schematic drawing of a PCR cycle 
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The PCR procedure starts from a small amount, potentially even a single molecule 
of dsDNA (Figure 1.8). To initiate replication, it is separated to give two lengths of 
single-stranded DNA (ssDNA) by heating (Step 1). The temperature is then 
lowered so the primers can anneal to the ssDNA (Step 2). The third step in the PCR 
process is the elongation of the DNA strands. The polymerase adds dNTPs to the 3' 
end of the primer and replicates along the template strand. When the elongation 
process is finished, the strands are again denatured, annealed and elongated. 
Typically between 20 and 35 cycles are performed to obtain the required amount of 
DNA.6 
1.2.2.2 Real-time PCR via selective labelling of DNA amplicons 
PCR is very successful at exponential amplification of DNA, however no 
quantification is possible, as the amount of DNA produced per cycle plateaus off, 
as the primers are used up. Real-time PCR has been developed to address this and 
thus enables genotyping, mutation detection and chimerism analysis. 2 ' Detection of 
PCR products is achieved by measuring fluorescence changes in the PCR mixture 
as the reaction progresses. Fluorescence is generated either by adding a dsDNA-
specific dye or a ssDNA sequence specific fluorescent probe, such as TaqMan, 22 
Molecular Beacons 2 and hybridization probes. 24 As they rely on hybridisation with 
the PCR product, the probes and primers need to be designed to avoid problems 
with intramolecular structures and the sequence to be amplified needs to be known. 
A novel real-time PCR monitoring method has been described recently, based on 
selective incorporation of a third base pair, isoguanosine (iG):5-methylisocytidine 
(iC). 25 Specific incorporation of a quencher linked to iG opposite iC, which was 
linked to a fluorophore, lead to a decrease of fluorescence thus quantitation of the 
PCR product in a sealed-tube format. 26 
0 




5• 	 a 
3 
	 Quenching 
Figure 1.9 Real-time PCR using sire-spec j/Ic quenching during amplification 
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The target to be amplified was annealed to a primer labelled at the 5' end of iC 
with a fluorophore (Figure 1.9). Amplification was performed in the presence of 
dabcyl-diGTP (Figure 1.10) and site-specific incorporation of the quencher 
occurred opposite iC. The close proximity of fluorophore and quencher reduced the 
fluorescence intensity over 35 cycles. The percentage of quenching varied from 71 
to 35 % depending on the fluorophore used. 26 
OH 
Figure 1.10 Structure of quencher dabcvl-diGTP 
1.2.2.3 Aptamers 
Aptamers are RNA or DNA sequences that bind tightly to a specific entity for 
which they have been selected by adopting a complex three-dimensional shape 
through intramolecular interactions that allows binding to the target. High-affinity 
aptamers have been identified for enzymes, growth factors, antibodies, amino 
acids, drugs, organic dyes, antibiotics, nucleotides and peptides. 27 
Aptamers are developed using a systematic evolution of ligands by an exponential 
enrichment (SELEX) process. A random-sequence combinatorial library of 10 14 to 
10 individual sequences, comprising a 40 nucleotide random sequence, is 
incubated with the target, immobilised on a solid support. The sequences that bind 
are retained, while the other sequences are removed by washing. The hits are 
amplified by 'error-prone' PCR, which introduces a small degree of mutations to 
enrich the pool. After 8 to 15 cycles of selection and amplification, the sequences 
are cloned and sequenced. 
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Figure 1.11 Endonuclease resistant RNA aptamers 
For use of aptamers in biological fluids, i.e. for medicinal applications, they need 
resistance towards nucleases which degrade RNA readily, especially next to 
pyrimidine bases. This can be achieved by introducing phosphorothioate linkages 28 
(Figure 1.11a), substitution of 2' position on pyrimidine nucleotides with amino 29 
and fluoro3°  groups (Figure 1.11b) or 4'-thio substitution on the sugar (Figure 
1.12). 
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Figure 1.12 Structures 4 '-thiopyrmidine triphosphates 
Added diversity over the natural bases can be achieved by incorporating unnatural 
base pairs. 3 ' Examples include alternative H-bonding pairs such as 1CIiG25 and 2,6-
diaminopyrimidine/xanthine. 32 Base pair analogues which are shape mimics and do 





1.2.3 	DNA sequencing 
The advent of DNA sequencing has revolutionised biology and enabled high-
profile research projects, such as the Human Genome project. 4 In 1977 two 
separate methods enabling analysis of genes at the nucleotide level were reported 
by Maxam & Gilbert 35 and Sanger.' Other methods developed since then, are 
pyrosequencing, 36 ' 3738 single molecule sequencing with an exonuclease 39 and DNA 
sequencing by MALDI-MS.4° For high-throughput DNA sequencing, a level of 
automation is required, which so far had only been achieved for the Sanger 
method. 3 Recently, an automated instrument has also become available based on 
Pyrosequencing, enabling increased throughput. 4 ' 
1.2.3.1 San ger's dideoxynucleotide chain termination method 
The Sanger chain termination method is the most influential and widely used 
method to date and led to the award of a Nobel Prize to F. Sanger in 1980. It can be 
summarized as an enzyme catalysed reaction that synthesises DNA fragments 
complementary to a DNA template of unknown sequence. A brief overview of the 
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Originally a labelled primer was annealed to a specific region on the DNA 
sequence of interest and subjected to DNA polymerisation in the presence of all 
four dNTPs and a small percentage of a ddNTP. Dideoxy NTPs (ddNTPs) differ 
from dNTPs by having a hydrogen atom attached to the 3' carbon instead of a 
hydroxyl group. They are substrates for polymerases, but terminate elongation as 
they cannot form the subsequent phosphodiester bond (Scheme 1.4). 
The reaction was carried out four times in parallel to yield four pools of DNA 
fragments of different lengths, each terminating with a different ddNTP. All DNA 
fragments obtained have the same 5' end, as they were started on the same primer 
(Figure 1.13a). As illustrated for A, the DNA strand to be sequenced is treated with 
all four dNTPs, as well as ddATP to give controlled chain terminated fragments. 
As all fragments were started from the same primer, their lengths can be compared 
by four-lane electrophoresis. In this technique, the smallest fragment moves 
farthest from the loading point on the gel and the 3' end nucleotides can be read off 
with increasing size (Figure 1.13b). 
3• 	 5• 
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CTTAA 
Polymerase, dATP, 
dCTP, dGTP, dTTP, - GCGATtACG - GCGAITAC 
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(a) 	 (b) 
Figure 1.13 (a) Synthesis of chain terminated fragments for A; (b) Four lane 
elect ropho resis to read the DNA sequence 
1.2.3.2 Fluorescentiv labelled chain terminators 
In Sanger's original dideoxy chain termination method, DNA fragments were 
visualised by incorporating 2P or 5S radioisotopes into the primer, but radio-labels 
have now been superseded by fluorescent labels. Two methods to do so have 




the 5' end of the primer42 and more recently dye-labelled terminator sequencing 
where the terminating ddNTPs carry the fluorescent dye. 42.43  A typical ddNTP 
chain terminator, as used by Prober et al. is shown below (Figure 1.14). In some 
studies different speeds for incorporating labelled ddNTPs and un-labelled dNTPs 
were observed, giving rise to peaks of different intensities which could result in 
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Figure 1.14 Structure offluorescently labelled chain terminator 
1.2.3.3 Automation 
The advantage of fluorescence labelling over radio-labels is the ability to automate 
DNA sequencing, as each nucleotide is identified through a different fluorophore 
and all four families of terminated DNA fragments are synthesised in one pot and 
analysed by array capillary electrophoresis with laser-induced fluorescence 
detection. This is the state of the art technology that was used for the Human 
Genorne Project. This technique is referred to as 'Four Colour DNA sequencing.' 
Modem automated DNA sequencers can analyse as many as 384 fluorescently 
labelled samples in a run and perform as many as 24 runs a day. 
10 	 20 	 30 	 40 	 50 	 60 	 70 	 80 	 90 
ATfl A 7 - *GCOOCQ3( AAcocCCr T1C1C TG P03 A SO PrTT,CftCOCATD TO C TO AMTTOOCGOTOCCQO AG TGCGC TCN CO 
N 1 
Figure 1.15 Four colour DNA sequencing electropherogram, reproduced with pennission4' 
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The data from the sequencing is obtained as an electropherogram. An example of 
the start of a Sanger sequencing read is given (Figure 1.15). The four bases are 
detected using different fluorescent labels, which are represented as peaks of 
different colours, which can then be interpreted to determine the base sequence. 
The limitations of the Four Colour DNA sequencing are a relatively high cost for 
on-demand sequencing which makes the potential associated with personalised 
medicine prohibitively expensive. 
Electrophoresis based separations are also limited by band compression in GC rich 
regions and the technology is ambiguous in assigning heterozogytes (single 
nucleotide polymorphisms). Several approaches are being pursued to circumvent 
electrophoresis and reduce cost, 45 three of which will be discussed below. 
1.2.4 	DNA sequencing by MALDI-MS 
This technique makes use of the strongest non-covalent proteinlsubstrate 
interactions known in nature: the binding between biotin and streptavidin. Biotin is 
used as a purification handle to obtain Sanger DNA fragments in a purity sufficient 
for MS. The fragments are generated using biotin labelled ddNTPs in the 
p01 ymerase reaction. (Figure 1.16) 
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Figure 1.16 Example of a biotin labelled chain terminator 
The polymerase reaction is carried out in the presence of all four dNTPs and all 
four ddNTPs in one pot, then all the terminated DNA fragments with 3'-biotin 
incorporation are isolated on streptavidin covered magnetic beads. Excess primer, 
polymerase and falsely terminated DNA fragments are washed off the support, thus 
removing all factors which in previbus methods contributed to difficulties in the 




beads and analysed by MALDI-TOF-MS. The mass difference between fragment 
peaks determines the identity of individual nucleosides, thus the sequence. Mass 
spectrometry is a fast method that provides a high-throughput method for DNA 
sequencing for up to 100 base pairs with current instrumentation. 47 
1.2.5 	DNA sequencing by synthesis 
DNA sequencing by synthesis (SBS) on a chip is an interesting alternative to Four 
Colour sequencing. The concept of SBS was first discussed in 1988 by Hyman, 48 
and recent developments in microarray technology mean the potential for this high-
throughput method have come within reach. 
SBS involves detecting the identity of each nucleotide as it is incorporated into the 
nascent DNA chain during the polymerase reaction. The principle can be broken 
down into three steps: probing, read-out and label removal (Figure 1.17). 
1-I-i1. iIi, 
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Figure 1.17 Principle of DNA SBS. (a) Probing, (b) negative read-out, (c) probing, (d) 
positive read-out, (e) label removal 
A primer is immobilised on a surface and hybridised with an oligonucleotide with a 
sequence of interest. This sequence is probed with a labelled dNTP in the presence 
of a DNA polymerase (a). If the dNTP is not complementary, the read-out is 
negative and no signal is detected (b). Probing continues with the other labelled 
dNTPs until fluorescence is observed (d). This allows assigning one nucleotide and 
after removal of the label (e), the cycle can be repeated. 
Fluorescence detection offers great sensitivity, provided the label can be destroyed 
to avoid interference with the subsequent nucleoside read-out. To date, removal of 




by use of a photo-cleavable linker. 50 '5 ' Four-colour DNA sequencing by synthesis 
was recently published using four photocleavable fluorescent nucleotides. 5° The 
nucleotide analogues were labelled with a different fluorophore, via the 7 position 
for purines and the 5 position for pyrimidines. 
The method enabled identification of 12 contiguous bases. The template used did 
however not contain homopolymeric runs, thus problems such as double 
incorporation of a dNTP would not have been identified. It is likely that the 
nucleotide analogues described do not act as chain terminators, despite their steric 
bulk, as the same group more recently described the synthesis and application of a 
3' allyl protected analogue to DNA SBS (Figure 1 . 18) . 52 
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Figure 1.18 Structure of 3 '-allyl-dGTP-PC-Bodipy 
1.2.6 	Polony sequencing 
In this technique, amplification of the DNA is localized on a glass slide, by 
performing PCR in a polyacrylamide gel. Due to restricted diffusion, the amplicons 
remain close to the template and lead to PCR colonies' or polonies. 53 Polonies can 
be sequenced by performing cycles of primer extension with reversibly labelled 
fluorescent dNTPs in a highly parallel fashion on the slide. DNA strands are 
irnmobilised onto the gel, denatured and hybridised to a universal primer. The 
primers are extended by sequential treatment with one of four fluorescently 
labelled dNTPs (Figure 1.19). The fluorescent label is removed by cleaving the 
disulfide linker under reducing conditions. 54 Current limitations are detachment of 
the gel from the slide after 10-14 cycles and multiple incorporations for 






Figure 1.19 Structure of Cv5-SS-dCTP 
1.2.7 	High-throughput SNP analysis 
Single nucleotide polymorphisms (SNPs) account for 90 % of all human genetic 
variations and occur on average once every 1000 to 2000 nucleotides. The fully 
annotated sequence resulting form the Human Genome Project contained some 1.4 
million sites of variation along the 3.2 billion base pairs. 55 SNPs are of great value 
to biomedical research as they can affect how humans develop diseases and 
respond to pathogens and drugs. SNPs can be detected using a range of 
techniques. 56 A few of the techniques have been transposed onto a multiplexing 
platform to meet the high-throughput requirements of large-scale genetic studies. 57 
1.2.7.1 Allele specific primer elongation on nücroarrays 
This SNP detection protocol relies on the specificity of Taq DNA polymerase to 
discriminate against single base mismatches. ssDNA targets hybridised to a primer, 
immobilised on a DNA chip, serve as templates in elongation reactions. The match 
and mismatch sequences differ in their 3' base. Elongation and thus incorporation 
of a labelled dNTP takes place only if the variable nucleotide is complementary to 
the primer (Figure 1.20).58  Specific elongation of the primer took place in the 
presence of three natural dNTPs and a labelled dTTP analogue and sites of 




Figure 1.20 Allele-specific primer elongation: (a) immobilisation, (b) hybridisation, (c) 
allele specific elongation with labelled dNTP 
1.2.7.2 Mini-sequencing 
An alternative technique for SNP detection is mini-sequencing. It is analogous to 
SBS, with the difference that terminators such as dcLNTPs are used. The primers are 
annealed immediately next to a SNP of interest, followed by a single labelled 
ddNTP base extension. 
On the microarray, the technique was first demonstrated for 33P-ddNTP terminators 
for the detection of 9 SNPs. 59 An advantage over allele-specific extension is the 
fact that only one primer is required per SNP. 
Another application of mini-sequencing is the use of tag-arrays. The primer is 
attached to a 5' tag, which enables the extension of the primer hybridised to the 
target ssDNA, to be performed in solution. To decode the extension products they 
are then hybridised onto DNA chips, which have been covalently modified with 
anti-tags, complementary oligonucleotides to the tag. Using this tag technology, 
mini-sequencing was performed using four differently labelled ddNTPs, thus 
giving Four Colour Mini -sequencing. 60 
Mini-sequencing has also been applied to flow-cytometry based separation of 
microspheres. Fluorescein labelled microspheres were coupled to anti-tags, while 
primers were extended in solution with fluorogenically labelled ddNTPs and 







Syntheses of nucleotide triphosphates 
The first synthesis and isolation of the triphosphate ATP, was a formidable 
challenge in 1949.63  In practical terms, the synthesis and isolation of triphosphates 
has moved on a great deal in this time from successive barium salt precipitations, 
but the area of synthesis is still dogged with the inherent problems of the chemistry. 
It requires reaction between lipophilic protected nucleosides and multiply charged 
pyrophosphate ions under rigorously dry conditions, followed by ion-exchange 
chromatography and then HPLC purification. Added to the synthesis issues, is the 
fact that triphosphates are not stable and some are known to decompose at room 
temperature. 64 
1.3.1 	Retrosynthesis of a triphosphate 
A range of procedures have been reported for the conversion of a nucleoside to its 
triphosphate. A comprehensive review of synthetically useful methods for 
triphosphate preparation was published in 2000 by Burgess and Cook. Based on 
this review, the different approaches can be summarized in a few general routes, 
exemplified by the disconnection of the triphosphate moiety. (Figure 1.21) 
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Nucleophilic attack of triphosphate on an activated nucleoside 
This is the route that conceptually looks most efficient, however only few examples 
have been shown to be synthetically useful. This is in part due to the instability of 
triphosphate ions and has only been shown to be practical for the synthesis of 
ATP.65 '66 
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Scheme 1.5 Synthesis of a triphosphate via triphosphate attack on an activated nucleoside 
Interesting examples exist for triphosphate analogues though, where the oxygens 
between the phosphorus atoms have been replaced with methylene groups 67 or 
nitrogens. 
Nucleophilic attack of a nucleoside diphosphate on an activated phosphate 
The unprotected nucleoside diphosphate is added to an activated phosphate, here a 
phosphoroimidazolide (Scheme 1.6) to give the methyl triphosphate of guanosine 
in good yield. 
G 	 00 	C 
a 	P P P o4o4o, 	
+ TMS0 NN 	 0 0 
	
-V jo I 	I 	I I 	I _o o 
OHOH 	 - 	 OHOH 
(a) ZnC12, DMF, 4 h, rt, 86 % yield 
Scheme 1.6 Synthesis of a triphosphate via a diphosphate attack on an activated phosphate 
It was found that for the reaction to progress at a reasonable rate, Lewis acidic 
metal ions had to be added. 68  No further examples using this disconnection have 
been reported. 
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1.3.4 
	
C: Nucleophilic attack of a phosphate on an activated nucleoside diphosphate 
This route also involves a nucleoside diphosphate and a monophosphate; however 
in this case, the roles of nucleophile and electrophile are reversed. Syntheses using 
this disconnection have chiefly been employed for the introduction of a radio-
labelled 32P isotope at the ' phosphorus. Thus a nucleoside diphosphate was treated 
with 1,1'-carbonyldiimidazole to activate specifically the f3 position, which was 
then treated with a phosphate. 69 Selective activation of the 1 rather than a position 
was verified incidentally when radio-labelled phosphorus was found only in the y 















- 	 0H0H 
(a) (i) (Im)2CO 3 DMF, rt, 12 h, (ii) MeOH; (b) HNBu 3 H232PO4 , DMIF, rt, 36 h 
Scheme 1.7 Synthesis of a triphosphate via phosphate attack on an activated diphosphate 
This method has found no general applications, probably because, as a group of 
compounds, nucleoside diphosphates are even harder to synthesise. 
1.3.5 
	
D: Nucleophilic attack of pyrophosphate on an activated nucleoside 
monophosphate 
The greatest number of procedures can be grouped under route D. The 
monophosphate nucleotide is activated to pyrophosphate attack by introducing a 
leaving group on the monophosphate. Examples of the most commonly used 





Early work by Yoshikawa using POC13/tri  alkylphosph ate mixtures to selectively 
monophosphorylate at the 5'-OH position,7° were exploited by others by treating 
the activated dichloromonophosphate 7 with a pyrophosphate solution to give a 
cyclic triphosphate, which was quenched to yield the triphosphate (Scheme 1.8).71 
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(a) POC13 , (MeO) 3P0, 0°C, 1.5 h; (b)(HNBu 3)2 H2P207 , B11 3N, rt, 1 mm; (c) TEAB buffer 
Scheme 1.8 Synthesis of a triphosphate via a dichiorophosphate 
By replacing POd3 with PSC13, u-thio triphosphates can also be accessed. 72 While 
this chemistry has an appealing 'one pot-three step' efficiency, it does have 
drawbacks in that steps are very substrate-dependent and the monophosporylation 
step is often not as selective as in the first reported cases. 
1.3.5.2 Phosphoramidates 
An alternative leaving group that can be introduced is an amine, which is typically 
morpholine, to give the nucleoside phosphoramidate. The appeal of the 
methodology lies in the fact that it starts from the monophosphate. Mofatt et al.73 
used DCC and morpholine to produce the phosphoroamidate 8, which reacts with 
bis-(tributylammonium) pyrophosphate to give the triphosphate, but di and 
tetraphosphates are formed through disproportionation reactions. This is reduced in 
the presence of DMSO, 74 but reaction times of a few days are necessary, to reach 
yields of 70 to 80% (Scheme 1.9). 
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(a) DCC, morpholine, tBuOHJH2O reflux, 6 h; (b) (HNBu 3)2 H2P107, DMSO, rt, 2-4 d 




1.3.5.3 Charged phosphoramidates 
Borch et al.75 recently applied a more reactive phosphoramidate to triphosphate 
synthesis, which progresses via a highly reactive zwitterionic intermediate. 
Following a nine-step solution phase procedure 76 to obtain phosphoramidate 9, the 
phosphate ester is deprotected catalytically, which activates the alkyl chloride side 
chain to nucleophilic attack from the nitrogen. Zwitterionic pyrrolidinium 10 is 
displaced to form the tnphosphate. (Scheme 1.10) 
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(a) H2, PdJC, THF, rt; (b) (NBu 4) 3HP207 , THE; 77 % yield 
Scheme 1.10 Synthesis of a triphosphate via a charged phosphoroamidate 
This method was applied to the synthesis of dTTP, dCTP, UTP and two nucleoside 
drugs in 55-77 % yields. Apart for the lengthy preparation of the starting material, 
no reference is made to the synthesis of purine triphosphates and to the base 
protection requirements of nucleophilic amino groups. 
1.3.5.4 Other activation methods 
Dervan et al. 25 activated the monophosphate with 1,1'-carbonyldiimidazole and 
subjected it to tributylammonium pyrophosphate to yield the triphosphate. Other 
activation methods for monophosphates are triazoles, 77 mixed phosphate 
anhydrides with (tB u)2PSC1 ,78  (PhO)2P0C1 79 or trifluoroacetic anh ydnde. 8° 
3'-azido-thymidine was triphosphorylated with tris-imidazolyiphosphate, followed 
by MeOH addition to give 5'-imidazolylmethylphosphate and pyrophosphate 
attack gave the triphosphate in a 77 % yield. The high yield was attributed to 




Reactions which fall in the realm of biocatalysis are mentioned at this point, as the 
principle can be applied to any of the previous routes, availability of an enzyme 
performing the required reaction and recognition of the desired substrate• 
permitting. An enzymatic approach is almost perfect in some cases, while it is 
utterly unsuited in others. 
The approach for the synthesis of ATP is exemplified (Scheme 1.11), where the 
total conversion was 98 %•82  However, the overall efficiency still depends on the 
isolation procedure and enzyme access. 
a 	 b 	 c 
adenosine 	 - AMP 	 ADP 	 ATP 
- 
(a) adenosine kinase; (b) adenylate kinase, cat. ATP; (c) acetate kinase 
Scheme 1.11 Synthesis of a triphosphate via biocatalysis 
The use of enzymatic reactions in tnphosphorylation requires suitable enzymes to 
accept synthetic substrates and is also not always successful. This initial investment 
is most suitable for bulk synthesis of triphosphates. 
E: Nucleophilic attack of pyrophosphate on an activated nucleoside phosphite 
1.3.7.1 The Ludwig-Eckstein reagent 
An attractive alternative to the previously mentioned methods is the one-pot 
Ludwig-Eckstein method, 83 where the nucleoside is reacted in situ with salicyl 




Figure 1.22 Structure of 2-chloro-benzo[1, 3, 2]dioxaphosphinin-4 -one 11 
1.3.6 
1.3.7 
The phosphitylated nucleoside intermediate 12 undergoes two subsequent 
nucleophilic substitutions with pyrophosphate to give a cyclic triphosphite, which 
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is oxidised with iodine/pyridine and hydrolysed with aqueous ammonia (Scheme 
1.12). Base protection has not been found to be necessary, while 2' and 3' OH 
groups need protection, as even at -78 °C little selectivity for primary alcohols over 
secondary alcohols was observed. 83 (Counterions omitted for clarity) 
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(a) ii ,py/THF; (b) pyrophosphate; (c) 12 in pyridinelH2O; (d) H20; (e) NH3 in H2O 
Scheme 1.12 Thymidine triphosphate synthesis by Ludwig and Eckstein 
This method is widely used for synthesis of nucleoside triphosphates. It has also 
been applied to the synthesis of modified triphosphate analogues such as a-thio, 83 
a-borano, 84 a-thio-a-borano, 85 a,a-dithio and a,'y-dithio triphosphates 
86  It has 
also been used to access a-thio, a-borano and a-seleno diphosphates 87 and 
dinucleoside tetra- and pentaphosphates. 88 A recent literature survey showed that 
over 600 examples of its use in synthesis had been reported. 89 
Even though it was a significant improvement on other methods, the Ludwig-
Eckstein method still requires the resultant triphosphate to be purified by ion-
exchange chromatography, followed by preparative HPLC. Isolated yields for 
simple triphosphates can be as high as 50-70 %, but for modified nucleoside or 
fluorophore labelled nucleosides yields can be very low, if the reaction works at all. 




1.3.7.2 Oxathiaphospholane methodology 
This method also relies on the activation of a nucleoside monophosphite towards 
nucleophilic attack. First reports of oxathiophospholane 13 centered on using 
intermediates such as 14 for the generation of P0/PS chimeric oligonucleotides. 
Its application to triphosphate synthesis has recently been reported. 90 Protection of 
exocylic amines was not necessary. 9 ' The nucleoside alcohol is phosphitylated and 
in situ oxidised to the thio analogue or the seleno analogue (Scheme 1.13). This is 
followed by nucleophilic displacement with pyrophosphate and deprotection to 
give 48-78 % conversion by 31 P NMR, but only 10-30 % isolated products for the 
DNA and RNA a-thiotriphosphates. 
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18 % yield 
Scheme 1.13 Thymidine a-thiotriphosphate synthesis using oxathiaphospholane 13 
Analogously, the a-selenotriphosphate of adenosine could be accessed in 31 % 
yield and the unmodified triphosphate of adenosine could be formed by oxidising 
its thio-analogue with H 202 in 65 % yield. No discussion was however made with 







Hi gh -throughput synthesis is of huge importance in the generation of small 
molecules. These are required to interact with potential therapeutic targets, which 
have been uncovered by recent progresses in genomic and proteomic sciences. 92 
Not only do the molecules need to be synthesised in a pure and timely fashion, 
there is also pressure to do this in an environmentally friendly manner and with 
minimum manipulation. One technology able to provide the tools to satisfy these 
goals is the use of solid-supported reagents. 
1.4.1 
	
Immobilised reagents in solution phase synthesis 
Solid-supported reagents were developed to combine the advantages of 
combinatorial chemistry and solution phase chemistry. Immobilised reagents can 
be added to the substrate of interest without compromising the purity of the 
product. Additionally, all the real-time monitoring procedures like tIc, HPLC and 
MS of solution phase chemistry can be applied. As supported reagents have gained 
in popularity, so have their applications. The general topics will be briefly 
discussed below and illustrated with an example. The field of polymer supported 
reagents and its aspects have been extensively reviewed. 92,93,94,95 
1.4.1.1 As a reagent 
The supported reagent is used in an excess relative to the substrate of interest, thus, 
the reaction is pushed to completion. Excess reagent is simply removed by 
filtration and does not complicate isolation. With appropriate protocols, the 
reaction product can then reacted subsequently without further purification. 
Examples in this area cover oxidations and reductions, halogenations, C-C bond 
forming reactions, nucleophilic substitution reactions and deprotection and 
dehydrating reagents. 95 
a Y0 TEA, PhH, 76 % Br
2 	
N C N J3 
Scheme 1.14 Synthesis of carbodiimides using a supported triphenyiphosphine complex 
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Triphenyiphosphine has many applications in organic synthesis, but this is marred 
by purification problems caused by its by-product triphenyiphosphine oxide as it is 
an especially difficult purification and the use of polymer-supported 
triphenyiphosphine has been able to remedy this. A PS-PPh 3-Br2 complex has been 
employed for the formation of carbodiimides from ureas (Scheme 1. 14). 96 
1.4.1.2 As a scavenger 
There is also scope to use supports to clean up reaction mixtures in a rapid and 
efficient manner. By adding a supported reagent complementary to an undeirabJe 
component in the reaction mixture, it is bound to the support either through ionic 
interactions or covalent bonds and removed through filtration. Scavenging reagents 
can be grouped into two groups: scavengers for electrophiles or nucleophiles via 
covalent bonds and acidic or basic scavengers which form ionic interactions. 97 '98 
In the synthesis of pyrazole 15, a polymer-bound amine was used to neutralise the 
salt and then excess hydrazine was scavenged by a polymer-bound isocyanate to 
give a supported urea-type adduct, which was readily removed to give the pyrazole 
in excellent purity (Scheme 1.15). 99  




b 	 HO2C 	15 
(a) MeOH, rt, 2.5 h; (b) MeOH, rt, 16 h; 48 % yield, 97 % HPLC purity 
Scheme 1.15 Synthesis of pyrazole using an electrophilic scavenger 
1.4.1.3As a catalyst 
The same principles as for reagents can also be applied to catalytic systems. The 
active catalyst is encapsulated or bound to the support and removed by filtration 
after the reaction and re-used. 
In a recent example described by Bradley et al., palladium (0) was encapsulated 
inside a Tentagel resin. Palladium leaching out of solid-supports was addressed by 
entrapping palladium as nanoparticles. Aqueous Suzuki couplings to aryl bromides 
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could be performed at 10 mol % of catalyst in good to excellent yields (Scheme 
1.16). The catalyst was recycled up to six times without loss of activity.' 00 
0 
HN 1 6 
a 	H 
Br + R2—j---B(OH)2 
	0 
RiaL 	 Ri 
(a) 3 eq K2CO3, 10 mol % 16, H20, 80 °C, 4-16 h, 10 examples, 62-99 % yield 
Scheme 1.16 Aqueous Suzuki couplings using supported Palladium nanoparticles 
1.4.1.4 To reduce hazards 
A range of chemical transformations involve reagents or by-products that are either 
toxic, smelly or hazardous. By immobilising them, their hazardous nature is 
obviously greatly reduced or removed and thus making them much easier and safer 
to handle. This was demonstrated by the elimination of the volatile sulfur 
compounds of a Swern oxidation. Phenylmethlychlorosulfonium salt 17 was 
irnmobilised and used successfully to obtain the desired aldehyde (Scheme 1. 17).b01 
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(a) TEA, 4 h, 100 % 	 H 
Scheme 1.17 Oxidation of a primary alcohol using a supported Swern-type oxidation 
1.4.1.5 Catch-and-release resins 
This methodology combines polymer supported synthesis and scavenging 
protocols. Functionalised polymers have been developed which trap the substrate 
as a supported reactive intermediate. After washing the support to remove soluble 
by-products, the intermediate is subjected to a second reaction which provokes a 
chemical transformation and concomitant release from the resin. Acyl and sulfonyl 
transfers, alkylations, ring closing cleavage reactions and selenium based reactions 




Polymer-supported carbodiimide 18 was reacted with various alcohols under Cu 
(II) catalysis to yield the corresponding O-alkyl isourea 19, which was treated with 
carboxylic acids to give esters in excellent yield (>90 %) and purity (>95 %) under 
heating or microwave irradiation (Scheme 1.18).103 








(a) (i) BnOH, Cu(OTf) 2, THF, 16 h, (ii) TMIEDA, CH202 ; (b) RCO2H, 125 °C, gw, 3 mm 
Scheme 1.18 Synthesis of esters using polymer supported 0-alkylisoureas 
Various ketones were trapped as sulfonyl hydrazones on PS-sulfonyl-hydrazide 
resin 20. Hurd-Mori reaction 104 and concomitant cleavage was initiated by 
treatment with SOd2 to yield the desired 1,2,3-thiadiazole 21 in good yield and 






(a) AcOHJTHF, 50 °C; (b) SOd12 , (CH2C1) 2 , 60 °C; 82 % yield, 94 % GC purity 




Of particular relevance to nucleoside chemistry is a Mitsunobu protocol applied 
recently to the conversion of a primary alcohol to an amine. Polymer-supported 
phthamlimide 22 was coupled to the 5' hydroxyl group of adenosine. The resultant 
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(a) 	PPh3 , DEAD, THF; (b) N 2R, EtOH, CH202 ; >96 % yield 
Scheme 1.20 A polymer supported Mitsunobu reaction 
1.4.1.6 Multi-step reactions 
The potential to exploit reactions in a one-pot-multi-step reaction sequence, where 
the individual reagents are mutually incompatible, but while bound on a support do 











t— SO®H3NNH2 	 24 
THE; 91 % yield 
Scheme 1.21 Simultaneous use of mutually incompatible reagents to prepare pyrazole 24 
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One of the first examples was reported by Patchomik et al. " Two insoluble 
polymers containing functionalities which react when mixed in solution, could be 
employed in a one-pot reaction sequence. The strong base 25 and the acylation 
reagent 26 were reacted together in the presence of acetophenone to yield a 
diketone anion, which was treated immediately with a supported hydrazine to yield 
the substituted pyrazole 24 in excellent yield (Scheme 1.21). 
1.4.2 
	
Synthesis and properties of resins 
Work has been concentrated mainly on polystyrene-divinylbenzene co-polymers as 
a support, however graft polymers of other monomers, as well as glass, paper and 
zeolites have also found their uses. The inherent properties of the resins vary 
significantly; therefore careful selection of the polymer is often necessary. 
1.4.2.1 Polystyrene-based resins 
The first resins to come into synthetic use were polystyrene (PS) based. Cross-
linking was found to be necessary to impart mechanical stability. Currently used 
resins contain 1-2 % cross-linking introduced using divinylbenzene (DVB) 28 
added during the polymerisation with vinylbenzene 27 and 0.5 to 3.5 mmolg' 
loading introduced either via the addition of a suitable monomer, like 
chloromethylvinylbenzene 29, in the desired portion or subsequent chemical 
modification of the benzene ring through Friedel-Crafts chemistry (Figure 1.23). 
CI 	 CI 
27 	28 	29 Ph Ph Ph 
Figure 1.23 Structure of monomers and of chioromethyl polystyrene resin 
The hydrophobic properties of polystyrene make the resin swell in non-polar 
organic solvents up to five times its dry volume.' 08 The resin, however, suffers 
from poor swelling in water and some polar solvents, thus reactions cannot 
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proceed. To date polystyrene is arguably the most widely used type of resin, 
however due to its lack of swelling in aqueous and polar solvents, alternatives have 
been developed. 
A low cross-linked resin which, when swollen, forms a gel and thus makes all 
functionalisation sites throughout the resin bead accessible. This type of resin is 
referred to as microporous resin. 
1.4.2.2 Highly cross-linked PS resins 
By increasing the proportion of the cross-linking monomer to 20 or 30 % w/v, the 
resin appreciably changes its swelling properties and becomes rigid. When a 
porogen is added during the polymerisation, it is referred to as a macroporous resin. 
The accessible resin functionalities are reached through the rigid pores. Highly 
cross-linked PS resins are used mostly as support for scavengers and for synthesis 
of oligonucleotides. 
1.4.2.3 Grafted PS resins 
Graft resins combining the properties of hydrophobic microporous PS and water 
soluble polyethylene-glycol (PEG) chains were developed to access more 
hydrophilic resins. They contain a PS core which is modified by linking a PEG 
chain through an ether bond. PS-PEG is commercialised as Tentagel 30 and 
contains around 70-80 % by weight of PEG (Figure 1.24). Disadvantages are 
loading levels, the potential of the PEG chains to complex Lewis acids and the 
potential instability of PEG and the tendency to become sticky and difficult to 





Figure 1.24 Structures of PS-PEG resins: Tentagel 30 and Quadragel 31 
The properties of PS-PEG resins such as Tentagel have been modulated with a 
view to lessening these issues, by incorporating a defined tetraethylene glycol unit. 
This resin is being marketed as Quadragel 31 for a microporous PS core and 
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Quadrapore for the macroporous analogue. Quadragel could be employed 
favourably over Argogel, a PS-PEG resin analogous to Tentagel with Ca. 60 
ethylene glycol units, when a Lewis acid (SnC14) mediated reaction needed to be 
performed.' °9 This was attributed to reduced amount of Lewis basic ethylene glycol 
chains. 
1.4.2.4 Controlled Pore Glasss 
Controlled Pore Glass (CPG) is a rigid glass-derived material compatible with any 
type of solvent and extremes of pressure and temperature that are occasionally used 
in synthesis. Loading levels are low as all functionalities are located on the 
surfaces. CPG is formed using a Si-O network and is functionalised with short 
carbon chains and an amine, such as propylamine. 
In CPG beads a considerable amount of the surface silanols are linked to vincinal 
silanols. Only free silylic acids can be functionalised with silanes. Loadings are 
typically between 0.1 and 0.2 mmolg', which is suitable for oligonucleotide 
synthesis. 
Higher loading levels can be achieved by functionalising silica, which differs from 
CPG by having all surface silanols free and thus available for functionalisation. 
The difference in surface properties between CPG and silica arises from the 
difference in temperature used in their respective production processes. Loading of 
commercial silica range between 0.5 and 1.5 mmolg' and they can be used as 
scavengers, catalysts and reagents. 
1.5 	Solid phase approaches to phosphorylated nucleosides 
The vast majority of nucleic acid chemistry on solid support reported is in the area 
of oligonucleotide synthesis, but there is also research into facilitating synthesis of 
phosphorylated nucleosides using solid phase approaches. 
1.5.1 	Synthesis of oligonucleotides 
The first reported synthesis of an oligonucleotide reaches back to Todd and 
Michelson synthesis of a dinucleotide in 1955.110  Despite some heroic efforts in 
developing new protecting groups, coupling agents and synthesis strategies, the 




supports for oligonucleotide synthesis." 1 The first report in 1965 used the 
phosphotriester approach," 2 but this chemistry has now been superseded by 





























(a) aminopropyl-CPG; (b) 3 % trichioroacetic acid; (c) condensation; (d) 12 in 
pyridine/H20; (e) NH 3 in H20 
Scheme 1.22 Synthesis of oligonucleotides using phosphoramidite chemistry 
The synthesis is most commonly performed on CG" 3 or macroporous 
polystyrene." 4 The beads are coupled to the linker on the starting nucleoside, then 
after 5'-OH deprotection, the resin is treated with a phosphoramidite monomer. 
Typically, the phosphate and the bases are protected with base labile protecting 
groups. After successful coupling, the phosphite triester is oxidized to the 
phosphate triester and the next coupling cycle can start. After the required amount 
of cycles, the oligonucleotide is cleaved and deprotected (Scheme 1.22). 
This chemistry is used most widely for oligonucleotide synthesis and SOmers are 
no longer a synthetic challenge. This was made possible with the development of 
automated synthesizers and readily available and cheap starting materials. 
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1.5.2 	Solid phase approaches to phosphorylated nucleosides 
1.5.2.1 Monophosphates 
Access to nucleoside and carbohydrate monophosphates is a requirement for 
studying fundamental biological pathways. A supported monophosphityl ating 
procedure for synthesising monophosphates has been developed by Parang et al. 115 
The method is based on phosphoramidite chemistry and involves construction of an 
activated monophosphite on the resin. The resin was loaded with the alcohol, then 
oxidised, deprotected and cleaved to yield the monophosphate in 41-67 % yield 
(Scheme 1.23). The trapped methine quinone 32 can be recycled and reused. 
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(a) ('Pr) 2NP(C1)OCH2CH2CN, DIPEA, THF; (b) dT, THF, DMSO, 1H-tetrazole, 24 h; (c) 
tBuOOH, THF, 1 h; (d) DBU, THF, 48 h; (e) 50:50 TFA:CH 2C12 , 30 mm; 55 % yield 
Scheme 1.23 Synthesis of nucleoside inonophosphate on solid support 
Another solid-supported mono-phosphitylation reagent was published by the same 
group, relying on a similar principle." 6 
1.5.2.2 Immobilisation of nucleotide monophosphates 
Borch et al. have applied their method for triphosphate synthesis (discussed in 
1.3.5.3) also to nucleotide monophosphates. 7 The charged pynolidinium 10 was 
intercepted with nucleophilic amine immobilised on CPG to yield the immobilised 
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(a) CPG-NH2, TEA, THF, 15 h; (b) 50:50 HCO 2H:H20, 8 h; 55 % yield based on loading 
Scheme 1.24 Immobilisation and release of a nucleotide monophosphate 
1.5.3 	Solid phase approaches to nucleoside triphosphates 
The shortcomings of the triphosphate syntheses described in Section 1.3, have been 
recognised by many researchers. An efficient and general synthesis of 
triphosphates would indeed be a very desirable procedure. Several methods have 
been reported previously to utilize resins for more efficient triphosphate synthesis. 
There are two approaches to immobilise the nucleoside onto the resin: (i) 
attachment via a linker to the sugar or base or (ii) attachment via the alcohol to 
release the triphosphate from the resin after formation. Both approaches will be 
discussed in turn and their relative merits highlighted. 
1.5.3.1 Attachment via a linker 
The use of a linker implies that there is a functional group on the nucleoside that 
can be involved in this bond. This condition has resulted previously in utilising the 
2' or 3' positions on the sugar for linker attachment. This unfortunately excludes 
all dideoxy and dideoxy-didehydro nucleoside analogues, thus such a method can 
never be universal. Nonetheless it has been shown to be valuable for synthesis of 
specific groups. 
2'0-methyl RNA triphosphates were accessed by Gaur et al. by applying the linker 
and resins commonly using in oligonucleotide synthesis. 118 The 3' hydroxyl group 
was functionalised with a succinimidyl linker which was then attached to amino-
propyl functionalised CPG, then the resin was deprotected and yielded the 
supported nucleoside triphosphate under Ludwig-Eckstein conditions. The 
tnphosphate was released from the resin using ammonolysis at elevated 





























I 	 PPh 2 
PS 
( ZLNO 






(a) (i) 11 py/THF, (ii) pyrophosphate, (iii) 12  in pyridineIH20; (b) NH3JH20, 50 °C, 2 h 
Scheme 1.25 Gaur's method of supported synthesis of triphosphates 
2'-amino triphosphates were synthesised by Schoetzau et al. from their 2'-azido 
analogues in a one pot triphosphorylationlreduction sequence. 119 The method was 
based on Staudinger chemistry, where the azide was immobilised on polystyrene-
tnphenylphosphine resin, phosphorylated according to the Ludwig-Eckstein 
method and cleaved to yield the triphosphate (Scheme 1.26). 
(a) dioxane; (b) (i) 11 py/TI-IF, (ii) pyrophosphate, (iii) 12  in pyridinelH20, (iv) H20; (c) 
NH3 in H20 
Scheme 1.26 Schoetzau 's method for synthesis of a,nino-nucleoside triphosphates 
1.5.3.2 Attachment via the alcohol 
This approach has the advantage that it could be applicable to all molecules of 
' 20 interest as it does not rely on functionality to attach the linker. Parang et al., 
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published an example of such a method recently. It is analogous to the method 
discussed in 1.5.2.1 and utilises phosphoramidite chemistry, where a cyanoethyl 
protected triphosphite phosphoramidite is constructed on the resin, which is then 
treated with an alcohol (R-OH), oxidised either to the triphosphate or the tn-
thiophosphate, deprotected and cleaved to yield carbohydrate or nucleoside 
triphosphates in typically 45 - 80 % yields. While this method has been shown to 
work for simple molecules such as unmodified nucleosides and carbohydrates, this 
method has not been demonstrated to be applicable to molecules with more 
elaborate functionalities. 
x x x 
1101 
a 
	 0,6060  o 
R 
x x x 
C 	 0. 
(a) tBuOOH, THF (X=O) or Beaucage's reagent, MeCN (X=S); (b) DBU, THF; (c) TFA, 
DCM, H20 





1.6 	Aims of the project 
As shown in the above section (1.3), a range of triphosphate syntheses have been 
developed which indicates, quite rightly, that none of them is wholly satisfactory. 
There is a strong need for a general triphosphorylation reagent which enables a 
straightforward conversion of any alcohol, especially nucleosides to their 
triphosphate. Using an excess of phosphorylating reagent, then even more sluggish 
substrates will be able to be pushed to completion. 
The aim of the project was to develop such a phosphorylating reagent and we 
sought to develop it as a supported reagent to take advantage of the ease of 
purification and the chance to drive reactions to completion. The chemistry will be 
based on the Ludwig-Eckstein method (section 1.3.7.1), as it is the most well 
established technique in triphosphate synthesis. 
To transpose the chemistry from solution to solid phase, a suitable resin has to be 
designed and synthesised. The target will be a resin coupled to 2,4-dihydroxy 
benzoic acid which can then be converted to the supported Ludwig-Eckstein 
reagent (Figure 1.25). An ether bond was chosen to link the resin to the salicylic 
acid linker, as it was judged to be most suitable to resist Lewis acids such as Pd3. 
9 
P..-.cI 
Figure 1.25 Supported Ludwig-Eckstein based resin 
Different resins are available for developing a supported reagent, so different 
supports will be investigated with the hope to identify the properties required from 







Development of a supported Ludwig-Eckstein reagent 
The Ludwig-Eckstein reagent 
Introduction 
The Ludwig-Eckstein reagent 11 was first synthesised in 1887 by Anschütz et al. 12 ' 
but its structure and fundamental chemistry were only established in 1952 by 
Young.' 22 Its first application to nucleoside chemistry was reported by Marugg et 



















HI 0H 34 
(a) 1.25 eq 11, 5 mm; (b) H20 
Scheme 2.1 Synthesis of 3'0-H-phosphonates using 11 
The full scope of the reagent was realised and exploited by the seminal work of 
Ludwig and Eckstein who recognised that the phosphitylated alcohol could 
undergo two further substitutions. 83 Pyrophosphate could attack twice on the P(M) 
centre, yielding a cyclic triphosphite which could then be oxidised to a cyclic 
triphosphate. Hydrolysis, followed by ammonolysis gave access to thymidine 
triphosphate in a 72 % overall yield after Sephadex DEAE purification and 































(a) pyrophosphate; (b) 12 in pyridinefH20; (c) H20; (d) NH3  in H20 
Scheme 2.2 Triphosphate synthesis according to Ludwig and Eckstein 
Synthesis 
Two reaction conditions have been reported for the formation of the Ludwig-
Eckstein reagent. 124" 25 The first method refluxes phosphorus trichioride with 
salicylic acid in the presence of a dry solvent. In the second method, salicylic acid 
is dissolved in a dry solvent with pyridine which is then added to a cooled solution 
of PCI3. During the course of my PhD, both methods were reproduced successfully 
to prepare reagent 11 (Scheme 2.3). The reagent is also available commercially, but 
it was found to be of variable quality and direct synthesis was preferred. 
0 	 0 
0
1 C] 	 a or b 0H 	 ecrPcl 
11 
(a) 2 eq Pd 3 , THF, 60 °C, 2 h, 80%; (b) 1 eq PC1 3 , 2 eq pyridine, THF, -15 °C tort, 15 h, 
45 % 
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Using method (a), 11 was isolated using vacuum distillation to remove THF, then 
excess phosphorus tnchlonde to furnish the desired compound. Using method (b), 
distillation was preceded by a filtration to remove precipitated salts. In both cases, 
care had to be exercised to keep the isolated product air and moisture-free, as 11 
could be readily oxidised and hydrolysed. 
2.2 
	
Solution phase model 
2.2.1 	Benzylation of 4-hydroxy salicylic acid 
In a solution model, the selectivity of the benzylation of 2,4-dihydroxy benzoic 
acid was assessed via methyl ester protection of the acid as per Astles et al.'26 
followed by benzylation under Finkelstein conditions. 
(a) MeOH, conc. H2SO4,  reflux, 66 h, 79 %; (b) BnC1, K2CO3,  KI, TBA-C1, acetone, 
reflux, 10 h, 72 %; (c) 2 M NaOH, dioxane, reflux, 5 h, 91 % 
Scheme 2.4 Benzylation via a methyl ester derivative 
NOESY experiments on the methyl ester 36 to determine which regio-isomer was 
formed; therefore a second route was explored via an acetonide protection of the 
carboxylic acid and the 2-hydroxy group. (Scheme 2.5) 
Acetonide 38 was accessed using dehydrating condjtions' 27 and the benzylation of 
the para-OH group was readily performed via a Mitsunobu reaction. 128 The 
deprotection of the acetonide was not straightforward as classical methods for 
acetonide deprotection, such as refluxing 2 M HC1, or refluxing 2 M NaOH gave 




material producing an unidentified side-product, but presumably a poly-ester. 
Deprotection was finally achieved in good yield using a method of Danishefsky et 












(a) Acetone, Piv20, cat. H2SO4,  10 h, 47 %; (b) BnOH, DIAD, PPh 3, THF, 0°C to rt, 15 h, 
96 %; (c) 48 % KOH, DMSO, 60 °C, 30 mm, 85 % 
Scheme 2.5 Benzylation via an acetonide derivative 
Synthesis of supported reagent on microporous PS 
Different resins were evaluated as supports for the linker as their different 
properties were expected to fundamentally influence the chemistry. 
Attachment of the linker to microporous PS resin 
Microporous polystyrene (1 % DVB cross-linking, 75-150 /flii, 1.75 mmolg 1 ) was 
chosen as the first resin type to explore the chemistry developed above to allow 
immobilisation of the desired linker 35. (Scheme 2.6) 
[II 
'f0H 
8'40 	 ;'41 a)  
(a) 3 eq 35, acetone, K 2CO3, K1, 60 °C, 2 d; (b) Bu4NOH, THF, 60°C, 2 d, then 2 M HC1 




The reaction was monitored by 13C Gel-Phase NIvIR and after 2 days, the 
Finkeistein coupling of the phenol had gone to completion. ( 1 H MAS NMR was 
also attempted, but the observed signals obtained were too broad to be useful.) The 
deprotection conditions were modified and tetrabutylammonium hydroxide was 
chosen over NaOH as a deprotection reagent, as it is more suitable for resin 
chemistry. Acidification of the carboxylate was found to be essential to enable the 
resin construct to be visible by Gel-Phase NMR. 
Comparison of the Gel-Phase NMR of PS-supported 2-hydroxy benzoic acid 41 
and 4-benzyloxy-2-hydroxy benzoic acid 37 (Figure 2.1) showed all the expected 
signals. Additional signals were assigned to the polystyrene resin backbone (40-50, 
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Figure 2.1 13C Gel Phase NMR spectra of37 and 41 in d 6-acetone 
Different solvents were used for the gel-phase NMR studies. The ideal solvent 
requires swelling of the resin to enable recording of the spectra, however if 
swelling is too large, lower concentrations will be exposed to the magnetic field, 




however one drawback of its use with PS, is the fact that the resin floats, thus 
excess solvent needs to be removed from the bottom of the NMR tube, which can 
be difficult without introducing air bubbles into the resin bed. d 6-acetone was found 
to be a suitable substitute, as the resin sinks in it, while still giving adequate 
signals. 
The alternative route using an acetonide was also transposed to the solid phase. 
Hydroxymethyl PS resin 42 was treated with acetonide 38 under Mitsunobu 
conditions. After 15 h, the coupling was not complete, as judged by Gel-Phase 
NMR, but was pushed to completion after 2 days. The deprotection was incomplete 




(a) 5 eq 38, PPh3, DIAD, THF, 2 d; (b) 48 % KOH, THF, 60 °C, 7 h, then 2 M HCl 
Scheme 2.7 Synthesis of supported 2-hydroxy benzoic acid using Mitsunobu conditions 
Both routes were shown to be viable, however the route via the methyl ester 
protection was preferred as the deprotection step was less likely to cause problems 
and this route was used in all further resin functionalisations, where a methyl ester 
protection of the carboxylic acid was appropriate. 
2.3.2 	Synthesis of a solid-supported Ludwig-Eckstein reagent 
The literature presents two methods for preparing the reagent, thus it was important 
to investigate both methods for transposition to the solid phase. The adaptation to 
the support requires taking into account reactions that have longer reaction times 
on the resin, while on the other hand purification can be greatly simplified as 




swollen, the washing steps are thorough and the by-products are soluble in the 
solvent used for rinsing the resin. 
2.3.2.1 MethodA: refluxing PC13 
Method A: Refluxing Pd 3 with salicylic acid in a dry solvent for 15 h (Scheme 
2.3a). To adapt it to the resin, it was found that the easiest approach experimentally 
was to heat the resin in a syringe immersed in an oil bath. After formation of the 
reagent, the resin was rinsed with dry solvents using positive nitrogen pressure. 
a 
(a) 4 eq PC1 3, THE, 2 h, 60 °C 
Scheme 2.8 Formation of Ludwig-Eckstein reagent on the resin using method A 
The supported Ludwig-Eckstein reagent was formed successfully after reaction for 
2 h in dry THE with an excess of Pd 3 at 60 °C (Scheme 2.8). Resin 44 was 
characterised by ICP (phosphorus content) and combustion analysis (chlorine 
content). The reaction was performed at 2 different concentrations of phosphorus 
trichloride; at both levels, the conversion based on phosphorus was excellent (90 % 
from the starting Merrifield resin). The accuracy of the chlorine analysis was 
however less convincing, especially as a higher loading was obtained for a reduced 
concentration. (Table 2.1) 
Table 2.1 Combustion results for formation of reagent on resin 
Entry 	Time Cone. P P yield Cl Cl yield 
(h) (M) (%) (mmolg1) (%)a  (%) (mmolg') (%)a 
1 	2 0.8 3.45 1.11 90 1.72 0.485 40 
2 2 0.27 3.45 1.11 90 2.29 0.646 53 
a theoretical yield 1.23 mmolg' based on inanfacturer's loading of Merrifield resin 
To verify the microanalysis data, resin 44 was also characterised by 31 P Gel Phase 
NIVIR. CDC13 was used as a solvent to reduce hydrolysis expected from the use of 
d6-acetone. Gratifyingly, it showed the expected signal centered at 149 ppm (see 
Figure 2.2). A second signal at -2.5 ppm can be attributed to a hydrolysis product. 
Integration shows 82 % of the correct 'P species on the resin. The lower than 
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expected chlorine result was thus not reflected in the NIVIR data, suggesting 




Figure 2.2 31P Gel Phase NMR of resin 44 in CDC13 at 145 MHz 
Thus it could be concluded that, using method A, the solid-supported Ludwig-
Eckstein reagent could be successfully synthesised from Merrifield resin in tIiree 
steps in an overall 90 % yield, based on P loading. 
2.3.2.2 Method B: PC13 in pyridine at room temperature 
The, results using method A looked very promising, however refluxing with PC1 3 
may not be suitable for other resins; therefore an alternative method was also 
investigated. 
Method B in solution is performed by treating salicylic acid with pyridine at -10 
°C, followed by the addition of phosphorus trichioride. As cooling resins requires 
greater manipulation and, more crucially, makes dry conditions difficult to 




(a) 4 eq PC1 3 , 16 eq py, THF, rt, 0.8 M 




This method produces pyridinium hydrochloride as a by-product. (Scheme 2.9) It 
was found that it cannot be removed from the resin, as all solvents which would 
dissolve it (H20, MeOH, EtOH) would hydrolyse the acid chloride on the resin. 
While this causes problems with characterisation, the presence of pyridinium 
hydrochloride salt was hoped to be of no significance in the loading and cleavage 
reactions. The resin produced using method B was thus not characterised at this 
stage. 
The conditions required for complete substitution of the chlorine were evaluated 
using the attachment of a nucleoside, followed by nucleophilic attack of water for 
resins prepared via both methods (see sections 2.3.4 and 2.3.5). 
2.3.3 
	
Synthesis and characterisation of nucleoside loaded resin 
2.3.3.1 Synthesis of model nucleoside to assess the supported reagent 
Ludwig-Eckstein derived reagents were tested using a simple nucleoside. 
Thymidine 46 was chosen, since 2'-deoxy riboses are less susceptible to hydrolysis 
than riboses. 
The Ludwig-Eckstein reagent has been shown not to be selective for the primary 
5'-OH over the secondary 3'-011 , 83 thus thymidine 46 was protected by selective 
reaction on the primary 5'-OH group with DMT-Cl, followed by acetylation of the 
3'-OH group, with 3'-OAc-T 49 was obtained by acidic hydrolysis of the DMT 
group (Scheme 2.10). 
0 	 0 
N'ZO 	 N'ZO 
HO 	 HO 
a, b, c 
OH 	 OAc 
46 	 49 
(a) DMT-C1, pyridine, 2 h, 93 %; (b) Ac 20, DMAP, TEA, pyridine, 45 mm, 99 %; (c) 
MeOH:TFA 5:1, 1 h, 54 % 
Scheme 2.10 Synthesis of 3 '-OAc-T 49 
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2.3.3.2 Loading of the solid-supported Ludwig-Eckstein reagent 
The synthesis and characterisation of the resin was based on the supported reagent 
derived via Method A. To enable full loading of the nucleoside on the resin, 
supported reagent 44 was derivatised by displacement with 2 eq of 3'-OAc-T 49 at 
0.27 M in TI-IF (Scheme 2.11) to yield 50 (Table 2.2). 
0 
(a) 2 eq 3'-OAc-T 49, THF, 0.27 M, see table 
Scheme 2.11 Displacement of Ludwig-Eckstein reagent on the resin with 3 'OAc-T 
Usually, the nucleoside would have been dissolved in pyridine:TFIF (1:3), so that 
HC1 generated in the attachment is neutralised to form pyridinium hydrochloride. 
This was not suitable in this case, as its presence would have distorted the analysis. 
Table 2.2 Combustion results for displacement reaction 
Entry Time Cone. P 	P 	yield 
(mm) (M) (%) (mmolg1) (%)a 
1 	60 	0.27 2.67 	0.861 	91 
a theoretical yield for coupling 0.945 inmolg 
The nucleoside loaded resin was rinsed with THF and dried. ICP analysis of the 
phosphorus content indicated a loading 0.861 mmolg' (cf starting loading on 
Merrifield resin 1.75 mmolg'). Nucleoside derived resin 50 was also characterised 
by 31 P Gel-Phase NMR and showed the expected signal centered at 127 ppm and 
all reactive sites functionalised as judged by the absence of a signal at 148 ppm 
(see Figure 2.3). 
The observed signal was broad, as resin 50 is a diasteromeric mixture at 
phosphorus; the 31 P NIvIR signals have been reported at 127.6 ppm and 126.3 ppm 
respectively. 83 Integration of all 31 P NIvIR signals gives 82 % of nucleoside loading 
on the phosphonnone species. Peaks in the 7 to 11 ppm range can be attributed to 
hydrolysis products, affected by residual water present in CDC13. 
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It can therefore be concluded that the supported Ludwig-Eckstein reagent was 
successfully loaded with a deoxy-nucleoside. 
0 
0 	 o"IJ 
OAc 
150 	 50 
Figure 2.3 31P Gel Phase NMR of resin 50 in CDC13 at 145 MHz 
2.3.4 	Cleavage of nucleoside loaded resin 
Several ways were considered for following progress of the reactions on the resins 
and subsequent product analyses. 31 P NMR of cleaved product mixtures looked 
promising, however, while the signals are indicative of the phosphorus group, they 
have little dependence on an alkyl group attached to them, thus for example the 
difference in the 31 P NMR signal between a phosphonate salt and mono-H-
phosphonate 51 is about 1 ppm, which leads to inconclusive results. Therefore 
HPLC was found to be the best option, by comparing crude reaction mixtures to 
known standards. 
2.3.4.1 Cleavage using water 
Nucleophilic attack of water on the nucleoside loaded resin 50 should yield mono-
H-phosphonate 51 (Scheme 2.12). This was exploited to indirectly optimise 
formation of the Ludwig-Eckstein reagent on the resin and attachment of the 
nucleoside to it. Formation of mono-H-phosphonate 51 was monitored by RP-
HPLC on a C18 column eluting with a 0.1 M TEABIMeCN gradient (see 
experimental section for details). 
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Scheme 2.12 Hydrolysis of nucleoside loaded resin 50 to yield mono-H -phosphonate 
The immediate product of the cleavage reaction is thought to be the triphosphite 
monoester 52. As the P=0 double bond is thermodynamically more stable than the 
P-O single bond, the triphosphite taütomerises to the favoured tetrahedral H-
phosphonate form, which is the one that was isolated (Scheme 2.13). 
(a) H2O 
Scheme 2.13 Tauto,nerism of triphosphite rnonoester and mono-H -phosphonate ester 
2.3.4.2 Synthesis of mono-H -phosphonate 51 in solution phase 
To enable monitoring of the formation of mono-H-phosphonate 51, it was 
synthesised in solution using the method reported by Marugg et al. (Scheme 
2 . 14) . 123  Several methods were attempted for the purification of 51. Silica. 
chromatography eluting with a MeOWCH202 gradient has been reported for a 
protected guanosine analogue 130 and a DMT protected thymidine anaIogue
11 , 
however in this instance the increased hydrophilicity of 51, rendered elution 
impossible even with gradients up to 30:70 MeOH:CH 202 . Sephadex DEAE ion 
exchange chromatography was investigated as an alternative; at ionic strengths as 
low as 0.05 M TEAB neither salicylic acid, nor mono-H-phosphonate 51 could be 














(a) 1.5 eq 11, py/THF, 10 mm; (b) H20, 5 mm; 23 % 
Scheme 2.14 Solution phase preparation of the mono-H -phosphonate 51 
The mono-H-phosphonate 51 was purified eventually using Prep HPLC on an 
Xterra C18 column. Purification was found to be easier when changing the buffer 
from TEAB to NH4OAc, as separation from residual starting material 3'-OAc-T 49 
was greater. The product was isolated as its ammonium salt in good yield after 
excess buffer had been removed by lyophilisation. 
2.3.4.3 Cleavage using pyrophosphate 
Nucleoside resin 50 can be used in a more synthetically useful way and yield cyclic 
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(a) pyrophosphate ion 
Scheme 2.15 Cleavage with pyrophosphate of nucleoside resin 50 
2.3.4.4 Synthesis of cyclic triphosphite 53 in solution phase 
The compound was first synthesised in solution to obtain an HPLC standard to 
monitor cleavage of the compound from the resin and optimise that step. Cyclic 
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(a) 1.5 eq 11, py/THF, 10 mm; (b) 1.5 eq 0.5 M (Bu 3N)2 pyrophosphate in DMIF, 4 eq 
Bu3N, 30 mm; not isolated 
Scheme 2.16 Solution phase preparation of cyclic triphosphite 53 
31 NIvIR of the crude reaction mixture showed the characteristic signals 31 P NTvIIR 
signals of the triphosphite ring as reported by Ludwig and Eckstein 83 (105.7 (t), - 
19.1 (q), -19.3 (q)). However, subjecting the crude mixture to a CH 2Cl2/0.1M 
TEAB extraction gave the mono-H-phosphonate 51. 
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Scheme 2.17 Decomposition of cyclic triphosphite 53 to nzono-H-phosphonate 51 
It was thus postulated that the cyclic tnphosphite 53 is susceptible to nucleophilic 
attack by water which leads to disproportionation to the mono-H-phosphonate 51 
and pyrophosphate (Scheme 2.17). This can be rationalised as pyrophosphate is a 
good leaving group. This observation was corrobated by HPLC, as the 
chromatogram of the crude reaction mixture only showed mono-H-phosphonate 
and no additional peaks. 
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2.3.4.5 Synthesis of triphosphaze 54 in solution phase 
As it was not possible to monitor the direct cleavage product by I-IPLC, the next 
step was added before HPLC analysis. Thus, the cyclic triphosphite was oxidised 
with iodine in aqueous pyridine, followed by ring opening under aqueous 
conditions to yield 3'-OAc-dTTP 54 (Scheme 2.18). 3'-OAc-dTTP 54 was purified 
by Prep HPLC and isolated as its tetrakis [triethylammonium] salt after 
lyophilisation in 24 % overall yield. 
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(a) 1.5 eq 11. pyrl'HF, 10 mm; (b) 1.5 eq 0.5 M (Bu3N)2 pyrophosphate in DMF, 4 eq 
Bu 3N, 30 mm; (c) 1.5 eq 0.5 M 12 in 98:2 pyridine:H 20; (d) H20; 24 % yield 
Scheme 2.18 Solution phase preparation of 3 'OAc triphosphate 54 
2.3.4.6 HPLC traces of standards 
The HPLC traces of nucleoside derived compounds were monitored and recorded 
at 282 nm run using a gradient using 0 to 100 % MeCN in 0.1 M TEAB buffer over 
25 mm. HPLC traces for all standards run: 3'-OAc-T 49 (blue), mono-H-
phosphonate 51 (red) and 3'-OAc-dTTP 54 (green) (Figure 2.4). It is important to 
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2.3.5 	Optimisations for cleavage of nucleoside resin with water 
2.3.5.1 General 
Optimisation of a reaction on the resin requires a choice of washing routine which 
removes excess reagents and by-products, while leaving the resin functionalisation 
intact. It was, therefore important to use dry solvents throughout and filter the resin 
with positive nitrogen pressure to minimise premature hydrolysis from the 
salicylate linker. Optimisation reactions were carried out on 100 mg of resin and 3 
eq of resin were used relative to the nucleoside, with all reagents stored in a 
desicator over P205 prior to use. The resin was washed with dry solvents prior to 
starting the reaction sequence. 
2.3.5.2 Swelling and rinsing time of resin 
Initial studies on the rinsing of resin 44, after formation of the supported reagent, 
showed that too short a rinsing time caused side-products: 'H NIMIR of the 
nucleoside after attachement and hydrolysis indicated racemisation at the H-i' 
position. Acetyl deprotected nucleoside was also isolated from some reactions. 
Both problems were eliminated when supported reagent 44 was swollen twice for 5 
min in THF before loading the nucleoside. 
2.3.5.3 Attachment of nucleoside to supported reagent from method A 
For the preparation of the Gel Phase NMR samples of nucleoside resin 50 (2.3.3.2), 
the nucleoside was used in excess. This will however not be desirable in future, as 
the resin is more expendable. Furthermore the phosphorinone species formed on 
the resin after chloride displacement is a powerful electrophile able to react with an 
excess of alcohol. In the initial tests, the solvent volume used to swell the resin was 
maintained and nucleoside was added in the desired amount. However it soon 
became apparent that with a lowered concentration, reactions were not going to 
completion. It was necessary to dry the resin after formation of the supported 
reagent by flushing with nitrogen prior to adding the nucleoside solution, to reach a 
high enough concentration. The nucleoside was fully loaded when used at 0.1 M 





Table 2.3 Reaction conditions used for method A 
Reaction 	 eq Conc. Time Temp. Outcome 
(M) 	(h) 	( ° C) 
Formation of reagent 	4 	0.27 2 60 	- 
Loading of Y-OAc-T 0.33 0.10 	1 	rt complete 
2.3.5.4 Attachment of nucleoside to supported reagent from method B 
The same reaction conditions as for the loading step were applied. Completion of 
the reaction was again judged by absence of starting material 3'-OAc-T 49 in the 
drained solution. The loading of the nucleoside did not now go to completion 
(Table 2.4). The reactions were more sluggish, which was probably due to 
pyridinium hydrochloride impeding the diffusion into and out of the polymer gel. It 
was decided at this point to pursue method A to form the supported reagent on the 
resin. 
Table 2.4 Reaction conditions used for method B 
Entry 	Reaction eq Cone. Time Temp. 	Outcome 
(M) (h) (°C) 
1 	Formation of reagent 4 0.27 0.25 rt 	- 
Loading of 3'-OAc-T 0.33 0.10 1 rt incomplete 
2 	Formation of reagent 4 0.27 2 rt 	- 
Loading of 3'-OAc-T 0.33 0.10 1 rt incomplete 
2.3.5.5 Isolation of products 
As the supported reagent could be loaded successfully, the reaction conditions were 
scaled up and performed on enough resin to load 0.1 mmol of nucleoside. The 
purity of the cleaved mixture was excellent and the only nucleoside based impurity 
present was some remaining starting material (Figure 2.5). 
mono-H-phosphonate 
3'-OAc-T 
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Mono-H-phosphonate 51 was isolated by Prep IIPLC (eluting with 0.1 M 
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(a) 3 eq Ps -P-Cl 44, py/THF 1/3, rt, 1 h, 0.10 M; (b) THF:H2O 1:1,2 x 5 mm; 58% yield 
Scheme 2.19 Synthesis of mono -H-phosphonate 51 using supported reagent 
2.3.5.6 Summary 
At this point, it can be concluded that the supported reagent was prepared and used 
successfully to load a nucleoside with subsequent cleavage as its mono -H-
phosphonate 51. The reaction conditions developed for loading of the nucleoside 
are summarized below (Table 2.5). 
Table 2.5 Reaction conditions developed 
Reaction - 	 eq Conc. Time Temp. 
M 	h 	Oc 
Formation of reagent (A) 4 	0.27 2 60 
Loading of 3'-OAc-T 	0.33 0.10 	1 	rt 
Hydrolysis 	 - 	 - 	 0.17 rt 
2.3.6 	Optimisations for cleavage of nucleoside resin with pyrophosphate 
2.3.6.1 General 
Using the reaction conditions established to synthesise and load the supported 
reagent, it was next attempted to perform the cleavage with pyrophosphate to 
obtain the protected tnphosphate after oxidation. 
It became very soon all too apparent that the success of this chemistry hinges on 
the quality and dryness of all reagents utilised. The phosphorinone on resin 50 is in 
fact a very powerful electrophile which will readily react with any nucleophile 
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present. To minimise side-reactions, the reagents used had to be purified 
painstakingly as discussed below. 
2.3.6.2 Tributylamine 
Tributylamine is used as a base during the pyrophosphorylation to dissolve salts 
formed during the two previous steps. Samples of even the purest grade available 
were positive by Ninhydrin test, indicating presence of primary amines. These 
could be removed by storing over ninhydrin, followed by vacuum distillation. The 
purified amine was stored in the dark over 4 A MS at rt and was still dry and free 
of primary amines after 6 months. 
2.3.6.3 Preparation of pyrophosphate salt 
A pyrophosphate salt with 1.6 mol of tnbutylamine per mol of pyrophosphate is 
available commercially (Sigma). Its 31 P NMR indicated however that it is contains 
only about 75 % pyrophosphate, the remainder being a phosphate, which yielded 
close-running impurities (Figure 2.6). The mono-H-phosphonate peak results from 




Figure 2.6 HPLC of crude reaction mixture when using commercial pyrophosphate salt 
Bis (tributylammonium) pyrophosphate was therefore prepared by adapting the 
method by Ludwig and Eckstein. 83 The pyrophosphate salt was eluted off an ion 
exchange column to give pyrophosphoric acid, which was treated with 
tributylamine and lyophilised until the oily residue turned into a white powder. It 
was then dissolved in dry DMF and transferred by canula onto cooled molecular 
sieves which had been activated by microwave irradiation. This preparation 
contained typically >95 % of pyrophosphate, as judged by 31 P NMR. This 





IS 	 tO 	 5 	 0 	 -5 	 -tO 	 -15 
Figure 2.7 31P NMRs of (a) commercial and (b) in-house prepared bis (rribuiylammonium) 
pyrophosphate 
2.3.6.4 Reaction conditions for pyrophosphaze attack 
Reaction conditions were used as described earlier (Table 2.5). For the 
pyrophosphate cleavage, the reagents were prepared as for the solution phase 
method and added onto the nitrogen flushed resin, giving a concentration of 0.37 M 
for the pyrophosphate ion. 
Table 2.6 Reaction conditions used for pyrophosphate attack 
Reaction name eq Cone. Time Temp. 
(M) (h) ( ° C) 
Formation of reagent 4 0.27 2 60 
Loading of 3'-OAc-T 0.33 0.10 1 rt 
Pyrophosphate cleavage 1.5 0.37 see text rt 
Oxidation 1.5 0.37 0.50 rt 
Hydrolysis - - 0.25 rt 
Cleavage of the resin with pyrophosphate was performed for 30 mm, 1 h and 2 h. 
The ratio of triphosphate to mono-H-phosphonate looked most favourable for 
triphosphate formation after 30 min cleavage time. This judgement was made due 
to the presence of mono-H-phosphonate 51 when the resin was treated with water 
after the pyrophosphate cleavage had finished. The necessity for short cleavage 
times can be rationalised by the fact that the labile cyclic triphosphite decomposes 
to the mono-H-phosphonate during prolonged reaction times. It was therefore 
desirable to minimise cleavage times to maximise the yield. 
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2.3.6.5 Isolation of product 
The synthesis was scaled up to 0.10 mmol nucleoside. It was realised when 
performing the cleavage reaction that it was more efficient to subject the resin to 
three x 10 minute cleavages rather than one 30 minute cleavage. The triphosphate 
was synthesised (Scheme 2.20) and isolated after CH2C12/0.1 M TEAB work-up 
and Prep HPLC. The work-up was found to be essential; otherwise the sample 
needed to be dissolved in too much MeCN, which resulted in column-
breakthrough. Ac-dTTP 54 was obtained as its tetrakis riethylammonium] salt 
after lyophilisation in a 14 % yield. This yield was acceptable, though lower than 













(a) 3 eq ps-P-cl 44, py/TFIF 1/3, ii, 1 h. 0.10 M; (b) 1.5 eq 0.5 M (Bu 3 N) 2 pyrophosphate 
in DMF, 4 eq Bu 3N, ii, 3 x 10 mint (c) 1.5 eq 0.5 M 1 2/98:2 pyridine:H 20. 15 mm; (d) H20, 
30 mm; 14 % yield 
Scheme 2.20 Synthesis  of 3 '-OAc-d77'P 54 using supported reagent 
01 
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Figure 2.8 HPLC chromatogram of crude 3'OAc-dTTP 54 
2.3.6.6 Synthesis  of dTP 55 after deprotection 
The final step of the synthesis, the acetyl deprotection, was then added onto the 
synthetic sequence (Scheme 2.21). The crude HPLC indicated dTTP 55 to be of 
acceptable purity (Figure 2.9). Close-running impurities were readily separated by 
Prep HPLC (Figure 2.10) and dTFP 55 was isolated in a 50 % overall yield from 
3'OAc-T 49. 
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The difference in yields sems to suggest that the triphosphate is easier isolated in 
its unprotected form, maybe due to solubility difficulties. It could also be that the 
acetate protecting group on the 3' hydroxyl group is not stable to the synthesis or 
the I-IPLC purification conditions, which is performed at pH 8-9 buffer and thus 
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(a) 3 eq PS-P-Cl 44, py/THF 1/3, rt, 1 h, 0.10 M; (b) 1.5 eq 0.5 M (Bu3N) 2 pyrophosphate 
in DMF, 4 eq 1311 3N, 11, 3 x 10 mm; (c) 1.5 eq 0.5 M 12/98:2 pyridine:H 20, 15 mm; (d) H20, 
30 mm; (e) NHIH20, 1 h; 50 % yield 
Scheme 2.21 Synthesis of dlTP 55 using the supported reagent on Gel PS 
Figure 2.9 Analytical HPLC chromatogram of crude dTTP 55 
rrLAU 
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Figure 2.10 Prep HPLC chromatogram of d17'P 55 
2.3.6.7 Comparison to solution phase synthesis 
It was of course important to evaluate how this new method compared to the 
established procedure. The compounds were again isolated using a work-up, 
followed by Prep HPLC. The synthesis for 3'-OAc-dTTP 54 gave a 24 % yield 
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(Scheme 2.18), whereas for dTTP 55, a yield of 36 % was obtained after 
anmionolysis of the acetate group. These yields show that isolation of the fully 
deprotected dTTP 55 compares favourably to the solution phase procedure. 
2.3.7 	Conclusion 
Microporous polystyrene was used successfully as a support for the Ludwig-
Eckstein reagent. It was used to synthesise thymidine triphosphate 55 as its tetrakis 
[triethylammonium] salt in a 50 % yield from its 3'-O-acetyl protected analogue. 
This yield compares favourably to the solution phase methodology, where in our 
hands a yield of 36 % could be obtained using Prep HPLC as isolation method. 
To understand the factors involved in determining the yield obtained with PS resin, 
other resins were studied. In the next few sections, the synthesis and application of 
such resins to the supported reagent will be discussed. The same reaction 
conditions used for all resin types to allow direct comparison. Results and yields 
obtained for all resins are summarised and rationalised in Section 2.7. 
2.4 	Attachment of the linker to macroporous PS 
Macroporous polystyrene typically has a DVB crosslinking of 20-30 % resulting in 
a non-swellable resin, thus making the chemistry more accessible in hydrophilic 
solvents as the sites remain available. In the context of the pyrophosphate cleavage, 





(a) 3 eq 35, acetone, K2CO3,  KI, 60 °C, 90 h; (b) TBA-OH, THF, 60°C, 2 d, then 2 M HC1 




The resin (20 % DVB cross-linking, 150-350 itm, 2.0 mmolg 1 ) was functionalised 
with the same method as for the microporous resin (Scheme 2.22). Monitoring by 
Gel-Phase NIVIR was not possible here as the resin does not solvate and therefore it 
is not possible to record any spectra. Instead, couplings were monitored by 
elemental analysis of remaining halogen content. 
As expected, couplings to macroporous resin were sluggish compared to 
microporous resin. After 24 h, a 43 % conversion was obtained which could 
pushed up to 76 % by reacting for a total of 90 h. (Table 2.7) 
The methyl ester was deprotected using the method established previously, giving a 
macroporous resin 57 with a loading of 0.93 nmiolg'. 
Table 2.7 Monitoring of Finkeistein coupling on macroporous PS 
t (h) Cl Cl Cl Cl I I loading loading 
%b mmolg' %d minolg' %b mrnolg 1 mmolg1 %f 
0 8.04 2.27 7.09 2.0' 
24 3.61 1.02 2.66 0 . 75e 1.88 0.15 0.68 43 
90 1.99 0.56 1.04 0 . 29e 1.15 0.09 1.20 76 
aavailable  loading (value supplied by manufacturer), 'measured by elemental analysis, 
ctotal Cl loading, dloading  available for substitution (obtained by subtracting residual Cl 
(0.27 mmolg' or 0.95 %)from experimental value), eCl  loading available for substitution, 
theoretical yield 1.58 mmolg' based on loading available for substitution 
2.5 	Attachment of the linker to Quadragel and Quadrapore 
Quadragel and Quadrapore resins have a polystyrene core which has been 
functionalized with a tetraethyleneglycol unit. This is claimed to impart advantages 
to the resin over polystyrene, such as compatibility with polar and non-polar 
solvents, better accessibility of sites leading to purer peptides and 
oligonucleotides.' 32 Quadragel is a gel polymer with a low-crosslinking of 1 % 
DYB, whereas Quadrapore has a cross-linking of 33 %. 
The hydroxyl functionalised resins were coupled to the methyl ester protected 
salicylate linker 35 under Mitsunobu conditions, as previously used for 
microporous PS (Sëheme 2.23). The resins were checked for completion using 















(a) 4 eq 35, PPh3 , DIAD, THF, 12 h; (b) TBA-OH, THF, 65 °C, 2 d 
Scheme 2.23 Attachment of linker onto Quadragel & Quadrapore resins 
The identity of the resin was checked by Gel-Phase 1 3  C NMR. High-quality spectra 
could be obtained for Quadragel. It compared favourably to polystyrene, as the 
added tetraethylene glycol linker makes the functionality much more flexible, thus 
easier to visualise by NMR. (Figure 2.11) 
0 
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Figure 2.11 13C Gel Phase NMR of Quadragel resin 58a 
The deprotection conditions were used as previously described for the PS resins. 
The completion of the reaction was verified by 1 3  C Gel-Phase NMR. The methyl 
ester signal which is visible at 50 ppm (Figure 2.11), was not present (Figure 2.12). 
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Figure 2.12 13C Gel Phase NMR of Quadragel resin 59a 
For the macroporous analogue, Quadrapore, it was not possible to perform Gel-
Phase NMR, despite the tetrathylene glycol linker. The Mitsunobu coupling was 
monitored by the DMT test and the deprotection was performed as for Quadragel. 
Attachment of the linker to silica based resin 
Development of salicylate linker for silica 
CPG is formed of a Si-O network and is typically surface-functionalised with short 
carbon chains and an amine, such as propylamine. The protection group strategy 
for the carboxylic acid on the salicylic acid had to be reconsidered, as aqueous base 
is not suitable; under these conditions all functionalisation will be cleaved off the 
resin and the resin eventually dissolved. 
2.6.1.1 Screening for non-basic deprotection conditions of methyl 2,4-dihydroxy benzoate 
In the first instance, an attempt was made to find alternative deprotection 
conditions for methyl ester 35 (Scheme 2.24). A well published alternative to basic 
conditions is nucleophilic attack of on iodide ion on the methyl group to give Mel 














Various conditions were attempted, but none of them were satisfactory for on-resin 
deprotection (Table 2.8). The most promising set of conditions involved in situ 
generation of TMS-I via formation of the TMS ester, which is readily hydrolysed 
to the carboxylic acid. The model reaction is not identical, but the adjacent phenol 
was an identical mimic to that observed in the real compound. The methyl ester 
was abandoned as a protecting group for CPG, as the cleavage was deemed to be 
poor on CPG. 
Table 2.8 Attempted conditions for deprotection 
Conditions temp time product impurity SM Ref 
3 eq Lii, EtOAc, 0.2 M 65 15 h 29 - 71 135 
3 eq LiT, EtOAc, 0.2 M 65 3 d 30 19 51 135 
3 eq Ca12, Toluene, 0.3 M 95 18 h - - 100 136 
TMS-Cl, Nal, MeCN 65 15 h 55 15 30 137 
TMS-Cl, LiT, MeCN 65 24 h 4 1 95 
3 eq KO tBu, DMSO, 0.3 M rt 18 h 6 46 48 138 
LiOH, THF:MeOH, 20:1, 0.2 M rt 15 h - - 100 
Pig liver esterase, PBS buffer 35 	- 3 h - - 100 139 
a  Conversions by HPLC peak area in UV at 254 nm 
2.6.1.2 Synthesis of allyl 2,4-dihydroxy benzoic acid 
It was then decided to synthesise the allyl ester, which is readily cleaved under 
neutral conditions with Pd (0) activating it to nucleophilic attack. Typical species 
used for intercepting the Pd-allyl complex are carbon nucleophiles, amines, thiols, 
carboxylates and hydride donors. 
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Scheme 2.25 Protection as allyl ester 
Allyl esters can be accessed via esterification of the corresponding carboxylic acid 
(route A) or via trans-esterification of an existing ester (route B) (Scheme 2.25). 
Both approaches were considered. Synthesis of allyl ester was attempted via acid-
catalysed esterification under Dean-Stark conditions (Table 2.9). Using toluene as 
the solvent resulted in a charred mixture, due to the temperature required for reflux 
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(Entry 1). Using benzene, that problem was solved, but isolated yields were low 
and the product obtained was of less than optimal purity (Entry 2). Longer reaction 
times (6 days), while increasing the overall yield, also increased the amount of co-
purifying impurities. 
Table 2.9 Conditions for allyl ester synthesis 
Entry Conditions temp. time product SM Ref 
°C % 	% 
1 A 	2 eq allyl alcohol, 10 % p- 130 3 d charred 
TsOH, Dean-Stark, PhMe 
2 A 	3 eq allyl alcohol, 10 % p- 115 3 d 13a 	
140 
TsOH, Dean-Stark, PhH, 0.6 M 
3 B 	10 % (Bu2Sn)O, 100 eq A11OH 95 24 h 10" 	90b 	141 
4 A 	0.95 eq Proton sponge, 1.5 eq 70 1 h 78' 
allyl bromide, DMF, 0.45 M 
a  Isolated yield, vConversions  by HPLC peak area in UV at 254 nm 
A dibutyltinoxide mediated transesterification gave only a low conversion over 24 
h, even though for salicylic acid quantitative conversion had been reported within 5 
h (Entry 3). The most suitable method developed used proton sponge which 
deprotonated the carboxylic acid and resulted in alkylation in good yield and 
product isolation in excellent purity after work-up (Entry 4). 
2.6.2 	Synthesis of an allyl ester based linker and coupling to aminoproppyl-CPG 
Allyl ester 60 was alkylated on the para-phenol position after deprotonation with 
sodium hydride with tbutyl  bromoacetate to give the alkylated product 61 in good 
yield. Selective deprotection was performed with TFA in CH202 to yield the linker 







62 60 61 
(a) tbutyl bromoacetate, 1 eq NaH, DMF, 1 h, 64 %; (b) 30 % TFA in CH2C12, 2.5 eq 
Et3SiH, 45 mm, 68 % 
Scheme 2.26 Synthesis of carboxylic acid flinctionalised salicylic acid derivative 
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CPG used was of 50-100 jim diameter with 46 nm pore size, as supplied by 
Trisoperl. Functionalisation of the aminopropyl CPG is known to be sluggish, 























(a) 10 eq linker 62, DICJHOBt, DCMJDMIF 4/1, 60 °C, 3.5 h; (b) 1 % [Pd(PPh 3)4], 1.5 eq 
morpholine, THF, 1 h; (c) 10 eq Fmoc-Ahx-OH, DICIHOBt, DCM/DMF 4/1, 60 °C, 24 h; 
(d) 20 % piperidine/DMF 
Scheme 2.27 Synthesis of CPG based 2-hydroxy benzoic acids 
Progression of reaction was monitored by a qualitative ninhydrin test. Moreover, to 
reduce surface interactions between the resin and the functionality, an additional 
linker, 6-amino-hexanoic acid, was coupled to the glass surface prior to adding the 
salicylate linker. Using this strategy, two supports 64 and 67 were obtained after 
allyl ester deprotection for testing. 
2.6.3 	. Synthesis of the solid-supported reagent on CPG 
As monitoring of the allyl ester deprotection was not possible, the two supports 64 
and 67 were immediately tested to see whether they could form the supported 




(PC13/pyridine in THF at rt), as refluxing PC13 was not deemed suitable for the 
CPG construct which contained amide bonds. 
The reagent was formed on the resin using method B and quenched with D 20. This 
would enable assement of whether the reagent had been formed on the resin, as a 
P-D coupling would be observed for the phosphonate salt formed (Scheme 2.28). 
For resin 64 no P-D phosphonate salt was formed. To verify whether this 
observation was due to absence of the reagent on the resin or steric surface 
interactions, it was repeated for resin 67. Again no P-D couplings were observed. 
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(a) 16 eq pyridine, 4 eq PC1 3 , THF, 10 mm, 0.27 M; (b) D20 
Scheme 2.28 Displacement of Ludwig-Eckstein reagent on the resin with D 20 
The microporous PS based reagent 44 was readily quenched and drained to yield a 
phosphonate salt with P-D coupling as judged by 31 P NMR. As this however was 
not possible for either of the CPG supports, it was decided at this point not to 
pursue CPG further. 
A few reasons for the lack of success in the use of CPG can be cited: 
. The method for preparing the reagent involves production of pyridinium 
hydrochloride, which might have lead to blocking of the pores. 
• The success of the aiiyi ester deprotection reaction could not be verified, i.e. 
the nucleophiie might not have been suitable, as it is a base. 
• The amide bonds in the resin construct could have undergone Viismeier-
Haack type reactions with the PC13. 
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2.6.4 	Attachment of the linker to high-loading silica 
As attempts on commercial aminopropyl-functionalised CPG were unsuccessful, 
attention was focused onto silica supports. Functionalised silica was obtained with 
a diameter of 40-63 /.tm with typical loadings of 1.4 mmolg 1 from Silicycle. 
Two silica supports were selected for coupling to the salicylate linker by forming 
phenol ether bonds. The methods used previously for PS resin (K 2CO3/acetone) 
were not suitable for silica, as the base was expected to cause undesired side 
reactions by dissolving the silica. The first resin was functionalised with propyl 
bromide and was loaded with allyl ester protected linker 60 in the presence of 
DIPEA (Scheme 2.29). The yield, determined by residual bromine elemental 
analysis, was 0.29 mmolg 1 , which equates to a 25 % loading. (Table 2.10) 
0 
(~~3Br 	 a 	J3 0 &0H 
68 
(a) 5 eq 60, DIPEA, 40 °C, 34 h, THF, 0.9 M 
Scheme 2.29 Functionalisation of bromo-propyl -silica with allyl ester protected linker 
Table 2.10 Monitoring of silica functionalisation by elemental analysis 
Time 	Br 	Br loading loading 
(%) 	(mmolg1) (%)C (mmolg1) 
SM 	 1.43a 
SM 8.61 	108b 
lOh 	8.04 1.01 18 0.23 
34 h 7.03 	0.88 29 0.35 
a Value supplied by manufacturer, bderived  by elemental analysis, ctheoretical  yield for 
coupling 1.23 mmolg' 
The starting material was also tested for bromine content and there was in fact a 
considerable underloading on the stated value, thus the yields and loadings are 
based on that determined experimental value. The second resin chosen contained a 
benzyl chloride group and was functionalised with the preformed sodium phenolate 









(a) 5 eq 60, 5 eq NaH, 50 °C, 48 h, THF, 0.9 M 
Scheme 2.30 Functionalisation of silica with allyl ester protected linker 
Table 2.11 Monitoring ofsilicafunctionalisation by elemental analysis 
Time 	Cl 	Cl loading loading 
(%) 	(mmolg') 
(%)C (mmolg1) 
SM 	 1.34a 
SM 3.64 	1 .03'  
24 h 	2.48 0.70 37 0.41 
48 h 1.98 	0.56 50 0.55 
a Value supplied by manufacturer, b  derived by elemental analysis, 
C  theoretical yield for 
coupling 1.11 mmolg' 
2.6.4.1 Screening for deprotection conditions of allyl ester in solution 
The deprotection conditions were modelled in solution by deprotection of a 
benzylated analogue of the allyl ester, analogous to resin 69. The resin mimic 70 
was obtained from 60 under Finkeistein conditions in a 69 % yield. The palladium 
source chosen was palladium triphenyiphosphine tetrakis complex, as this is 
soluble in organic solvents, while other sources such as Pd(OAc)2 are not. 
0 	 0 
OH 
a 
OH 	 OH . 
70 
(a) 5 % [Pd(PPh 3)4], 0.14 M, 1.5 eq nucleophile 
Scheme 2.31 Deprotection of solution model of the allyl ester 
The reactions were run in parallel with different nucleophiles and monitored by 
HPLC after 15 and 45 minutes. The products were isolated through a work-up for 
the reactions that had gone to completion. The purity of the crude product was 




Table 2.12 Deprotection conditions for allyl ester 
Nucleophile solvent Conversion Yield Purity 	Ref 
(NMR) 
Pyrrolidine THF 91 - 
Morpholine THF 100 51 no product 	143 
Dimedone THF 100 6 moderate 
Barbituric acid THF 100 52 good 
Phenyl silane THF 100 96 good 	. 	 144 
p-toluene sulfinic acid, TF1F/ 100 73 good 145 
sodium salt MeOH 
aHpLC conversions by peak area in ELSD after 45 mm, "Isolated yield after work-up 
Good yields and purity of the isolated product were obtained for phenylsilane and 
the sodium salt of p-toluenesulfinic acid. 
In light of unsuccessful attempts to use an aminopropyl-CPG as a support (Section 
2.6.3), it is interesting to note that when morpholine was used as the nucleophile, 
the correct product was not isolated. 
2.6.4.2 Deprotection of resins 
Out of the two possible scavengers, it was decided to use phenylsilane for the on-
resin deprotection of the supported allyl esters, as this reagent generates the silyl 
ester in situ, which is then readily cleaved with water. The resins were obtained 




OH 	 J'O 'OH 
= 	 or 
71 	 g :r72 ' 
(a) 5 % Pd(PPh 3)4, 5 eq PhSiH3 , THF; H20 
Scheme 2.32 Allyl ester deprotection of silica resins 
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2.7 	Comparison of resins 
2.7.1 	Yields using solid-supported Ludwig-Eckstein reagent 
The new supports were tested using the reaction conditions in Section 2.3.6.5, as 
developed for microporous polystyrene. The test compound remained dTTP 55. 
The results obtained for all the isolated dTTP products from the syntheses are 
summarized below (Table 2.13). 
Table 2.13 Summaiy of syntheses of dITP using different resins 
Resin 	 Type loading Yield Bead size 
- 	mmolg' %a 
41a Microporous PS gel 1.34 50 75-150 
57 Macroporous PS rigid 0.93 15 150-350 
59a Quadragel gel 0.75 19 150-300 
59b Quadrapore rigid 0.65 26 150-300 
71 Silica rigid 0.35 8 40-63 
72 Silica rigid 0.56 4 40-63 
alsolated yield after Prep HPLC purification 
Macroporous PS based reagent 57 was readily amenable to the synthetic sequence. 
No problems were observed during the synthesis and a yield of 15 % could be 
obtained after purification. 
The Quadragel based reagent 59a exihibited different swelling properties than 
microporous PS; an increased swelling of the resin was observed in THF, which 
would be expected to facilitate reactions. For Quadrapore 59b no swelling was 
observed, as is usual for a macroporous resin. The yields were 19 % and 26 % 
respectively, which might indicate that the macroporous nature of it could impart 
advantages over the gel type resin for this transformation. 
The silica based materials 71 and 72 on the hand gave even lower yields. It is likely 
that this is due to steric interactions with the resin surface. This means that either 
more forcing condtions are necessary for the loading and cleavage reactions to 
proceed or that the reagent needs to be distanced further from the support to enable 
a more solution phase like synthesis. This could be achieved by coupling a 
polyethylene glycol linker to the resin prior to coupling the salicylate linker. 
The results show that microporous polystyrene as a support for the Ludwig- 





almost surprising that the synthesis works this well, considering that the key step, 
the pyrophosphate cleavage, relies on a charged species interacting favourably with 
the highly hydrophobic polystyrene support. Intuitively this combination would be 
expected to give less favourable results than macroporous resins or polyethylene 
glygol grafted resins. 
One clue towards explaining the observations comes from considering the bead 
size for the polystyrene based resins. The batch of microporous polystyrene was 
100-200 mesh, i.e. a bead diameter of 75-150 tm, whereas the other resins had 
much higher size specifications, more poignantly illustrated below (Figure 2.13). 
60 
50 
40 	 •microPS 
macro PS 
v30 
x 	 quadragel 
> 20 	 x quadrapore 
10 
0 
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average bead size (urn) 
Figure 2.13 Gorrolation between yield and average bead size 
For the polystyrene based resins, leaving aside all other factors momentarily, a 
correlation seems to exist between bead size and yield. Of course, this statement 
must be made only very catiously, as there are indeed many other factors 
differentiating the resins, such as nature of support, level of crosslinking, loading 
and presence or absence of a PEG linker. 
Thus it can be summarized at this point that no firm conclusions can be drawn 
across the different types of resins. If a direct comparison between resins is sought, 








2.7.2 	Synthesis and evaluation of further microporous polystyrene resins 
As the bead size seemed to be one factor impacting on the triphosphate yield 
obtained, a more complete series of supported reagents was synthesised for 
mcroporous polystyrene resin. These resins were chosen, as additi9nal particle 
sizes were available commercially and, while the yield was already good, there was 
scope for further improvement with a smaller bead size. 
The synthetic scheme was followed as developed earlier (Scheme 2.33) and the 
resins were used as supported reagents for dTTP synthesis as described in Section 
2.3.6.5. The yields obtained are tabulated below (Table 2.14). 
(a) 3 eq 35, acetone, K2CO3, KI, 60 °C, 2 d; (b) TBAOH, THF, 60°C, 2 d, then 2 M HC1 
Scheme 2.33 Synthesis of microporous resins 
When the reactions using the resin 75 with 38-75 jim bead size were carried out, it 
was noticed that this resin was blocking the frist and more diffcult to handle than 
the previously used 75-150 jim bead size, as the pressure required to drain the 
vessel increased considerably. This is not unexpected and has been reported.' °8 The 
yield obtained was also considerably lower than for the 75-150 jim beads, due to 
difficult washing and the prolonged handling required. 
Table 2.14 Summary of syntheses of dITP using dfferent microporous PS resins 
Bead size Resin Type loading Average Yield 
(sm) (mmol g') (%) 
75 	38-75 Microporous PS gel 1.05 13 
41a. 	75-150 Microporous PS gel 1.34 50 
76 150-300 Microporous PS gel 1.42 20 
For the bigger bead size resin 76, no handling issues were observed and the 
reactions proceeded smoothly. The yield obtained for dTTP 55 synthesis was 20 % 
after lyophilisation, which is a reduction on the yield observed previously. Thus it 








Comparison between similar bead sizes 
For all four resins in the -150-300 .tm region, it is apparent that the yields obtained 




 ,JI j 
Figure 2.14 Yield for resins in the 150-300 pm bead size range 
2.8 	Conclusion 
In summary, a supported phosphorylation reagent has been synthesised and its 
application to triphosphate synthesis has been developed and optimized using 
thymidine triphosphate. A range of different resins were functionalized and 
employed as a basis for the support. 
The bead size was found to an important factor that governed the yields obtained, 
presumably due to the fact that cleavage times had to be short and the intermediate 
formed is labile. Microporous polystyrene of 75-150 p.m gave a 50 % yield after 
HPLC purification for the trial compound and desalting and ion exchange 
chromatography was not necessary. 
The reaction conditions developed are tabulated below (Table 2.15). The scope of 
the reagent will be described in the next chapters with a view to accessing other 
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triphosphates, labeled triphosphate nucleosides and other phosphorylated 
nucleosides. 
Table 2.15 Reaction conditions 
Reaction name eq Cone. Time Temp. 
(M) (mm) (°C) 
Loading of nucleoside 0.33 0.10 60 rt 
Pyrophosphate cleavage 1.5 0.37 3 x 10 ii 
Oxidation 1.5 0.37 15 rt 
Hydrolysis - - 30 rt 




Application to triphosphate synthesis 
3.1 
	




The use of the supported phosphorylation reagent was extended to the synthesis of 
the other three DNA nucleosides. The Ludwig-Eckstein procedure established the 
need for protection of the 3' hydroxyl group, whereas protection of the exocyclic 
amino groups was reported not to be necessary. 83 Since removal of the base 
protection groups (Bz and 'Bu) can be performed in the same step as the acetate 




















Figure 3.1 Protected DNA nucleosides 
3.1.2 	Phosphorylation reactions 
The phosphorylation conditions developed in Chapter 2 were used to phosphorylate 
the other DNA nucleosides (Table 2.15). 
Table 3.1 Reaction conditions used for triphosphate synthesis 
Reaction name eq Conc. Time Temp. 
(M) (mm) (°C) 
Loading of nucleoside 0.33 0.10 60 rt 
Pyrophosphate cleavage 1.5 0.37 3 x 10 rt 
Oxidation 1.5 0.37 15 rt 
Hydrolysis - - 30 rt 







Cytdine nucleoside 77 was stored over P205 in a desicator for a week prior to use. 
The phosphorylation conditions were used as detailed in Table 2.15 and the 
intermediates were not characterised in this instance. 
It was found that nucleoside 77 was not fully soluble in 1/3 pyridine/THF at the 
desired 0.1 M concentration, thus the solvent for the loading step was modified to 
include dry DMF in a ratio of 1/1/2 DMF/pyrdine/THF. This is in line with Ludwig 
and Eckstein, who also added DMF to solubilise cytidine. 83 The pyrophosphate 
cleavage, oxidation and hydrolysis steps proceeded smoothly (Scheme 3.1). 
NHBz 	 NH2 
LNO 	 LNO 
HO, see Table 3.1 
I 	 I
0, 11 '0' 11 .'0' 11 '0"'~j 
	
OAc 	 OH 
77 .4TEAH 	 80 
Scheme 3.1 Synthesis of cytidine triphosphate using PS-P-cl 44 
The final deprotection step required to deprotect the 3' acetate as well as a benzoyl 
group on the base. It was found that a one hour of treatment with concentrated 
aqueous ammonia was sufficient to effect full deprotection to yield the free 
cytidine triphosphate. After an aqueous wash, the crude triphosphate was purified 
by Prep HPLC. Inspection of the HPLC chromatogram of the resultant compound 
(Figure 3.2) shows that it had excellent purity. The yield obtained after several 
lyophilisation steps was however too elevated and 'H NtVIR confirmed presence of 
further triethylammonium salts. 
I 
0 2.5 5 7.5 10 12.5 
I 
15 17.5 20 22.5 rranj  
Figure 3.2 HPLC chromatogram of dCTP 80 after Prep HPLCpurfication 
Chapter 3 	 84 
The 1 11 NMR showed that the ratio of counterion to nucleoside peaks was too high, 
thus it seemed reasonable to conclude that salts present in the crude mixture were 
not completely removed by Prep HPLC. This is possible as, under the HPLC 
purification conditions used the crude cytidine triphosphate eluted quickly at Ca. 3 
mm, thus separation from salts must have been insufficient. A second Prep HPLC 
purification was thus performed and since the bulk of the impurities had already 
been removed, the retention time now slowed to 6.3 min under the same elution 
conditions and cytidine triphosphate 80 could be isolated in a 12 % yield as its 
tetrakis triethylammonium salt after two Prep HPLC purifications. 
This yield is lower than would have been hoped for considering the thymidine 
triphosphate yield. The lowered yield can be attributed to be fact that two Prep 
HPLC purifications had to be performed, and as mass recovery on a Prep HPLC 
system is not perfect, this contributed to lowering the yield. 
3.1.4 	dGTP 
Guanidine nucleoside 78 was readily soluble in py/THF and after drying over P 205 
in a desicator was phosphorylated as detailed in Table 3.1. The following steps also 
proceeded as expected, but the final deprotection step was found to require longer 
time. The reaction was stined for 15 h before evaporating and was then purified 
using Prep HPLC. 
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Scheme 3.2 Synthesis of guanosine triphosphate using PS-P-Cl 44 
The crude reaction mixture showed good purity in the HPLC (Figure 3.3) and was 
isolated and dried as previously. Guanosine triphosphate 81 was isolated as its 










The synthesis and purification for adenosine triphosphate 82 was carried out 
analogously to the other triphosphates (Scheme 3.3). Again, the deprotection step 
of the exocyclic amine required prolonged reaction time, shown by MS analysis 
after 2.5 h, where the molecular ion corresponding to the benzoyl protected 
analogue was present. 
Bz 	 NH2 
NLN <I 
	
see Table 3.1 - 0 0 0 	NN 0,11,01 11 
 
I 	I 	I 
-o-o ç5 
OH 
.4TEAH 	 82 79 
Scheme 3.3 Synthesis of adenosine triphosphate using PS-P-Cl 44 
The detrotection reaction was thus left to stir for a total of 15 h, before isolation of 
the product. Again, an HPLC of excellent purity was measured (Figure 3.4) and 
adenosine triphosphate was isolated in an excellent 45 % yield after lyophilisations. 
Io 	 o 	12 	 14 :I- 




3.2 	On-resin oxidation 
3.2.1 	Introduction 
During the course of the development of this approach, a different reaction 
sequence was also investigated. Rather than performing a solution phase oxidation 
on the cyclic triphosphite, it was decided to establish whether it was possible to 
convert the immobilised phosphitylated nucleoside 83 to a phosphorylated 
nucleoside 84 and whether this analogue was still electrophilic enough to be 















(a) Oxidation; (b) nucleophilic cleavage; (c) hydrolysis 
Scheme 3.4 Projected reaction sequence using on-resin oxidation 
A reaction relevant to this study was reported by Cremlyn et al.'46 who found that 
salicyl phosphorochlondate 85 could be treated with a range of alcohols (EtOH, 
PrOH, 'PrOH, BnOH) to yield the alkoxy derivative 86 in excellent yield, which in 
turn hydrolysed to the 2-carboxyphenyl phosphate 87 (Scheme 3.5). 
0 	 -o 	 0 OH 
ecr K  C1 	 ecr KO__1­1 	 6H 
b 
(a) 1 eq EtOH, 1 eq py, PhH, 2 h, 100 %; (b) 30 % aq dioxane, rt, 7 d, 58 % 







Therefore, the on-resin oxidation sequence could have a significant advantage over 
the original method. Premature hydrolysis of the nucleoside loaded resin 83, which 
is a problem controlled by using dry solvents, would be reduced. As the 
phosphorus centre is less electrophilic in the oxidised state, premature hydrolysis 
would not only be dimished, but additionally, when it does occur, the product 
would not be released into solution remaining immobilised on the support, which 
should lead to a cleaner triphosphate pioduct. 
In solution 
The model nucleoside 3'OAc-T 49 was treated in solution with the phosphitylation 
reagent and oxidised to prove that the salicyl phosphate ester could be obtained. 
3'OAc-T 49 was readily phosphitylated as previously to yield 12, which was 
oxidised in situ with 0.5 M 12  in 98:2 py:H20. The intermediate formed is the 
phosphonium iodide salt 88. Addition of water displaces the iodine from 
phosphorus and hydrolyses the P-O bond to give the desired 2-carboxyphenyl 
phosphate 89 in a 27 % yield after Prep HPLC purification (Scheme 3.6). 
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(a) 1.5 eq 11, py/THF, 0.19 M, 10 mm; (b) 1.5 eq 0.5 M I2 in py:H20 (98:2), 15 mm; (c) 
H20, 5 mm; 27 % 




3.2.3 	On the resin 
I- 
The oxidation step was then transferred onto the resin and studied on immobilised 
phosphitylated nucleoside 50. In order to ensure complete conversion, different 
oxidation agents were considered and the intermediates verified by 31 P gel phase 
NMR. 
3.2.3.1 Investigation of an oxidising agent 
The nucleoside loaded resin 50 was treated with 0.5 M 12  in pyridine (Scheme 3.7). 
Excess iodine was washing off the resin with DCM and THF. A minium of iodine 
remained though, which left the resin a brown colour. Phosphonium iodide salt 90 
was characterised by 31 P Gel-Phase NIvIIR. 
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(a) 5 eq 0.5 M 12/pyridine, THF, 0.33 M, 1 h 
Scheme 3.7 On-resin oxidation using iodine 
The 31 P Gel-Phase NIMIR obtained was unsatisfactory; not only were two species 
present, but the signals observed were also very broad (Figure 3.5). 
	
rI 	 I 
Figure 3.5 31P Gel-Phase NMR using iodine oxidation 
Alternative oxidiation reagents for P (ifi) exist, one of which, tbutylhydroperoxide 




concentration as in the previous reaction for iodine (Scheme 3.8). The resulting 
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(a) 5 eq 5-6 M tBuOOH in nonane, THF, 0.33 M, 1 h 
Scheme 3.8 On-resin oxidation using 'butyihydroperoxide 
Using tbutylhydroperoxide  as the oxidant, a 31 P gel-phase NMR of excellent purity 
was obtained (Figure 3.6). It also shows that the previous oxidiation method 
probably resulted in incomplete oxidation. 
P­ (") 
Figure 3.6 31P Gel-Phase NMR using 'bulyihydroperoxide oxidation 
3.2.3.2 Application to triphosphate synthesis 
On the basis of the 31 P NMRs of the resins, tbutylhydroperoxide  looked as the more 
promising oxidant for application to triphosphate syntyhesis. It was thus applied in 
the synthesis of dTTP using microprous PS, with the details given below (Table 
3.2). The nucleoside was loaded onto the resin as previously and after rinsing, was 
treated with tbutylhydroperoxide.  The phosphate resin 91 was then subjected to 
pyrophosphate cleavage (Scheme 3.9). In light of the reduced electrophilicity of the 
phosphorus, it was expected that the conditions developed earlier would not be 
sufficient to cleave the nucleoside fully. 
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Table 3.2 Reaction conditions for triphosphate synthesis using on-resin oxidation 
Scheme 3.9 eq Conc. Time Temp. 
(M) (mm) (°C) 
Loading of nucleoside 0.33 0.10 60 rt 
Oxidation (BuOOH) 1.5 0.33 60 rt 
Pyrophosphate cleavage 1.5 0.37 3 x 10 rt 
Hydrolysis - - 30 rt 
Deprotection - - 60 rt 
The pyrophosphate cleavage reaction was carried out as previously developed 
using three 10 minute cleavage steps and the resulting drained solution was 
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(a) 5 eq 5 -6 M tBuOOH in nonane, THF, 0.33 M, 1 h, rt, 1 h; (b) 1.5 eq 0.5 M (Bu 3N)2 
pyrophosphate in DMIF, 4 eq Bu3N, rt, 3 x 10 mm; (c) H2O, 30 mm; (d) NH3/H20, 1 h; 3 % 
yield 
Scheme 3.9 Synthesis of d7TP 55 using on-resin oxidation 
An HPLC of the crude product after work-up and lyophilisation (Figure 3.7) 
compared favourably with the HPLC chromatogram of crude dTTP 55 obtained 
from the solution phase oxidation with iodine (Figure 3.8), although the dTT'P was 
isolated by Prep HPLC in only a 3 % yield. This indicates that due to the lowered 
electrophilicity of the phosphorus centre, the cleavage conditions will need to be 
re-evaluated to push the reaction to completion with material remaining attached to 
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Figure 3.7 Analytical HPLC of crude d7TP 55 using on-resin oxidation 
Figure 3.8 Anal vtical HPLC chrornatogram of crude d77'P 55 using solution phase 
oxidation 
3.2.3.3 Investigation of pyrophosphate counterion 
An alternative to optimising the cleavage time, temperature or equivalents of the 
pyrophosphate ion used is to re-consider the counter-ion used with the 
pyrophosphate. Up until now, a bis (tri-n-butylammonium) salt of pyrophosphate 
was used. 
Ti-is (tetra-n-butylammonium) hydrogen pyrophosphate has been proposed for 
synthesis of isoprenoid diphosphates' 47 and triphosphate synthesis using the 
oxathiaphopholane approach 9° or using activated nucleoside phosphorami dates. 75 
In those cases tri-n-butylammonium had been investigated as a counterion, but 
found not to be sufficiently nucleophilic. It was also reported that a displacement 
which was complete in 4 hours using the bis (tri-n-butylammonium) salt, took less 
than 10 minutes using the ti-is (tetra-n-butylammonium) salt. 
With this in mind, tris (tetra-n-butylammonium) hydrogen pyrophosphate was 
investigated to cleave the nucleoside as a tnphosphate from the resin. As the 
reagent is commercially available, this was considered first, however analysis by 
31 P NMR precluded its use, due to its abysmal 'purity' (Figure 3.9a). Tris (tetra-n-
butylammonium) hydrogen pyrophosphate was thus synthesised according to the 





chromatography to give pyrophosphoric acid, which was neutralised with aqueous 
tetrabutylammonium hydroxide. 31 P NMR of thus prepared pyrophosphate gave a 
much purer profile (Figure 3.9b). 
N 	 IQ 
15 	 10 	 5 	 0 	 -6. 	 -10 	 -15 
pprT(f1) 
Figure 3.9 31P NMR of (a) commercial and (b) in-house prepared Iris 
(retrabutvlammonium) pyrophosphate in CDC'1 3 
The only concern remained the water of hydration; it has been reported that ti -is 
(tetra-n-butylammonium) hydrogen pyrophosphate contains at least 3 molecules of 
water per pyrophosphate if re-crystallised from EtOAc.' 47 Aezotropic removal of 
water by repeated evaporation from dry MeCN is possible,' 47 but was found to 
leave still too much water for attack on oxathiaphopholane nucleosides; 90 drying by 
molecular sieves of a MeCN solution was thus advocated by these authors. 
With this previous work in mind, the tris (tetra-n-butylammonium) hydrogen 
pyrophosphate salt was dissolved in CHC13 at a 0.5 M concentration. Chloroform 
was chosen over DMF as it enables better swelling of the resin and with the added 
hydrophobic counter-ions the salt was fully soluble in chloroform. This compares 
more than favourably to the tributylammonium salt, which requires sonication to 
dissolve even in DMF. The chloroform solution was then dried over 4 A molecular 
sieves prior to use. 
The triphosphorylation conditions were repeated as per Scheme 3.9 and Table 3.2, 
apart for the cleavage step; three ten minute cleavage steps were used without 
added base. Then, the collected solution was treated with water to hydrolyse the 
cyclic triphosphate and the acetate group was removed under ammonolysis. An 
HPLC chromatogram of the cleaved and deprotected tymdine triphosphate showed 
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only a very small amount of tnphosphate present (data not shown). A purification 
by Sephadex DEAE chromatography was preformed; however no compound could 
be recovered. 
This would leave the conclusion that most likely the pyrophosphate preparation 
with the tetrabutylammonium counter-ion was not sufficiently dry and hydrolysis 
of the supported phosphorylated nucleoside 91 would have led to an immoblised 
salicylate phosphate ester, analogous to 89. Other solvents, which favour 
substitution chemistry (as before) should alsobe explored. 
3.2.4 	Conclusion 
The possibility of performing the oxidation of the phosphitylated nucleoside was 
explored in this section. Tert-butyl hydroperoxide was found to be able to affect the 
oxidation step efficiently and cleanly as asserted be 31 P Gel Phase NMR of the 
intermediate. 
The cyclic triphosphate could be cleaved off the resin in low yield, but excellent 
purity using the same cleavage conditions as for the P (ffi) analogue. Due to the 
reduced electrophilicity of P (ffi), a reduced yield can be rationalised. It is expected 
that the yield could be significantly improved upon if longer reaction times or 
higher temperatures or even more equivalents were to be used. These investigations 
were not performed; instead the method developed in Chapter 2 was used for the 
further work. 
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3.3 	Synthesis of propargylamino linked triphosphates 
3.3.1 	Protease cleavable nucleosides 
There is a long-standing interest in the group to synthesise triphosphates of 
nucleosides with a dye-peptide modification for DNA sequencing by synthesis 
applications. However, direct triphosphorylation of compounds such as 92 was 
found to be impossible. 148 This part of the work will discuss synthesis and 
triphosphorylation of linker modified pyrimidine bases, which can be used 
subsequently to react with an activated ester of the dye-peptide, such as an N-
hydroxy succinimide ester (NHS). 
NAN(N} 






Figure 3.10 Peptide modfled nucleoside 
3.3.2 	Linkers for attaching reporter groups 
Modification of the base is required for attachment of a fluorophore or other 
reporter molecule. Alkynyl based linkers are easily accessed using Sonogashira 
chemistry and were used in the first studies into fluorophore labelled 
dideoxynucleotides. 43 Additionally, alkenyl- and alkyl linkers have been 
synthesised.' 49 With regards to spacer length, apart from the usual three carbon 
spacer, 5 and 12 carbons were investigated.' 50 
A vital property of the spacer is that their presence does not affect DNA 
polymerases. Incorporation of 5-modified purine nucleosides is dependent on the 
flexibility, stereochemistry and the length of the linker group. Considering all 
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factors, propargylamine introduced through Pd cross-coupling is the favoured 
linker for general applications, due to its ease of synthesis and acceptance by 
polymerases. 
3.3.3 	Aims of the work 
In the previous chapter a solid-supported triphosphorylation reagent was developed 
which incorporates the advantages of working on solid support, such a being able 
to push reactions to completion by using an excess of reagent without it interfering 
with the reaction. The plan was to apply this method to triphosphorylation of 
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Figure 3.11 Structure of targeted triphosphates 
3.3.4 	Synthesis of propargylaminouridine 
Propargylamine was protected as its tnfluoroacetate with trifluoroacetic anhydride 
(Scheme 3.10). The product was readily isolated by column chromatography in 
good yield. 
0 
a 	 NACF3 
95 
(a) 1.12 eq TFAA, 2 eq TEA, CH2Cl2, 0°C to rt, 1.1 M, 14 h, 74%. 
Schenze 3.10 Synthesis of protected propargylamino linker 95 
The thymidine analogue was accessed from commercial 5-iodo-uridine 96 via 
selective protection of the primary 5' alcohol with DMT-Cl to give 97 in good 
yield. Subsequent coupling of the 5-iodo to tnfluoroacetate protected 
propargylaniine 95 was executed under Sonogashira conditions to give 98. A small 
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amount of a close-running non-identified side-product could be separated by 
column chromatography; in light of a similar observation for cytidine (Scheme 
3.14), it is expected that it is a reduction product of the iodo group. Capping of the 
secondary 3' alcohol with acetic anhydnde accessed fully protected thymidine 
analogue 99 with a three carbon linker (Scheme 3.11). Selective deprotection of 
DMT group was readily performed using 3 % trichioroacetic acid (TCA) to yield 
the desired product initially as an oil. As having a dry nucleoside is vital for the 
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100 99 
(a) DMT-Cl, 0.2 eq DMAP, pyridine, 0.28 M, 3 h, 76 %; (b) 2.5 eq 95, 0.1 eq [Pd(PPh 3)4], 
0.2 eq Cu!, 5 eq TEA, DMF, 2.5 h, 0.5 M, 69 %; (c) 1.0 eq Ac 20, 0.25 eq DMAP, 2.5 eq 
TEA, pyridine, 0.15 M, 2 h, 93 %; (d) 3 % TCAJCH2C12, MeOH, 98 %. 
Scheme 3.11 Synthesis of protected uridine analogue 100 
3.3.5 	Synthesis of propargylaminocytidine 
The synthesis of a propargylamino modified cytidine analogue required 
consideration of the exocyclic amine of the cytosine base. Base protection is not 
required - for the phosphorylation step, however it may be easier to protect it in 
order to achieve protection of the 3' hydroxyl group. 
The first attempts towards the desired nucleoside were made from spacer modified 
cytosine 101. Again selective protection with DMT-Cl was carried out, but the 
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reaction was rather sluggish and did not go to completion in 24 h; nonetheless 102 
was isolated in acceptable yield (Scheme 3.12). The obtained cytidine analogue 
102 was then treated with an excess of acetic anhydnde under DMAP catalysis to 
acetylate both the 3' hydroxyl and the exocyclic amine. This however yielded 
complex mixtures and multiple acetylations, as asserted by LC-MS analysis. More 
vigorous conditions using acetyl chloride acetylated additionally the NH of 
propargylamine and gave rise to a series of compounds where the Tfa had been 
exchanged for an acetyl. 
	
N 	 NHAc H2 HTfa 	
2 
Tf a N 	
NH 	
NH 	 N HTfa 
0 N 0N 	 0 N  
DMTO 	 DM10 - - - 
aOj  
OH 	 OH 	 OAc 
101 102 
(a) DMT-Cl, 0.2 eq DMAP, pyridine, 0.25 M, 24 h, 55 %; (b) 5 eq Ac 20, 0.25 eq DMAP 
DCM, not isolated. 
Scheme 3.12 Attempted synthesis of protected cytidine analogue with linker 
A second approach was taken to circumvent acetylisation once the linker had been 
introduced. Compiercial 5-iodo-cytidine 103 was protected on the 5' hydroxy 
postion with DMT-C1 to yield 104 in a 61 % yield. Suitable acetylation conditions 
could now be developed on 104 (Scheme 3.13, Table 3.3). 
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• 	N ' 
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DMTO 	 - 
OH 
104  
NAc2 	 NHAc 	 NH2 
NTh 	 NYI 
ON 	 ON 	 ON 
DMTO 	 DMTO 	 DMTO
+ 	
_Oj 
OAc 	 OAc 	 OAc 
105 106 107 
Scheme 3.13 Acezylation of cytidine analogue 
Treatement of 104 with excess acetic anhydride under DMAP catalysis gave tn-
acetylated cytidine 105 in 31 % and di-acetylated cytidine 106 in 20 % yield (Entry 
1). This showed that both the 3'OH and the amine were readily acetylated. A 0.05 
M nucleoside solution was then treated with 1.0 eq of acetic anhydride. Analysis by 
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tic showed spot-to-spot conversion, which was isolated to give 107 with 3' 
acetylation in very good yieid (Entry 2). Neat addition of a 2'" eq of Ac20 yielded 
a mixture of 105 and 106. However, dropwise addition of a 2 eq Ac20 solution 
performed at higher dilution produced 106 selectively (data not shown). 
Table 3.3 Acetylation conditions 
Entry 	Conditions 	 Cone. Time 	105 106 107 
(M) (mm) % % %a 
1 	5 eq Ac20, 0.25 eq DMAP, C11202 	0.2 31 20 I 
2 1 eq Ac20, 0.25 eq DMAP, CH202 0.05 30 	I 3 89 
alsolated yield 
With the essential 3' protection in place, compounds, either with or without base 
protection, were available to take forward to couple the linker. Monoacetyl-base 
protected cytidine 106 was subjected to Sonogashira conditions (2.5 eq 95, 0.1 eq 
[Pd(PPh3)4], 0.2 eq Cul, 5 eq TEA, DMF, 0.5 M). The reaction, monitored by tic, 
gave however rise to a complex mixture of products, even before the starting 
material had been used up. 
A more satisfying result could be obtained with base unprotected 107, which was 
readily converted to the linker modified analogUe 108 in good yield (Scheme 3.14). 
A minor side-product was the reduced cytidine 109, which could be separated from 
the desired compound by careful column chromatography. It is expected that its 
presence could be reduced or eliminated altogether by lowering the catalyst 
loading. 
NH2 	 NH2 	 ?NH2 	 .-.. 
NYI 	 NyR 
NHTfa 
ON 	 ON 	 ON 
 HO,,J  DMTO 	
aDMTiç 	 b 
OAc 	 OAc 	 OAc 
107 	R = CCCH 2NHTfa, 108, 79%; 	110 
H, 109, 7 % 
(a) 2.5 eq 95, 0.1 eq [Pd(PPh 3)4], 0.5 eq Cul, 5 eq TEA, DMF, 2.5 h, 0.5 M; (b) 3 % 
TCA/CH2C12, 95 % 
Scheme 3.14 Attachement of linker to cytidine analogue 110 
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As the final step, the DMT group was removed by the standard conditions (3 % 
TCA in CH202) in excellent yield to give the desired nucleoside 110 as an oil 
which was isolated as a yellow powder after lyophilisation. 
3.3.6 	Phosphorylation of propargylaminouridine 
The triphosphate synthesis conditions developed previously are summarised below 
(Table 3.4) and were used as such for the phosphorylation of the pyrimidine 
nucleosides. 
Table 3.4 General reaction conditions for triphosphate synthesis 
Reaction name - 	 eq Conc. Time Temp. 
(M) (mm) (°C) 
Loading of nucleoside 0.33 0.10 60 rt 
Pyrophosphate cleavage 1.5 0.37 3 x 10 11 
Oxidation 1.5 0.37 15 rt 
Hydrolysis - - 30 rt 
Deprotection - - 60 rt 
Propargyl amino linked uridine nucleoside 100 was subjected to the 
phosphorylation conditions (Scheme 3.15); however this was met with no success 
in detecting any triphosphate in the cleaved solution by Prep HIPLC or Sephadex 
ion exchange chromatography. Initially this was attributed to the nucleoside not 
being sufficiently dried. This was eliminated as a possible explanation after 
experiments with prolonged drying of the nucleoside were equally unsuccessful. 
Increased steric bulk was considered as the cause, but after experiments on cytidine 










see Table 3.4 
I 	I 	I 
OH 
.3TEAH 	 93 
Scheme 3.15 Synthesis of propagylamino linked uridine triphosphate 
Finally, the drained solution from the nucleoside loading onto the resin was 
examined (Scheme 3.16). Apart from the starting nucleoside, a lower running spot 
was detected, which exhibited chemical shift changes of H-6 and H-5' by 'H NIVIR. 
It was tenatitively assigned to be 2,5'-anhydronucleoside 111. By HPLC, the 
anhydronucleoside 111 could be seen to be decomposing to starting nucleoside 100 
when TEA had been added. However, further characterisation of this 
anhydronucleoside 111 was not possible as it could only be isolated in small 
quantities and decomposed quickly. 
HN 	
NHTfa 	 NHTfa 
ON 	 0 
ill, 
 N 	
N 	 NHTfa 
a 
H" \/ "H 
OAc 	 OAc 	 OAc 
100 111 
(a) 3 eq PS-P-Cl 44, 0.1 M py/THF 1/3, lh, rt. 
Scheme 3.16 Synthesis of as 2,5 '-anhydrouridine analogue 
Previous syntheses of 2,5'-anhydrouridines activated the 5' hydroxyl group either 
as the tosylate, which yielded the corresponding 2,5'-anhydrouridine nucleoside 
upon treatment with DBU in 40 % yield over two steps, 151 or as the 5' 
naphalenesulfonyl derivative with subsequent NaOtBu  treatment.' 52 
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Scheme 3.17 Proposed mechanis,nforforination of 2,5 '-anhydrouridine nucleoside 
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In this instance, it is surmised that the enol tautomer of uridine attacks the 
phosphitylated 5' methylene. The oxygen, activated as a leaving group, remains on 
the resin, while the anhydro nucleoside is cleaved off the resin (Scheme 3.17). 
To assess the quantity of urdine nucleoside 100 that remained on the resin after 
self-c1eavage' under the phosphitylation conditions, the nucleoside was loaded 
onto 3 eq of the resin 44 for 1 h, as previously. The resin was drained, rinsed and 












(a) 3 eq PS-P-Cl 44,0.1 M py/TI-IF 1/3, lh, rt; (b) THF/H 20 1/1, 10 mm. 57 % yield. 
Scheme 3.18 Synthesis ofpropagylamino linked uridine-H-phosphonate 
Inspection of the crude chromatogram indicated a major product at 5.97 mm 
(Figure 3.12), which was shown to be the desired product by MS. Comparison of 
retention times with the starting material 100 showed that it was barely present 
(retention time of 4.5 mm). The product was isolated by Prep HPLC eluted in a 0.1 
M ammonium acetate/MeCN gradient. The other two products remain un-
identified 
J !H1C 3. 12 Crude IIPLL chru,nuiuruni of uridinc J)Ilo\/)il000lc 112 
\tter repeated lypohilisation, the H-phosphonate 112 was isolated in a 57 % yield 
its ammonium salt. Comparison with the formation of the H-phosphonate of 
OAc-T 49 under the same conditions is favourable as the yield obtained for this 




propargylamino linker does not interfere with the phosphitylation reaction of the 
primary alcohol. Any issues arising with this substrate thus are most likely to be 
due to solubility issues. 
It was next attempted to isolate the triphosphate. The resin was loaded and cleaved 
as previously and the collected solution oxidised and the remaining iodine 
quenched. The resulting cyclic tnphosphate was hydrolysed, which resulted in a 
clear yellowish solution. As no solubility problems were observed at this stage, it 
was decided to evaporate the solution and proceed to the animonolysis step. The 
resulting crude reaction mixture was washed with CH202 and analysed by HPLC 
(Figure 3.13). 
0• 
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Figure 3.13 Crude HPLC chrornatogram of uridine propgarg v/amino triphosphate 93 
The peak at 4.70 min was found to be the desired compound and the crude product 
was purified by Prep I-IPLC to yield the desired product in a 23 % yield as a 
tnethylammonium salt. 
Analysis of the 'H NMR of the resulting product however indicated that some 
triethylammonium salts were not purified out of the crude, as the integration of the 
triethylammonium relative to the nucleoside peaks was higher than expected. It 
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Figure 3.14 Crude HPLC chromatograin of uridine triphosphare 93 after Prep HPLC 
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Instead, it was opted to re-purify the resulting compound by a second Prep HPLC. 
Inspection of the subsequent IIPLC trace shows that with the majority of the 
impurities removed in the first Prep, the retention time of the compound slowed 
down to 6.22 mm (Figure 3.14). The remaining impurities were thus readily 
separated and 93 could be isolated readily as a white powder. 
The yield was estimated by UV-Vis absorbance to deduce the concentration, using 
the method by Battersby et al. who used an extinction coefficient of E290 = 9000 M 
1 cm to determine the yield for their synthesis of 93153  The amount obtained was 
calculated to be 680 nmol, which gives approximately a 1 % yield from 100. A 
comparison with the synthesis from Battersby et al. is not possible as the authors 
did not provide a yield. 
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Figure 3.15 UV-Vis spectrum of 93 in H20 
3.3.7 	Phosphorylation of propargylaminocytidine 
The synthesis of propagylamino linked cytidine tnphosphate 94 involved 
triphosphosphorylation of the corresponding 3' acetate protected nucleoside 110, 
which had been dried carefully before attempting the tnphosphorylation (Scheme 
3.19). The general reaction conditions as developed in the Chapter 2 and illustrated 












Schenze 3.19 Synthesis of propagylamino linked cyridine triphosphate 
The crude HPLC chromatogram showed four main peaks (Figure 3.16). They were 
separated by Prep HPLC, but could not be assigned to a particular compound using 
ES-MS. The remainder of the crude product was resuspended in NH3/H20. It was 
noted at that point that a considerable amount of the product was not soluble. After 
1 h treatment with NH3/H20, an aliquot was analysed by HPLC, however the peaks 
remained essentially unchanged. 
1A9 
12 
1 	 i 
67 
015 	15 17.5 	20 	22.5 	mm 
Figure 3.16 Crude HPLC of propargylamino linked cytidine triphosphate 94 
The synthesis was thus repeated, while taking care at each step that all the 
compound was fully dissolved. Thus, the loading of the cytidine nucleoside was 
easily achieved, as judged by the absence of nucleoside in the drained solution. The 
pyrophosphate cleavage step yielded a yellow solution which was treated with 
iodine solution to affect oxidation. After quenching of excess iodine with NaHS03, 
the solution was dissolved in water to hydrolyse to the cyclic triphosphate to the 
desired linear compound. After 30 minutes, the solution was reduced in vacuo to a 
oil with white solids. The final step was the deprotection step. Thus adding 
concentrated aqueous ammonia was required to deprotect the acetate and 
trifluoroacetate groups. However, it was noted that upon addition of the required 
amount of ammonia, a considerable amount of solids remained. Addition of 5 mL 
of water and brief sonication however managed to fully dissolve these solids and 




The crude reaction mixture was subjected to the usual work-up procedure, and then 
purification by Prep 1-IPLC was attempted. The crude HPLC shows a single main 
product, which was very satisfying, especially as it corresponded to one of the 
peaks from the previous attempt (Figure 3.17). Frustatingly enough, the HPLC 
peak could not be isolated without co-running with the impurities. Re-purification 
after the first Prep did in this case not improve the purity, thus in the future ion 
exchange chromatography on Sephadex will not be avoidable. 
•0 
15 


















Triphosphates of dideoxy and deoxy nucleosides are compounds with many 
important applications. Their straightforward synthesis is frustrated by the inability 
to form the triphosphate moiety if a large lipophilic group such as a fluorophore is 
present. In a recent study by Burgess et al. 154 this property of triphosphate synthesis 
was observed when their synthetic efforts to convert the rigid fluorescein labelled 
nucleosides 113 and 114 to their triphosphates were unsuccessful. They attributed 
their failure at performing these synthetic transformations to several issues. Most 
important were solubility problems which impacted on purification using ion 
exchange chromatography and HPLC purifications. 
113 	 114 
Figure 3.18 Rigid fluoroscein nucleosides 
3.4.2 	Aims of the work 
In the previous chapter a solid-supported triphosphorylation reagent was developed 
which incorporates the advantages of working on solid support, such a being able 
to push reactions to completion by using an excess of reagent without it interfering 
with the reaction. The plan is to develop a method to perform a direct 





something which so far has not been possible. The deoxy and dideoxy nucleoside 
tnphosphates which are envisaged in this study are illustrated below (Figure 3.19). 
The flurorophore envisaged was carboxy-fluorescein, which is commercially 
available as a mixture of regioisomers. 










Figure 3.19 Structure of targeted triphosphates 
3.4.3 	Synthesis of a labelled 2 1 -deoxy nucleoside 
In order to attempt a triphosphorylation of a fluorogenically labelled nucleoside, 
such a compound was synthesised. The chosen fluorophore, carboxyfluorescein, 
needed to be coupled to an amino modified linker on the nucleoside, so the initial 
target was an amino-modified thymidine analogue. 
3.4.3.1 Synthesis of propargylamino-uridine 
Fully protected undine 99 synthesised in the previous section (3.3.4) was used as a 
starting point for a thymidine analogue with a free amine group. Conditions for 
deprotecting the Tfa group in the presence of the acetate group were investigated 
and monitored by HPLC (Scheme 3.20). Apart from the desired product 115, two 
side products were observed: 116, where both protection groups had been removed 
and 117, where the acetate group had been deprotected in favour of the Tfa group. 
The literature conditions known for selective deprotection were not succesful for 
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99 
Scheme 3.20 Deprotection of the Tfa group in the presence of the Ac group 
In fact, a reversal of the selectivity was observed (Entry 1). Deprotection 
conditions under basic pH were also unsuccessful, as acetate deprotectiori was 
favoured (Entry 2). Attention was then turned to reducing conditions (Entry 3). 
Using NaBH4 the desired compound was observed with a good conversion, when 
fused calcium chloride was added to the reaction mixture to keep the reaction dry 
(Entry 4). (Presence of water hydrolyses NaBH4 to yield a basic solution.) 
Table 3.5 Conditions for trfluoroacetamide deprotection 
Conditions 	 time 99 115 116 117 Ref 
,,,a 	,,ia 	,,,a 	r,ia 
,'0 /0 /0 /0 
SM -Tfa -Ac -both 
1 10 % K2CO3, 5:2 MeOH:H20 25 mm 6 - 66 24 	
155 
2 phosphate pH 8:MeOH 1:1 17 h 80 - 18 - 
3 13 eq NaBH4, EtOH 30 mm 17 37 20 18 	
156 
4 5 eq NaBH4, 5 eq CaC12, EtOH 3 h 43 45 8 
157 5 
5 5 eq NaBH4, 5 eq CaC12, EtOH 3 h 7 64 8 21 
aConvers ions  obtained by peak area in UV at 282 nm 
Nonetheless, the reaction was not very reproducible (entries 4 and 5) and the 
isolated yield was low (23 % for Entry 5). It was therefore decided to look at 
performing the Sonogshira coupling directly on carboxyfluorescein derivatised 
propargylamine 118. 
3.4.3.2 Sonogashira coupling to alkynyifluorescein 
To pursue this second strategy, 5(6)-carboxyfluorescein 119 was activated with 
PyBOP and treated with the amine under basic conditions (Scheme 3.21). The 
conversion was quantitative and after several precipitations 118 was isolated with 









(a) 0.98 eq PyBOP, 1 eq propargylamine, 2 eq DTPEA, DMF, 0.125 M, 77% 
Scheme 3.21 Derviatisation of carboxy-fluorescein to its alkynyl derivative 
In order to have the required acetate group on the 3' OH, 5'-ODmt protected 5-iodo 
undine 97 was acetylated to give 120 in a quantitative yield. The Sonogashira 
reaction was monitored by tic and HPLC, but very little formation of coupling 
product 121 could be observed in the mixture (<5 %, IIPLC) (Scheme 3.22). 
HO 	O 	OH 
(•1 
0 	 0 
HN 	 HN 
ON 
DMTO 	I 	DMTO 
a 	
DMTO 
OH 	 OAc 	 OAc 
97 120 121 
(a) Ac20, 0.25 eq DMAP, 2.5 eq TEA, pyridine, 0.15 M, 2 h, 100 %; (b) 2.5 eq 95, 0.1 eq 
[Pd(PPh3)4], 0.2 eq Cul, 5 eq TEA, DMF, 0.5 M, 48 h, not reacted 
Scheme 3.22 Sonogashira coupling of uridine derivative 120 to alkynyifluorescein 118 
3.4.3.3 Coupling of unprotected alkynyl linker 
With both initiai strategies unsuccessful, attention was then turned to introducing 
the alkynyl linker without a protecting group. Sonogashira couplings of 5-iodo 
purines to prOpargylamine are known if the ratio of copper co-catalyst to Pd 
catalyst is adjusted to 5:1 from the customary 2:1 ratio. 150 This method has not 
found any general applicability as the ammonium salts generated are hard to 
remove from the polar products. However, the use of a supported amine in the 




Propargylamino modified uridine 122, with 3' and 5' protection, was accessed 
from 120 using the modified ratio of PdJCu catalysts to give the desired product in 
excellent yield (Scheme 3.23). Presence of the DMT group on the 5' postion is 
believed to have aided isolation of the product greatly, as it rendered it much more 
hydrophobic, as it was possible to perform a column chromatography without 















(a) 10 % [Pd(PPh1) 41, 50 % Cul, 3 eq propargylamine, 2 eq Amberlite IRA-67. 0.2 DMF, 
rt, 2 h, 87 % yield 
Scheme 3.23 Synthesis of propargylamino linked thymidine 122 
3.4.3.4 Synthesis of Ahx-fluorescein 123 
Before attempting coupling of 5(6)-carboxyfluorescein 119 to amino-modified 
uridine 122, it was modified by derivatising it with an amino-hexanoic acid linker. 
This is known to improve its reactivity, as the carboxylic acid on the alkyl chain is 
more reactive than the benzoic acid of fluorescein. 
Carboxyfluorescein exists in two tautomeric forms, lactone 124 and ring-opened 
form 125 (Figure 3.20). While it is the ring-opened form that exerts fluorescence 
through its conjugated 7t-system, the exact position of the equilibrium depends on 
the pH. 
HO 	0 	OH 
HO2C\ 	- 
124 - 	 12b 




The numbering of the benzofuran ring of lactone 124 starts of at the spiro carbon, 
thus giving positions 5 and 6 for the carboxy modified variant, whereas for the 
ring-opened variant 125, it starts at the ipso carbon of the benzene ring, giving 
postions 4 and 5 respectively. Carboxyfluorescein will be represented in its lactone 
form and the positions on the benzofuran numbered accordingly. 
Carboxyfluorescein is commercially available as a 40/60 mixture of 5 and 6-
carboxyfluorescein, which was used as such unless specified otherwise. 
Thus, 5(6)-carboxyfluorescein 119 was activated with PyBOP and treated with the 
methyl ester of the linker. The intermediate methyl ester was separated by acid 
precipitation from the by-product and readily deprotected under basic hydrolysis to 
yield the desired product 123 in good yield over two steps (Scheme 3.24). The 
hydrolysis step also served to remove phenolic esters side-products formed in the 
ester coupling step resulting from cross-coupling. 
i, b 	
HO'' 
119. 	 123 
(a) 0.98 eq PyBOP, 1 eq H-Ahx-OMe.HC1, 3 eq DIPEA, DMF, 0.13 M; (b) 2 M NaOH, 
DMF, 2 h, rt, 70 % yield 
Scheme 3.24 Coupling of carboxy-fluorescein to an amino-hexanoic acid linker 
3.4.3.5 Coupling of amino-modified uridine 122 to Alix-fluorescein 123 
The coupling reaction between amino-modified undine 122 and Ahx-fluorescein 
123 was investigated using a few different reaction conditions. Initial attempts to 
form the N-hydroxysuccinimide ester of Ahx-fluorescein were only moderately 
successful. 
Attention was then turned to carbodiimide mediated amide bond couplings (Figure 
3.21). Treatment of a carboxylic acid with a carbodiimide can yield an O-acyl 
isourea 126, an active ester, which reacts with an amine to yield amide 127 (route 
A). If however the coupling reaction is sluggish, O-acyl isoureas 126 rearrange to 
give the N-acylurea 129 (route Q. This removes the carboxylic acid from the 





be prevented by using an additive such as N-hydroxybenzotriazole (HOBt), which 
intercepts the O-acyl isourea 126 to form the HOBt-ester 128, which is 
subsequently transformed into the desired amide (route B). The addition of HOBt 
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Figure 3.21 Carbodiimide mediated amide bond fonnation 
As couplings with Ahx-fluorescein 123 with a carbodiimide were rather sluggish, 
addition of HOBt was necessary. A solid-supported analogue of HOBt was used to 
avoid it being extracted into the organic phase with 2-propanollCH2C12, the 
preferred solvent for fluorescein derivatives. 
U 
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0N 	 0N 
0 	OH a 
DMT0 	 DMT0 
	 'N OAc 	 OAc 
122 	 130 
PS-HOBt 
(a) 1 eq 123, 1.5 eq PS-HOBt. 4 eq DIC, DMF, 0.1 M, not isolated 
Scheme 3.25 Coupling of Ahx-fluorescein 123 to aminoproparvl-uridine 122 
PS-HOBt, a commercially available resin, was investigated. The supplier advocates 
a catch-and-release strategy, which pre-activates Ahx-fluorescein 123 as its PS- 
HOBt ester, which is cleaved off the resin with a sub-stoichimetric amount of 
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amine. This procedure was found to yield a considerable amount of hydrolysis 
product when washing the loaded resin, it was thus also attempted to add PS-HOBt 
as additive into the reaction mixture (Scheme 3.25). While the reaction was 
believed to successful to some extent, the resulting mixture was rather complex and 
could not be purified. 
3.4.3.6 Isomer purification of 5(6)-carboxy fluorescein 
As the purification of fluorgenically labelled nucleoside was unduly complicated 
by the isomers of carboxyfluorescein, 5(6)-carboxyfluorescein 119 was separated. 
Most methods achieve separation by column chromatography or Prep HPLC of 
phenolic fluorescein esters. A facile and simple method involving selective 
precipitation of the 6-isomer as its dipivalate diisopropylammonium salt' 59 was 
successfully applied to yield 6-carboxyfluorescein dipivalate 131 after subsequent 




(a) Piv20, 130 °C, 2 h; EtOH, 'Pr2NH, -20 °C; (b) 1 M HC1; 16 % yield 
Scheme 3.26 Isomer separation of 5(6)-carboxyfluorescein 
3.4.3.7 Synthesis offluorescein labelled nucleoside 132 
Carbodiimide mediated amide bond formation was then applied to couple the 
fluorophore to nucleoside 122. As the phenol groups had been protected for the 
isomer separation, this was taken advantage of for the coupling reaction. The 
reaction was performed in CH2C12 and while several components of the reaction 
mixture were thought to be due to decomposition of the protecting groups, the 
desired product was isolated by column chromatography (Scheme 3.27). 
The urea of the carbodiimide co-purified, however, and could only be removed 
through column chromatography after the DMT deprotection step. The desired 
















1.1 eq 131, 1.1 eq DIC, 0.1 M CH202 ; (b) 3 % TCA/CH 2C12 , 37 % yield over 2 steps 
Scheme 3.27 Synthesis offluorescein labelled uridine analogue 132 
3.4.4 	Synthesis of a labelled 2',3'-dideoxy nucleoside 
Additionally to the 2'deoxy nucleoside, synthesis of a 2',3'-dideoxy nucleoside 
was also envisaged. The synthetic scheme could be shortened, as there was no 
requirement to protect the primary alcohol to protect the secondary 3' position. 
Therefore, the Sonogshira coupling to the propargylamino linker was the first 
synthetic step. 
As there is a much higher cost associated with dideoxy nucleosides, the synthesis 
was optimised on the 2'-deoxy analogue first. The couplings were performed on 
both the protected and the unprotected propargylamino group for comparison 
(Scheme 3.28). 
5-Iodo-2'-deoxy-uridine 96 could be coupled efficiently to the trifluoroacetamide 
protected linker 95 to yield 133 in good yield. A small amount of the fluorescent 
furano-pyrimidine side-product 134 was detected by tic; its appearance under 
Sonogshira conditions has been associated with prolonged heating and/or reaction 
times of the reaction mixture. 160 The tnfluoroacetamide group could be readily 
removed with aqueous ammonia to yield 135. 
The Sonogashira product with the unprotected linker 135 could be accessed 
directly only in moderate yield (43 %) and was isolated by column chromatography 
eluted with 20 % ammonia saturated MeOH as eluant. Due to the eluant used in the 
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(a) 5 % [Pd(PPh 3)4], 0.2 eq Cul, 2 eq 95, 5 eq Amberlite IRA-67, 0.1 DMIF, 60 °C, 14 h, 80 
%; (b) N}3/H20,  80 mm, 68 %; (c) 10 % [Pd(PPh 3)4], 50 % Cul, 3 eq propargylamine, 2 
eq Amberlite IRA-67, 0.2 DMF, rt, 2 h, 43 % 
Scheme 3.28 Optimisation on 2 '-deoxy-5-iodouridine 
From the optimisation on the 2-deoxy model it was clear that it was easier to isolate 
the linker modified nucleoside in its protected form. Thus commercial dideoxy-5-
iodoundine was coupled under Sonogashira conditions to the Tfa protected 
propargylamino linker 136 (Scheme 3.29). 
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(a) propargylamine-trifluoroacetamide, [Pd(PPh 3)4], PS-TEA, DMF, 57 %; (b) NH 3 in 
H20; (c) 1.1 eq 131, 1.1 eqDIC, CH 202, -30%. 
Scheme 3.29 Application to 2 ',3 '-dideoxy-5-iodouridine 
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The Sonogashira reaction was carried out under the same conditions as for the 2'-
deoxy analogue, however did not go to completion within 22 h at rt. The product 
was isolated at this stage, as it was found to readily cyclise to the furanopyrimidine 
if heated. The Tfa-propargylamino linked dideoxyuridine 136 was thus isolated in a 
57 % yield, based on recovered starting material. 
The Tfa group was then cleaved using aqueous ammonia and the resulting product 
was used immediately in carbodiimide mediated amide bond formation to yield the 
desired fluorescent dideoxy nucleoside 137. The yield obtained was rather low, 
estimated at around 30 % yield. As there was only a small amount of nucleoside 
obtained, it was decided to only pursue the deoxynucleoside for phopshorylation. 
3.4.5 	Phosphorylation 
The triphosphorylation conditions developed in the earlier chapter formed again the 
basis for the triphosphorylation of fluorescein modified nucleoside 132. As 
mentioned previously, phosphorylations of fluorophore labelled nucleosides are 
notoriously difficult, which has been attributed by to a lack of phosphitylation of 
the primary alcohol. As this first step was thought to be the most difficult step, it 
was thus decided to concentrate first on finding suitable phosphitylation conditions 
to synthesise mono-H-phosphonate 138. 
Thus, as the reaction was thought to be difficult, more equivalents of resin were 
used to push the reaction to completion. In this instance, 6 eq of phosphitylation 
resin 44 were used with all the other parameters, such as concentration, solvent and 
reaction time remaining the same. 
After 1 h, the solution was drained and the resin washed with dry THE The eluate 
will be referred to as the drained solution. Then, the resin was treated with a 
H20/THF (1/1) mixture to cleave the phosphitylated nucleoside off as its mono-H-
phosphonate 138. This will be referred to as the cleaved solution. Both samples 
were analysed by LC-MS and 1 H and 31 P NIVIR to assess the extent of 
phosphitylation. 
The drained solution contained no 3 1 P NMR peak corresponding to phosphonate 
(ca. 7 ppm), thus it can be concluded that the loading of the nucleoside 132 was 
carried out under dry conditions, as there was no premature hydrolysis. LC-MS of 
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this solution indicated the presence of the starting nucleoside 132, thus the loading 
on the resin was not complete. 
Analysis of the cleaved solution by 31 P NMR revealed a phosphonate peak at 7 
ppm; however this is entirely expected as, there were 5 eq in excess of the 
nucleoside and the chemical shift does not indicate whether the phosphonate is 
attached to the nucleoside. LC-MS analysis of the sample showed no peak 
corresponding to the nucleoside phosphonate 138 or its pivaloyl deprotected 
analogues. 
The drained solution was purified by column chromatography to recover the staring 
nucleoside 132 and to assess the level of unattached nucleoside. Careful 
purification of the solution yielded a 50 % recovery of starting material, as well as 
substantial amount of pivaloyl deprotected nucleosides and other unidentified 
products, which leaves the conclusion that no or only very little of the compound 
was phosphitylated. 
The cleaved solution was thus examined with a view to isolate the mono-H-
phophonate, if any, that was present. However, as the mixture proved to be 
insoluble in aqueous buffer, it was decided to deprotect the pivaloyl esters. 













	 R = H, 139 
= Ac, 140 
(a) 6 eq PS-P-Cl 44, py/THF 1/3, 0.1 M, 1 h, it; (b) H20/THF 1/1, 2 x 10 mm; (c) 
NH3JH20, 30 sec. 
Scheme 3.30 Synthesis of mono-H -phosphonate offluorescein labelled uridine 
The mixture was treated with ammonium hydroxide for 30 sec and evaporated. 




groups. Analysis of the resulting mixture revealed two peaks at 15.1 min and 18.3 
mm (Figure 3.22). Using MS, they were assigned to the fully deprotected mono-H-
phosphonate 139 and 3'OAc-protected mono-H-phosphonate respectively 140. No 
further charactensation was performed. It shows that the brief arnmnonia treatment 
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Figure 3.22 Crude HPLC chrornatogram from resin hydrolysis 
This showed that the phosphitylation step, while difficult to achieve, was possible 
to some extent and thus efforts concentrated to optimise this step, before 
proceeding to attempting the triphosphorylation step. To push the phosphitylation 
step to completion, nucleoside 132 was dissolved in 1/3 pyridine/THF, but now to a 
more concentrated 0.2 M concentration. Additionally, the reaction was left for 2 h, 












(a) 6 eq PS-P-Cl 44, py/TFIF 1/3, 0.2 M, 2 h. it; (b) 1.5 eq 0.5 M (Bu 3N) 2 pyrophosphate in 
DMF, 4 eq Bu 3N, rt, 3 x 10 mm; (c) 1.5 eq 0.5 M 12/98:2 pyridine:H20, 15 mm; (d) H'O, 
30 mm; (e) NH 3/H20, 1 h. 
Scheme 3.31 Synthesis offluorescein labelled urkline triphosphare 141 
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The drained solution after 2 h, was analysed for presence of the starting material 
and gratifyingly, no starting nucleoside 132 could be detected. It was thus decided 
to treat the resin with the customary cleavage, oxidation and hydrolysis conditions. 
When the resulting crude was treated with ammonia solution, the reaction colour 
immediately turned the characteristic fluorescein colour. The reaction was 
evaporated after 1 h, then analysed by HPLC (Figure 3.23). 
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Figure 3.23 Crude HPLC chromarogram for dUTP-6-FAM 141 
Inspection of the I-IPLC chromatogram revealed a major peak a 9.52 mm. As the 
HPLC was run at identical conditions as for the phosphonates, it can be asserted 
with confidence then neither phosphonates are present in the reaction mixture, 
which indicates that all precautions to prevent premature hydrolysis of the resin 
were successful. 
The peak was isolated by Prep HPLC and lyophilised to yield an orange residue. A 
31 P NMR spectrum provided the confirmation that the triphosphate group was 
present by exhibiting the characteristic signals at -6, -11 and -22 ppm (Figure 3.24), 
while the 'H NMR spectrum proved too complicated to interpret. 
.1t 	 •20 	 .10 




The yield of 141 obtained could not be measured directly, as the mass obtained 
could not be reliably 'measured. An estimation of the yield was thus performed by 
measuring its UV-Vis absorbance and from that deducing the concentration, using 
a literature value for the extinction coefficient of 6495 = 80000 M' cm 1 . 161 The 
amount of 141 obtained was dissolved in 0.1 M TEAB buffer (Figure 3.25). The 
number of moles was calculated to be —50 nmol in the entire sample, sufficient for 
many biological assays. By comparing with starting amount of 44 p.mol, an 
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4.1.1 	HIV reverse transcriptase inhibitors 
The human immunodeficiency virus (HTV) virus has claimed millions of victims 
since the 1980's. Currently neither vaccine nor cure exists, but once infection takes 
place its spread can be contolled inside the host to delay the on-set of AIDS 
(aquired immuno deficiency syndrome). Knowledge of virus replication has 
enabled inhibition at various stages. HIV is a retro-virus, meaning that it carries its 
genetic information as RNA. When a host cell is hijacked, a reverse transcriptase 
(RT) of HIV translates it into DNA, whiëh is in turn integrated into the host's DNA 
by a integrase. Transcription/translation of this DNA generates a peptide which is 
cleaved by a protease, which enables production of more virions. RT inhibition is 
especially interesting as host cells do not have a RT, therefore this is a virus-
specific pathway. Nucleoside RT inhibitors (NRTIs) constituted the first approved 















Figure 4.1 Selected NRTIs with year in which they were first FDA approved 
The biosynthetic synthesis of dNTPs progresses via three kinases. Nucleosides are 
converted to the NIVIP (nucleoside monophosphate) with a specific nucleoside 
kinase and then the NMP is tranformed to the NDP by a specific NIVIP kinase. The 
NTP is obtained by an NDP kinase catalysed phosphoryl transfer from ATP 
(Scheme 4.1). Unlike for the previous two enzymes, the NDP kinase has little base 




that this phosphoryl transfer is stabilised by the interaction of the 3'OH with the 13-
phosphate via an H-bonding interaction. 164 
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Scheme 4.1 Biosynthetic activation of a nucleoside 
NRTIs need to go through the same enzymatic activation to be converted into the 
triphosphate, which means that drugs for therapeutic applications need to be good 
substrates for the kinases as well as for the RT. Low conversion to TPs has meant 
that a lot of drug candidates have fallen at this hurdle. Even the ones that have 
succeeded need to be administered in high doses that lead to toxicity problems. 
The phosphorylation pattern of nucleosides strongly depends on their structure. The 
conversion of AZT to AZTMP by thymidine kinase occurs with similar efficiency 
to natural thymidine, whereas for d4T, the efficiency is at least 200 times lower.' 65 
To circumvent the problems associated with NRTIs, introduction of nucleosides as 
masked monophosphate inhibitors has been investigated. 
4.1.2 	Prodrugs 
The reliance on host kinases is an inherent drawback of administering NIRTIs. 
Direct circumvention of phosphorylations is not possible as the nucleoside 
phosphates are susceptible to non-specific dephosphorylations in extra-cellular 
fluids and due to their charge can not penetrate the cell. Several approaches have 
been proposed to introduce prodrugs of the nucleoside monophosphate. 
The concept of prodrugs was introduced to medicinal chemistry in 1957 and is 
defined as molecules without intrinisic biological activity but which are activated 
to give a biologically active drug. 162 The transformations necessary for activation 





4.1.3 	Masked phosphate prodrugs 
Two types of prodrug approaches can be useful in nucleoside drug administration: 
5' carboxylic esters which transiently increase lipophilicity, cellular uptake and 
general bioavailabity and release the nucleoside through esterase activity.' 66 The 
other approach is referred to as kinase by-pass prodrugs, which release the 
nucleoside monophosphate intra-cellularly. The masked pronucleotides can readily 
cross cell membranes and are converted to the active nucleotides by enzymatic or 
chemical activation. A few examples of 5' phosphate prodrugs are described 
below; for a full discussion, the reader is referred to reviews on the topic.' 62" 65 " 67 
Dialkyl phosphate esters 142 were proposed as prodrugs by McGuigan et al., 
however their antiviral activity was generally lower than that of the parent 
nucleoside due to the metabolic 	stability 	of the 	alkyl 	phosphate.' 68 Diaryl 
phosphate esters showed more promise, but anti-viral activity was strongly 
dependent on para-substitution and was not maintained in kinase deficient cell 
lines.' 69  Diphosphoramidates 143 of AZT displayed some anti-viral activity,' 70 but 
due to low synthetic yields were not pursued further.' 7 ' Aryloxy phosphoramidate 
esters 144 were more successful; they retained activity in kinase deficient cells, 
where the nucleoside itself was inactive. 172 
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Figure 4.2 Proposed nucleoside prodrugs 
The intra-cellular release for aryloxy phosphoramidate esters 144 was described as 
proceeding via an esterase mediated ester hydrolysis. The loss of the phenol group 
was induced by intramolecular carboxylate attack on phosphorus. The resulting 
cyclic intermediate spontaneously ring opened to the amino acid phosphoramidate, 
which was indentified in vitro. 173 For the hydrolysis of the P-N bond, a putative 
phosphoramidase was invoked, even though no pure enzyme could be jsolated. 17 ' 
Hydrogen phosphonate derivatives of nucleosides 145 have also been explored. In 
particular, Phosphazid (R = H, Nuc = AZT) is in clinical trials as anti-HIIV drug. 




its selectivity relative to AZT. For the mechanism of action an intra-cellular 
oxidation has been proposed, 174 but is more likely that these compounds simply 
deliver the nucleoside.' 75  H-phosphonate diesters (R = 'Pr, Cy) of various drugs 
(AZT, d4T, ddA) have also been proposed, with some have them having higher 
selectivity indexes than the parent nucleoside.' 76 
Another potential group of prodrugs are boranophosphates. The rationale behind 
this is the significant inhibition of excision from terminated DNA chains observed 
with borano substitution. Thus borano substitution could offer a handle to treat 
variant RT in drug-resistant HTV strains. 177 Amino acid boranophosphoramidates 
146 were proposed by Shaw et al. 178 as a novel prodrugs class, as they not only 
exhibit nuclease inhibition, they also have greater lipophilicity. 
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Figure 4.3 Proposed nucleoside prodrugs 
Other prodrugs concepts involve pH dependant intra-cellular release of masked 
phosphates, such as the cycloSal derivatives 147, which release the phosphate 
under mild basic conditions. The half-life of the prodrugs could be modulated by 
appropriate substitutions on the benzene ring and anti-viral activity could be 
observed in kinase-deficient cells.' 79 
As a final example, Borch et al. developed cellular delivery of anti-cancer drugs 
based on enzymatic reduction and spontaneous explusion of one substituent (the 
nitrofuryl group), which then enables nucleophilic cyclisation of the nitrogen with 
concomitant halide expulsion. 180 The resulting charged phosphoramidate acts as a 
leaving group to deliver the nucleotide. Analogues of 148 with 2'-deoxy-5-
fluorouridine as nucleoside retained their cell proliferation activity when tested on 




4.2 	Aims of the work 
The aims of this part of the work were to establish whether the nucleoside resin 83 
could serve as starting point for the synthesis of nucleoside prodrugs. Such a 
property would be particularly advantageous if different types of prodrugs could be 
accessed from the same intermediate. It is envisaged that the phosphorus on 83 is 






a [R0 	 I 83 
0 
















(a) ROH; (b) oxidation; (c) (i) RNH 2 ; ( ii) oxidation 
Scheme 4.2 Nucleoside prodrug synthesis based on nucleoside resin 
Using an alcohol as a nucleophile, the initial product, the phosphite triester 149, 
reacts further through Arbuzov chemistry to give the phosphonate diester 150. If 
the reaction is intercepted prior to the dealkylation, the phosphorus can be oxidised 
to yield phosphate triester 151. Additionally, more nucleophilic amines should give 
access to diphosphoramidate phosphate esters 152 after oxidation (Scheme 3.4). 
These ideas were investigated using the nucleoside 3'-OAc-T 49 (for preparation, 
see Scheme 2.10). 
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Nucleoside H-phosphonate diesters 
Previous syntheses 
Nucleoside H-phosphonate diesters have been accessed by various methods. The 
mono-H-phosphonate ester, treated with a coupling agent, such as oxalyl 
chloride' 8 ' or pivalyl chloride, 182  gave a mixed anhydride, which yielded the mixed 
diester after addition of the alcohol. Transestenfication of diphenyiphosphite has 
also been proposed to give the double- or mono-exchange H-phosphonates. 183 
Selectivity issues arise for asymmetric targets, but they can be controlled by using 
diphenylphosphite in excess or by its slow addition. 184 
A one-pot synthesis of nucleoside H-phosphonate diesters was recently proposed. 
The nucleoside was treated with an excess of phosphorus trichioride, followed by 
alcoholysis to give the mixed phosphite triester (Scheme 4.3). Dealkylation through 
Arbuzov chemistry proceded spontaneously by involvement of the HC1 generated 
previously to generate the alkylchloride and the phosphonate ester which was 
isolated by careful column chromatography. 185 
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(a) 10 eq PC1 3 , CH202, -30 °C, 1 h, then 6 h, rt; (b) 2.5 eq ROH, CH202 , 0 °C, 30 mm, 
then 2 eq TEA; 18 - 88 % yield. 
Scheme 4.3 Synthesis of nucleoside H-phosphonate diesters 
4.3.2 	Synthesis using a supported Ludwig-Eckstein reagent 
The potential for application to nucleoside prodrugs synthesis was explored by 
starting from nucleoside resin 50 synthesised and charactensed in Chapter 2. The 
resin was subjected to alcohol cleavage as illustrated below (Scheme 4.4). 
One example of cleavage with a hydroxyl group, namely with water, was already 
discussed in Chapter 2, where the mono-H-phosphonate ammonium salt of 3'-
OAc-T 51 was isolated in a 58 % yield (Entry 1, Table 4.1). Thus extending the 
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Scheme 4.4 Nucleoside H-phosphonate diester synthesis based on nucleoside resin 
The supported phosphitylation reagent 44 was loaded with nucleoside 49 to give 
50, as described in Chapter 2, then was treated with benzyl alcohol. Analogously to 
the water cleavage, the reaction time was 10 mm, which was enough to cleave the 
nucleoside off, as evidenced by absence of nucleoside on the resin. Alcohol 
cleavage gave the mixed phosphite triester 153, which was not characterised, but it 
could be detected in the crude 31 P NItvIIR (145 ppm). The eluate was stirred. at rt for 
30 min for the dealkylation reaction to proceed (Scheme 4.5). 
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(a) 3 eq PS-P-Cl 44, 0.1 M py/THF 1/3, lh, ii; (b) BnOH, 10 mm; (c) 30 mm; see Table 
4.1. 
Scheme 4.5 Synthesis of H -phosphonate ester 154 
As the phosphite carries three ester groups, there are three possible CH2 groups to 
dealkylate. This will generate a mixture of the desired mixed H-phosphonate 
diester 154 to starting material 49 and symmetrical H-phosphonate dibenzyl ester 
155 (Scheme 4.6). 
The reaction was carried out at a 0.1 mmol scale with commercial anhydrous 
benzyl alcohol. The reaction mixture was purified by column chromatography to 
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yield the desired compound 154 in an 8 % yield and recovered starting material 49 
in a 24 % yield (Entry 2). Water present in the benzyl alcohol resulted in a 
significant amount of mono-H-phosphonate 51, as evidenced by a baseline spot on 
the tic plate. The benzyl H-phosphonate diester 154 was obtained as a 
diastereomeric mixture at phosphorus, as shown by having two signals in the 31 P 
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Scheme 4.6 Nucleoside H-phosphonate diester synthesis based on nucleoside resin 
A method published recently for H-phosphonate diester synthesis relied also on 
dealkylation of mixed phosphite triesters.' 85 To circumvent undesired dealkylation, 
the authors proposed using a 1:1 mixture of the desired alcohol and tbutanol  and 
thus improved the yield for the ethyl H-phosphonate of AZT from 22 % for ethanol 
alone to 61 % for this mixture. 185  They explained this observation by preferential 
dealkylation of the tb utyl cation over either of the secondary groups. 
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Scheme 4.7 Nucleoside H-phosphonate diester synthesis using 'butanol as additive 
It was thus decided to attempt to reproduce this work for this method. The cleavage 
solution constituted of a 1:1 mixture of anhydrous benzyl alcohol and tert-butyl 
alcohol. Purification of the resulting reaction mixture resulted however in an 




starting material 49. Additionally, the by-product dibenzyl phosphite 155 was 
isolated and was recovered in a 30 % yield based on the nucleoside loading. It is 
equally possible for 155 to result from benzyl alcohol being phosphitylated by the 
remaining functionality on the resin, followed by subsequent cleavage. 
The results for the H-phosphonate esters are summarised below (Table 4.1). It can 
be concluded that it is possible to use an immobilised phosphitylated nucleoside 
such as 50 as a handle for the synthesis of H-phosphonate esters. It was shown that 
mono-esters such as 51 as well as the more challenging diesters, exemplified by 
154, can be accessed. In this instance, the yield was frustrated by the level of water 
contained in the alcohol used. Thus to fully exploit this approach, it will be 
necessary to source dry alcohol. 
Table 4.1 Summary of H-phosphonate ester synthesis 
Entry Cleavage solvent Amount 	Cleavage Yield Yield 	SM 49 
Time (mm) % %a 
1 water 1 mL 	10 58 (51) - 	- 
2 benzyl alcohol 1 mL 10 8 (154) n.d. 24 
3 benzyl alcohol: 1 mL 	10 7 (154) 30' (155) 	48 
tbutanol(1:1)  
a isolated yield, "yield based on nucleoside loading 
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Nucleoside phosphate triesters 
Previous syntheses 
Phosphate triesters have been accessed essentially by two methods: Mitsunobu 
coupling of the H-phosphonate diester to an alcohol' 86 or reaction with the 
corresponding which in turn can be prepared from the H-
phosphonate diester and N-chlorosuccinimide. 18 ' 
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(a) DIAD, PPh 3 , THF, alcohol (R = Bn); (b) pyridine, alcohol (R = Et, Pr, Bu, Bn). 
Scheme 4.8 Synthesis of nucleoside phosphate triesters 
4.4.2 	Synthesis using a supported Ludwig-Eckstein reagent 
Phosphate triester synthesis using alcohol cleavage, followed by solution-phase 
oxidation, as proposed below requires that the oxidation step needs to be more 
rapid than the competing dealkylation reaction, which was exploited in the 
previous section (Scheme 4.9). 












Scheme 4.9 Nucleoside phosphate triester synthesis based on nucleoside resin 
Nonetheless, the cleavage reaction requires a certain amount of time to complete, 
thus a compromise needs to be struck to cleave all the nucleoside off as the 
phosphite triester, but without it decomposing before the oxidation step. It is 
expected that different alcohols will have different relative reaction rates for the 
cleavage and dealkylation steps, so a selection will be attempted to compare them. 
Before performing the reactions on the resin, it was attempted to determine the 
4.4 
4.4.1 
relative reaction times required for the dealkylation and oxidation steps. This was 
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attempted using the solution phase phosphitylation reagent 11. However, this 
approach was limited as the reaction yielded, as expected, the desired phosphate 
triester as well as starting material 3'-OAc-T 49. In the solution phase though, it 
was not possible to determine whether 49 resulted from incomplete phosphitylation 
or dealkylation. 
Thus, the reactions were performed directly on the resin instead; using this 
approach complete phosphitylation could be confidently achieved. As alcohol, 
initially ethanol was used with a cleavage time of 10 min as in the previous section. 
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R =Et, 157 
=Bn, 158 
= 'Pr, 159 OH 
(a) 3 eq Ps-P-cl 44, 0.1 Mpy/THF 1/3, lh,rt; (b) ROH, 10 rnin, (c) 0.5 M 12 in 
pyridine:H20, 98:2, 15 mm, then 5 % NaHS03 ; see Table 4.2. 
Scheme 4.10 Synthesis of phosphate triesters 
The crude reaction mixture was purified by column chromatography eluted with 
with a MeOWCH2C12 gradient, however it was not possible to separate product 
from starting material. The ratio of both compounds was thus determined by 
measuring the integration of the H-i' signal in the 'H proton spectrum of the 
mixture. It was thus determined that the ratio of starting material 49 to product 157 
was 1.00 to 0.13. This shows that for ethanol the dealkylation reaction is already 
mostly complete by the time the reaction mixture is exposed to the oxidant. 
Thus, it seemed valuable to explore a shorter cleavage time for ethanol. The loaded 
resin was therefore cleaved with three 30 sec cleavage steps and after oxidation and 
work-up showed a much more favourable ratio of starting material to product, 
giving an isolated yield 15 % for the product 157. 
Other than the primary alcohol ethanol, other alcohols were explored. Thus, benzyl 
alcohol, as well as a secondary alcohol, iso-propanol, and a tertiary alcohol, tert-
butyl alcohol, were used to synthesise their respective phosphate triesters. 
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Benzyi alcohol and 2-propanol both resulted in giving the desired phosphate 
triesters 158 in 27 % and 159 in 18 % yields respectively. In both instances, no 
starting material was visible by tic, thus the respective phosphite triesters seemed to 
be stable during the 10 minute cleavage step. When using the tertiary tert-butyl 
alcohol however, neither product, nor starting material could be detected, 
indicating that sterics interfered with cleaving the phosphite triester 50. 
The results for the phosphate tnesters are summarised below (Table 2.15). As can 
be seen, a range of phosphate esters can be accessed using this methodology. The 
alcohols used in this study were not dry enough to attain the maxium yields 
possible from the chemistry and were thus limited by producing the mono-H-
phosphonate esters as side-products. 
Table 4.2 Summary of phosphate triester synthesis 
Alcohol Volume Cleavage Yield SM 49 
Time (mm) 
Ethanol 3 x 1 mL 3 x 0.5 15 (157) 10 
benzyl alcohol 1 mL 10 27 (158) I 
2-propanol 1 mL 10 18 (159) I 
'butanol 1 mL 10 / 1 
a  Isolated yields 
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Nucleoside diphosphoramidates 
Previous syntheses 
Synthesis of nucleoside diphosphoramidates is generally not very straightforward. 
Due to the deactivating effect of the nitrogen, treatment of a phosphorochioridate is 
not successful. 187 Thus McGuigan et al. proposed treating the nucleoside with 
POC13 to give the dichiorophosphate intermediate with subsequent treatment with 
an excess of amine, such as amino acids or alkyl amines. 187 The same strategy was 
applied to morpholino and methoxyamino-nucleoside derivatives.' 88 
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(a) 2 eq POC1 3 , PO(OEt) 3 , 0 °C, then 5 eq RNH2 in (CH30CH2)2, 10 eq TEA, 4 °C, 5 d; 21 
-44 %yield. 
Scheme 4.11 Synthesis of nucleoside diphosphoramidates 
4.5.2 	Synthesis using a supported Ludwig-Eckstein reagent 
The putative scheme is outlined below. As amines are rather more powerful 
nucleophiles than alcohols, they should be able to readily achieve cleavage of the 
phosphitylated nucleoside 83 to give phosphoramidite 160. It is then expected that 



















The methodology was explored using benzylamine as a nucleophile. The 
nucleoside 3'OAc-T 49 was loaded onto the supported reagent 44 to give 
nucleoside resin 50. The resin was then subjected to 20 eq of benzylamine 
dissolved in THF at a 1.75 M concentration for 10 mm. No attempts were made to 
identify 162, instead the solution was oxidised with 0.5 M iodine in aqueous 
pyridine and quenched after 15 mm. 31 P NIVIR of the crude mixture revealed two 
major peaks at 15 and 17 ppm, tentatively assigned to 163 and 164. Their presence 
was further corrobated by LC-MS analysis. Purification by column 
chromatography was attempted, but due to the volume of eluent required, the 
products 163 and 164 could not be detected in the fractions. 
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Scheme 4.13 Nucleoside diphosphoramidate synthesis based on nucleoside resin 
This seems to indicate that the cleavage can be successfully performed with 
benzylamine. The resulting phosphoramidite is also readily oxidised under the 
same conditions as for the phosphate triesters. Nonetheless, the purification was not 






The aims of this thesis were to establish whether the method for synthesising 
nucleoside triphosphates of Ludwig and Eckstein, could be improved, by 
transposing it to the solid phase. By developing the Ludwig-Eckstein reagent as a 
solid-supported reagent, the benefits associated with supported reagents could be 
incorporated and hopefully extend its applications. 
The envisaged solid-supported reagent was synthesised by attaching a salicylate 
linker through an ether bond to Merrifield resin. The benzyl ether bond was robust 
enough to survive the conditions required to convert the linker into the reagent; this 
was most efficiently achieved by refluxing the resin with phosphorus trichlonde in 
dry conditions. 
Different solid-supports have established themselves for various applications in 
solid-phase chemistry, thus some were examined in turn. Microporous polystyrene 
was found to give the most satifactory results, as measured by the yield obtained 
for the synthesis of the model substrate 2'deoxy-thymidine triphosphate. Other 
supports investigated were macroporous polystyrene, polystyrene-poly 
ethyleneglycol graft resins, as well as silica based resins. The silica based resins 
were thought to give lower yields due to surface interactions with rigid silica 
surface. For the other resins, a factor that was noted to influence the yield obtained 
was the bead size. As the cleavage step generated a rather unstable species, 
cleavage times were kept short and thus it is expected that for bigger bead size this 
contributing towards lower yields. 
Additionally to an easier and higher yielding synthesis, it was also expected that 
the purification of tnphosphates could be simplified. Most synthesis protocols 
require a desalting step using ion exchange chromatography prior to preparative 
HPLC purification. Using the supported reagent, it was found that the Prep HPLC 
step could be preceeded with an aqueous work-up and thymidine triphosphate was 
isolated as its tetrakis alkylammonium salt in an excellent 50 % yield. 
An alternative reaction sequence was also explored. As opposed to oxidising the 
cyclic tnphosphite ring in solution, on-resin oxidation was explored. As the P (ifi) 
is kept in a tngonal configuration, it was readily oxidised to P (V) using anhydrous 
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tert-butyl hydroperoxide. The pyrophosphate cleavage was not sufficient to drive 
the reaction to completion, resulting in a low isolation yield. However the crude 
triphosphate obtained by on-resin oxidiation was purer, as asserted by HPLC. 
The method developed was then applied to the synthesis of the other three DNA 
tnphosphates. Simple DNA triphosphates could be isolated after Prep HPLC 
purification in good to excellent yield. Some limiations were observed for fast 
running nucleoside tnphosphates such as cytidine tnphosphate. This could be 
circumvented by duplicating the Prep HPLC purification, although this lead to loss 
in yield. The same observation could be made for proparglyamino modified 
pynmidine nucleoside triphosphates. Uridine triphosphate could be obtained in 
pure form after two Prep HPLCs, whereas the even more fast-running cytidine 
analogue could not be isolated using this method and requires ion exchange 
chromatography prior to HPLC purification. 
The method was also tested on the most challenging targets, the fluorescently 
labelled nucleoside triphosphates. A fluorescein labelled uridine analogue was 
synthesised and phosphitylation of the primary alcohol was found to be possible to 
yield the mono-H-phosphonate. Full loading of the nucleoside onto the resin could 
be achieved by increasing the amount of resin, the concentration and the reaction 
time. Treatment of the resin yielded a compound, which could be assigned to the 
expected triphosphate on the basis of its 31 P NMR. 
The applications of the supported reagent could also be extended to synthesis of 
nucleoside prodrugs. The immbolised phosphitylated nucleoside was shown to be 
used as a handle to access mixed phosphonate diesters and phosphate triesters 
using alcohols as cleavage reagents. The dryness of the alcohol was found to be 
very important and presence of water contributed to a lowering of the yield. Initial 
attempts were also made towards synthesising nucleoside phosphoramidates. Their 
presence could be verified spectroscopically, but the purification remained elusive. 
In conclusion, a solid-supported phosphorylation reagent was developed which 
enabled to the synthesis of the natural DNA triphosphates in high yields and which 






6.1 	General Information 
NIVIIR spectra were recorded on a Bruker ARX250, AV300, DPX360 and DPX 400 
spectrometers operating at 250 MHz, 300 MIHz, 360 MIHz and 400 MHz for 'H and 
62.5 MHz, 75 MHz, 90 MHz and 100 MHz for 13C spectra respectively. 31 P NMR 
spectra were recorded on Bruker ARX250 at 101 MHz, referenced to 85 % H3PO4 
in D20. 'H MAS NlvliR spectra were recorded on a Bruker DPX400. Gel phase 13C 
NMIR spectra were recorded on a Bruker DPX 360 or AV300 and and 31 P NMR 
Gel phase spectra on a Bruker DPX 360. Chemical shifts (ö), referenced to the 
residual protonated solvent as an internal standard, are quoted in ppm, coupling 
constants (J) are reported in Hz. Tnphosphate containing compounds were run in 
D20 for 'H and 13C spectra; for 31 P spectra 50 jiL of 2 M TEAB buffer was added. 
The resulting triethylammonium peaks are omitted from the NMR data. The 13C 
NIMIR data of Dmt-containing compounds have been assigned as far as possible. 
However, due to the chiral environment, the Dmt group displays more signals 
depending on the structure 
LRES mass spectra were recorded on a Fisons VG platform quadropole or a Waters 
ZMD single quadropole, equipped with an electronspray ionisation source, 
measuring monoisotopic masses. Major peaks are reported with percentage 
intensities of the base peak. HRMS were run on a Bruker APEX3. 
The Smith Synthesiser from Personal Chemsitry was used to perform microwave 
irradiations. Infra-red spectra were recorded on a BIORAD FTS 135 with a Golden 
Gate ATR access. All samples were run neat. Melting points were determined 
using a Gallenkamp melting point apparatus and are uncorrected. UV-Vis spectra 
were recorded using a 8452 A diode array detector. Microanalysis were performed 
by MEDAC Ltd., Surrey. 
Dry solvents were obtained by passing through an alumina column. Reagents were 
used as purchased from commercial sources unless otherwise specified. TLC 
analysis was carried out using foil-backed sheets coated with silica gel (0.25 mm) 
and containing the fluorescent indicator UV 254. Flash column chromatography was 




RP-HPLC was performed on a Hewlett Packard HP1 100 Chemstation eluting with 
(A) 0.1 % TFAJH20, (B) 0.04 % TFAJMeCN, (C) 0.1 % formic acidJH20 and (D) 
0.1 % formic acid IMeOH using the methods below. 
Method 1: Discovery (Supelco) C18 ODS analytical column, 4.6 mm x 30 mm i.d. 
5 pm, flow rate 1.0 mL min 1 , gradient: 90 % (A) to 10 % (A) in (B) over 3 mm, 
detection by UV at 220, 254, 260, 282 and 440 nm. 
Method 2: Phenomonex (Prodigy) C18 ODS analytical column, 4.6 mm x 150 mm 
i.d. 5 tm, flow rate 0.5 mL min', gradient: 90 % (A) to 10 % (A) in (B) over 10 
mm, detection by UV at 220, 254, 260, 282 and 440 nm. 
Method 3: Phenomonex (Gemini) C18 ODS analytical column, 4.6 mm x 100 thm 
i.d. 5 I.Im, flow rate 1.0 mL min 1 ,.gradient: 90 % (C) to 10 % (C) in (D) over 6 
mm, detection by UV at 214, 220, 254, 280 and 650 nm and ELSD (evaporative 
light scattering detection). 
Preparative RP-HPLC was performed on a Hewlett Packard HP1 100 
Chemstation eluting with (A) 0.1 M TEAB in H20, (B) MeCN and (C) 0.1 M 
NH40Ac in H20 on a Waters (Xterra) RP18 OBD preparative column, 19 mm x 
150 mm i.d. 5 pm at a flow rate of 10 mL min 1 , using the methods below. The 
fractions were collected using a Gilson G2250A robot. 
Method 4: gradient: 100 % (A) for 5 mm, 100 % (A) to 80 % (A) over 15 mm, 80 
% (A) to 0 % (A) in (B) over 4 mm, detection by UV at 230, 254, 260 and 282 nm. 
Method 5: 100 % (A) for 20 mm, detection by IJV at 254, 260 and 282 nm. 
Method 6: gradient: 100 % (A) to 97 % (A) over 8 mm, then isocratic for 14 min in 
(B), detection by UV at 230, 254, 260 and 282 nm. 
Method 7: gradient: 100 % (C) for 5 mm, 100 % (C) to 80 % (C) over 15 mm, 80 
% (C) to 0 % (C) in (B) over 4 mm, detection by UV at 230, 254, 260 and 282 nm. 
Method 8: gradient: 100 % (C) to 95 % (C) over 8 mm, then isocratic for 14 min in 
(B), detection by UV at 254, 260, 282 and 440 nm. 
Method 9: gradient: 100 % (C) to 0 % (C) over 10 mm in (B), detection by UV at 




6.2 	General solid-phase chemistry procedures 
6.2.1 	Calculation of theoretical loading 
The theoretical loading of a resin after a reaction was calculated using the equation: 
New loading (mmol/g) = [Old loading /(1+(Old loading x Mass added x 10)] 
where 'Old loading' is the loading of the starting resin (mmol/g) and 'Mass added' 
is the mass of compound added onto the resin. 
6.2.2 	Colorimetric tests 
6.2.2.1 Quantitative Ninhydrin test 
A known mass of resin (ca. 5 mg) in a small test tube was treated with 3 drops of 
reagent A and 1 drop of reagent B and heated at 100 °C for 10 mm. The test tube 
was cooled and 60 % aq EtOH (2 mL) added. The resin was removed by filtration 
through cotton wool and the deep blue filtrate collected in a 25 mL volumetric 
flask. The resin was washed with a solution of Et 4NC1 (0.5 M in CH202, 2 x 0.5 
mL) and the sample made up to 25 mL with 60 % ãq EtOH. The absorbance at 570 
nm was measured against a reagent blank. The level of amine present was 
calculated using the equation: 
Amount of amine present (mmol/g) = [(A570 x V)I(s570 x m)] x 10 3 
where A570 is the recorded absorbance at 570 nm, V is the final volume (mL), C570 
is an extinction coefficient suitable for most peptides (1.5 x 104 M 1 cm') and in is 
the mass of the resin sample (mg). 
Reagent A 
. Solution 1: Phenol (40.0 g) was dissolved in EtOH (10 mL) with warming 
and then stined over Amberlite mixed-bed resin MB-3 (4.0 g) for 45 mm. 
The mixture was filtered. 
. Solution 2: Potassium cyanide (65 mg) was dissolved in H2O (100 mL). A 2 
mL aliquot of this solution was diluted with pyridine (freshly distilled from 
ninhydrin) and stined over Amberlite mixed-bed resin MIB-3 (4.0 g). The 





Ninhydrin (2.5 g) was dissolved in absolute EtOH (50 mL). 
6.2.2.2 Quantitative Fmoc test 
A known mass of resin (ca. 5 mg) was weighed into a 1 mL SPE syringe and 
treated with 20 % pipendine in DMIF by percolating through the resin bed into a 25 
mL volumetric flask. The filtrate was made up to volume with 20 % piperidine in 
DMIF. The absorbance at 302 nm was measured against 20 % piperidine in DIvIF. 
The loading was calculated using the equation: 
Loading (mmollg) = [(A302 x V)I(E302 x m)] x 103 
where A302 is the recorded absorbance at 302 nm, V is the final volume (mL), e302 
is the extinction coefficient of the piperidyl-fulvene adduct (7.8 x 10 3 M 1 cm') and 
m is the mass of the resin sample (mg). 
6.2.2.3 Qualitative chioranil test 
To a small amount of resin (ca. 1-3 mg), one drop of 2 % acetaldehyde in DIVIF 
was added followed by one drop of 2 % p-chloranil in DIVIF and was allowed to 
stand for 5 mm. Blue stained beads indicated the presence of secondary amines. 
6.2.2.4 Quantitative DMT test 
A small amout of resin (ca. 5 - 10 mg) in 1 mL SPE syringe was treated with 0.5 M 
DMT-Cl in CH202 (0.5 mL), 0.5 M TBAN03 in CH 202 (0.5 mL) and dry pyridine 
(2 drops) for 15 minutes. The resin was drained, rinsed with dry CH2Cl2 (3 x 2 mL) 
and vacuum dried. The resin was weighed into a syringe and treated with 3 % 
trichioroacetic acid in CH 2C12 by percolating through the resin bed into a 25 mL 
volumetric flask and made up to volume. 
The absorbance at 502 nm was measured against 3 % trichioroacetic acid in 
CH202. The level of hydroxyl groups present was calculated using the equation: 
Loading (mmollg) = [(A502 x V)I(E502 x m)] x 10 
where A502 is the recorded absorbance at 502 nm, V is the final volume (mL), e502 
is an extinction coefficient of the DMT cation (7.6 x 10 4 M' cm') and m is the 




6.3 	Experimental for Chapter 2 
6.3.1 	General methods 
6.3.1.1 Preparation of buffers 
TEAB buffer 
Deionised water (650 mL) and TEA (278 mL) were mixed and stirred over an ice-
bath. Dry ice was placed in a concial flask and with tubing fitted to the top was left 
to bubble through the TEA/water solution until pH reached pH 7-8. The solution 
was diluted to 1 L to give a 2 M TEAB buffer and was stored at 4 °C. 
Ammonium acetate buffer 
Ammonium acetate powder (77 g, high purity grade) was dissolved in deionised 
water (500 mL) to a 2 M Ammonium acetate buffer. 
Both buffers were diluted to the required concentration immediately prior to use. 
6.3.1.2 Preparation and purification of reagents for phosphorylation reactions 
Resins 
After attachment of the linker, resins were dried in a vacuum oven at 40 °C for 1 
day, then stored over P205 in a desicator prior to use. 
Nucleosides 
Nucleosides were synthesised using methods described below or purchased from 
Chemgenes Corp (3OAc AI3z, 3'-OAc-C' and 3'-OAc-G'). Nucleosides were 
lyophilised from MeCNIH20 if obtained as an oil and then stored over P205 in a 
desicator prior to use. 
Tributylamine 
Tnbutylamine of >99.5 % purity was suspended in ninhydrin powder and stored for 
1 week with intermittent shaking. The yellow liquid was filtered off and distilled 
from a Kugelrohr @ 0.1 mbar and40 °C. The clear liquid obtained was negative by 
ninhydnn test and stored over 4A MS. 
Bis-tributylanunonium pyrophosphate 
Dowex 50 resin (50 g, 71 % moisture content) was soaked repeatedly with MeOH, 
N113 sat. MeOH, H20, 2 M HC1 and H20 until all solutions were running clear. The 
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dried resin was filled into a 150 mL SPE reservoir. Tetra sodium pyrophosphate 
decahydrate (2.23 g, 5.0 mmol) dissolved in H20 (50 mL) was added onto the 
column and was eluted with H20 (ca. 80 mL) until the pH rose to pH 5. The elutate 
was dropped directly into a stirred solution of Bu 3N (2.38 mL, 10.0 mmol) in EtOH 
(20 mL) stirred over an ice-bath. The eluate was freeze-dried until a white solid - 
appeared (ca. 1 week) and dissolved in anhydrous DMF (10 mL) with activated 4 
A MS to yield a 0.5 M bis(tnbutyiammonium) pyrophosphate solution. 31P NMR 
(121.5 MHz, CDC13) 8 p-11.24. 
Tris-tetrabutylammonium pyrophosphate 
Disodium dihydrogen pyrophosphate (2.22 g, 10.0 mmoi) dissolved in H 20 (50 
mL) was applied to a Dowex 50 column and was eluted with H 20 (ca. 80 mL) until 
the pH rose to pH 5. The elutate was neutralised to pH 7 with addition of 40 % w/v 
aqueous tetrabutylammonium hydroxide solution (18 mL) and then freeze-dried 
until a white solid appeared (ca. 1 week) and dissolved in anhydrous CHC13 (10 
mL) with activated 4 A MS to yield a 0.5 M tris(tetrabutyiammonium) 
pyrophoshate solution. 31P NMIR (121.5 MIHz, CDCI3) 8 p —5.72. 




P,  CI 
Method 1: Pc1 3 (900 j.iL, 10.3 mmol) was added to dry THF (10 mL) at -15 °c, 
then a salicylic acid (1.38 g, 10.0 mmoi) solution in dry pyridine (1.6 mL) and dry 
THF (5 mL) was added dropwise over 5 mm. The reaction mixture was warmed to 
rt and stirred for 15 h. The solid precipitate was filtered off through oven dried 
glassware and the filtrate concentrated in vacuo to yield a white solid (916 mg, 
4.52 mmoi, 45 % yield). Method 2: Salicylic acid (6.98 g, 50.5 mmol) was 
dissolved in dry THF (10 mL) under a N2 atmosphere at 70 °c. pc1 3 (9.0 mL, 103 
mmol) was added down the condenser. Hi gas was trapped by bubbling through 6 
M NaOH solution (100 mL). After 2 h, the reaction was cooled down to rt and THF 
and pc1 3 were evaporated in vacuo. A clear oil (9.46 g, 46.7 mmol, 92 % yield) 
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was distilled off at 110 °C, 0.57 mbar in a Kugelrohr. bp 110 °C at 0.57 mbar, 
lit.' 25- 75 °C at 0.1 mm Hg, 1H NMR (300 MHz, C6D6) 6H  7.93 (111, d, J = 7.5 Hz, 
CH), 7.07 (111, t, J = 7.5 Hz, CH), 6.78 (1H, t, J = 7.5 Hz, CH), 6.68 (114, d, J = 8.1 
Hz, CH), l3  N1VIR (75 M}Iz, C6D6) 8C  153.6 (d, Jpc = 6.9 Hz, CO2), 153.2 (d, Jpc 
= 6.4 Hz, CO), 137.1 (CH), 131.2 (d, Jpc = 2.0 Hz, CH), 125.6 (CH), 120.0 (CH), 
117.0 (d, Jpc = 13.4 Hz, CCO2), 31P NIVIIR (121.5 MIFIz, C6D6) 8P  149.03. 
Methyl 2 g4-dihydroxybenzoate (35) 
0 
HOOH 
Method 1: 2,4-dihydroxybenzoic acid (20.0 g, 0.130 mol) in MeOH (150 mL) was 
treated with conc. H2SO4  (5 mL) and refluxed at 70 °C for 66 h. The reaction was 
cooled to rt, neutralised by adding NaHCO3 powder and evaporated in vacuo. H20 
(500 mL) was added and extracted into CH2C12 (600 mL). The CH2CJ2 layer was 
washed with brine (500 mL), dried (Mg2SO4) and evaporated in vacuo to yield an 
off-white powder (17.3 g, 0.103 mol, 79 % yield). Method 2: To a cooled solution 
of 2,4-dihydroxybenzoic acid (4.66 g, 30.3 mmol) in MeOH (40 mL), SOd2 (10 
mL, 137 mmol, 4.5 eq.) was added dropwise while stirring at 0 °C. The solution 
was refluxed at 50 °C for 2 d and evaporated in vacuo. The residue was dissolved 
in CH2CL2 (50 mL), washed with 5 % NaHCO3 (100 mL) solution, dried (Na2SO 4) 
and concentrated in vacuo to give a salmon powder which was recrystallised from 
MeOHJH20 to yield an off-white powder (4.18 g, 24.9 mmol, 82 % yield). mp 
113-114 °C (aq MeOH), lit.'89 - 116-117 °C (benzene), IR (neat) 3331 (m), 3176 
(m), 1741 (w), 1637 (s), 1615 (s), 1434 (s), 1145 (s), 1095 (s) cm', 1 H NIVER (300 
MHz, CD3CN) 8H  10.80 (111, br signal, o-OH), 7.68 (1H, d, J = 8.7 Hz, o-CH), 
6.40 (1H, dd, J = 8.7, 2.2 Hz, m-CH), 6.34 (1H, d, J = 2.2 Hz, m-CH), 3.87 (311, s, 
CH3), 13C NMIR (75 MIHz, CD 3CN) c  171.4 (C=O), 164.8 (COH), 164.6 (COI-1), 
132.8 (o-CH), 109.1 (m-CH), 106.0 (C), 103.6 (m-CH), 52.8 (CH3), ES m/z (%) 
281.1 (M+TFA-H, 100), IIPLC (X220) tR 3.24 mm (Method 1), Rf 0.44 (7:3 
Hexane:EtOAc, UV). 
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Methyl 2-hydroxy-4-benzyloxybenzoate (36) 
0 
OH 
Using a procedure by Astles et al. 126 , phenol 35 (5.02 g, 29.9 mmol) dissolved in 
acetone (35 mL), treated with KI (2.55 g, 15.4 mmol), Bu4NC1 (51 mg, 0.19 
mmol), K2CO3  (4.74 g, 34.3 mmol) and BnCl (34 mL, 29.5 mmol), was refluxed at 
60 °C for 10 h. The mixture was filtered and the filtrate evaporated in vacuo. The 
pale orange residue was suspended in MeOH (10 mL), sonicated and filtered off to 
yield a white powder (5.53 g, 21.4 mmol, 72 % yield). mp 101-102 0,  lit. 126 - 101-
102 °C, IR (neat) 3332 (m), 3180 (m), 1738 (w), 1665 (s), 1621 (s), 1437 (s), 1344 
(s), 1247 (s), 1094 (s) cm, 1H NIMIR (300 MIHz, CDC13) 8H  11.00 (1H, s, o-OH), 
7.76 (1H, d, J = 8.8 Hz, o-CH), 7.21 - 7.43 (5H, m, Ph), 6.56 - 6.50 (2H, m, m-
CH), 5.09 (2H, s, CH2), 3.93 (3H, s, CH3), 13C N1'IR (75 MiFIz, CDC13) 8C  170.6 
(C=O), 164.8 (C-O), 163.9 (C-0), 136.2 (o-CH), 131.4 (C), 128.9 (CH), 128.8 
(CH), 127.7 (CII), 108.3 (m-CH), 105.8 (C), 101.8 (m-CH), 70.5 (CH2), 52.2 
(CH3), ES mlz (%) 257.1 (M-H, 100), HPLC (X220) tR 4.51 mm (Method 1), Rf 
0.65 (7:3 Hexane:EtOAc, UV). 
2-Hydroxy-4-benzyloxybenzoic acid (37) 
0 
OeOH 
Method 1: Using a procedure by Astles et al.'26 , ester 36 (5.48 g, 21.3 nimol) 
dissolved in 1,4-dioxane (50 mL) and 2 M NaOH solution (25 mL) was refluxed 
for 5 h. The mixture was concentrated in vacuo to give a white residue, which was 
dissolved in water (100 mL) and washed with EtOAc (50 mL). The pH of the 
aqueous layer was adjusted to pH 1 with conc. HCI (ca. 10 mL), after which a 
precipitate formed which was isolated by filtration as a white powder (4.74 g, 19.4 
mmol, 91 % yield). Method 2: Using a procedure as by Dushin & Danishefsky 129 , 
acetonide 39 (25 mg, 89 mol) in DMSO (0.3 mL) was treated with 48 % aqueous 
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KOH (50 j.iL) and the mixture was heated at 60 °C for 30 mm. Upon cooling, the 
solution was acidified with 1 M HC1 and extracted with EtOAc (3 x 5 mL). The 
extracts were washed with water (5 mL) and brine (5 mL), dried (Na2SO4) and 
evaporated in vacuo to yield a white powder (18 mg, 75 pimol, 85 % yield). mp 
184-185.5 °C, lit.' 26- 182 °C, IR (neat) 3012 (w), 2549 (w), 1738 (m), 1655 (s), 
1618 (s), 1453 (s), 1432 (s), 1378 (s), 1237 (s), 1149 (s), 1024 (s) cm', 1H N1\'IR 
(300 IvlIHz, (CD3)2C0) 8H  11.33 (1H, br signal, o-OH), 7.77 (1H, d, o-CH, J= 8.8 
Hz), 7.28- 7.47 (5H, m, Ph), 6.53-6.58 (2H, m, 2 m-CH), 5.16 (2H, s, CH2), 13C 
NMIR (75 MHz, (CD3)2C0) 8C  172.3 (C=O), 165.7 (COH), 165.0 (COH), 137.4 (o-
CH), 132.4 (C), 129.4 (CII), 128.7 (CII), 128.3 (CH), 108.4 (m-CH), 105.9 (C), 
102.2 (m-CH), 70.5 (CH2), ES mlz (%) 243.1 (M-ff, 100), HPLC (X220) tR 3.94 




Using a procedure as per Japan Patent 09194474 127 , 2,4-dihydroxybenzoic acid 
(10.0 g, 64.9 mmol) dissolved in dry acetone (20 mL), Piv 20 (143 mL, 70.5 mmol, 
1.1 eq) and conc. H2SO4  (0.2 mL) was stirred under N2 for 18 h. The mixture was 
evaporated in vacuo and adjusted to pH 6 with 5 % aq K2CO3 (ca. 50 mL). The 
organic layer was extracted with EtOAc (100 mL), washed with H20 (100 mL) and 
brine (100 mL), dried (Na2SO4) and evaporated in vacuo. The resulting slurry was 
dissolved in CH2C12:hexane:EtOAc (33 mL, 5:5:1), resulting in a white precipitate 
and a yellow solution, which was stored at 5 °C for 15 h. The precipitate was 
filtered off and rinsed with hexane:CH2C12 (4:1) to give an off-white powder (5.97 
g, 30.73 mmol, 47 % yield). mp 203-204 °C - lit' 90 203-204 °C (EtOAc), IR (neat) 
3126 (w), 1690 (s), 1590 (s), 1481 (m), 1310 (s), 1255 (s), 1188 (s) cm 1 , ' H NI\'IR 
(400 MHz, (CD3)2C0) 8H  7.69 (1H, d, J = 8.4 Hz, 5-CH), 6.61 (1H, dd, J = 8.4, 2.2 
Hz, 6-CH), 6.39 (1H, d, J = 2.2 Hz, 8-CH), 1.63 (6H, s, CH3), 13C NIVIR (100 
MIHz, (CD3)2C0) 8C 166.5 (C=O), 161.7 (CO), 159.7 (CO), 132.9 (o-CH), 112.9 
(m-CH), 107.6 (C), 107.3 (C), 104.5 (m-CH), 26.7 (CH3), ES mlz (%) 193.0 (M-H 







Using a procedure by Dushin & Danishefsky 129 , acetonide 38 (1.01 g, 5.20 mmol), 
PPh3 (1.46 g, 5.57 mmol, 1.1 eq) and anhydrous BnOH (0.6 mL, 5.80 mmol, 1.1 
eq) were dissolved in dry TIHF (20 mL) at 0 °C. DIAD (1.5 mL, 90 % tech grade, 
6.99 mmol, 1.3 eq) was added in 7 aliquots over 1.5 h. The mixture was warmed to 
rt and stirred for 15 h. The evaporated residue was purified by column 
chromatography eluted with 9:1 hexane:EtOAc to give a white powder (1.41 g, 
4.98 mmol, 96 % yield). mp 72-73 °C, IR (neat) 3070 (w), 1720 (s), 1613 (s), 1586 
(s), 1279 (s) cm', 1H NrvIIR (300 MIHz, CDC13) 6H  7.87 (1H, d, J =8.8 Hz, 5-CH), 
7.3 - 7.4 (5H, m, Ph), 6.72 (111, dd, J = 8.8, 2.6 Hz, 6-CH), 6.50 (1H, d, J = 2.6 Hz, 
8-CH), 5.09 (211, s, CH2), 1.72 (6H, s, CH3), '3C NIVIR (75 MIHz, CDC1 3) & 165.6 
(C=0), 161.1 (CO), 158.0 (CO), 135.8 (C), 131.4 (o-CH), 128.9 (CH), 128.6 (CH), 
127.7 (CH), 111.0 (m-CH), 106.6 (C), 106.5 (C), 102.1 (m-CH), 70.6 (CH2), 26.0 
(CH3), El nVz 284 (M, 4), HRMS (El) for C 17H1 604 M: calcd 284.10486, found 
284.10475, Anal. Calcd. for C 17H1 604: C 71.82, H 5.67, found: C 71.60, H 5.65, 
HPLC 0220) tR 4.32 mm (Method 1), Rf 0.58 (2:1 hexane:EtOAc, UV). 
Methyl 2-hydroxy-benzoate 4-oxymethyl microporous polystyrene resin. 75-
150 jm (40) 
Merrifield resin (20.4 g, 1.75 mmolg 1 , 35.7 mmol) suspended in acetone (250 mL) 
with KI (6.4 g, 38.6 mmol, 1 eq), K2CO3  (14.8 g, 0.11 mol, 3 eq) and 35 (18.0 g, 
0.11 mol, 3 eq) was refluxed at 60 °C for 2 days. The resin was drained, rinsed with 
H20, DMF/ H20, MeOHIH20, DMIF, MeOH, CH 2Cl2 and Et20 (3 x each), vacuum 




reaction mixture, by evaporation in vacuo, neutralisation with 2 M HC1 to pH 7, 
extraction into CH202, washing with sat. NaHCO3 and brine and evaporation in 
vacuo. IR (neat) 3026 (w), 2921 (w), 1668 (s), 1620 (m), 1439 (m), 1253 (s) cm', 
Gel-Phase 13C NIVIR (75 MHz, (CD3)2C0) 6C  170.8 (C=O), 164.3 (2 C-O), 125 - 
135 (resin), 108.6 (rn-CH), 106.0 (C), 102.4 (rn-CR), CR2 signal not observed, 52.1 
(CH3). 
2-Hydroxy-benzoic acid 4-oxymethyl microporous polystyrene resin, 75-150 
rn (41a) 
Resin 40 (ca. 20 g, 35.7 mmol) suspended in THF (100 mL) with 
tetrabutylanimonium hydroxide solution (50 mL, 40 % w/v in H 20) was refluxed at 
70 °C for 2 d. The light orange resin was cooled to r.t., drained, rinsed with H20, 
THF, 2 M HC1/THF (1/1), H20, THFJR20, THF, MeOH, DMF, CH 202 and Et20, 
vacuum oven dried and stored over P 205 . IR (neat) 3025 (w), 2923 (w), 1666 (m), 
1620 (m), 1493 (m), 1240 (s) cm, Gel-Phase 13C NMR (75 MHz, (CD3)2C0) 6C 
172.4 (C=O), 165.1 (2 C-O), 132.4 (o-CH), 128 - 132 (4 CH + resin), 108.5 (m-
CR), 106.0 (C), 102.2 (m-CH), 70.6 (CR2), 41.1 (resin). 
Hydroxymethyl microporous polystyrene resin, 75-150 urn (42) 
OH 
o 
Using a procedure by Basso' 91 , Memfield resin (3.02 g, 1.60 mmolg', 4.83 mmol) 
suspended in DMF (20 mL) was treated with anhydrous cesium acetate (3.16 g, 
16.5 mmol, 3.4 eq) and KI (70 mg, 0.42 mmol) and the resin was stirred at 50 °C 
for 2 days. The resin was drained, washed with H20, MeOH, DMF, C11 202 and 
Et20 and oven dried. Analysis by IR showed C=O stretch at 1735 cm. Resin 
suspended in THF (40 mL) and aq. Bu4NOR solution (40 % w/v in R20, 15 mL) 




and oven dried. IR (neat) 3024 (w), 2921 (m), 2853 (w), 1601 (w), 1493 (s), 1452 
(s), 1028 (m) cm 1 . 
2.2-djmethyl-benzo[1.3]dioxin-4-one 4-oxymethyl microporous polystyrene 
resin, 75-150 jm (43) 
Using a procedure by Basso, 191 hydroxymethyl polystyrene resin 42 (theoretical 
loading 1.64 mmolg 1 , 0.98 g, 1.61 mmol) was washed in dry THF (3 x 15 mL). A 
solution of acejonide 38 (1.12 g, 5.78 mmol) and PPh 3 (1.62 g, 6.18 mmol) in dry 
THF (12 mL) was added and the suspension was treated with DIAD (1.11 mL, 5.75 
mmol) added in 5 aliquots over 30 min and shaken at r.t. for 2 d. The resin was 
filtered, washed with THF, MeOH, DMF, CH202 and Et20 and oven dried. IR 
(neat) 3026 (m), 2921 (m), 1738 (s), 1617 (s), 1493 (s) cm 1 , MAS 1H NM.IR (400 
MHz, CDC13) 8H  7.9 (1H, s, 5-CH), 6.3 - 7.2 (resin background), 5.0 (2H, s, CH2), 
1.3 - 2.0 (resin), 1.7 (6H, s, 2 CH3), Gel-Phase 13C NIVIR (75 MHz, C6D6) 8C 
165.7 (C=O), 160.3 (C-O), 158.3 (C-O), 131.6 (o-CH), 128 - 132 (4 CH + resin), 
110.8 (m-CH), 107.2 (C), 106.1 (C), 102.2 (m-CH), 70.4 (CH2), 40.9 (resin), 25.6 
(CH3), 21.9 (resin). 
2-hydroxy-benzoic acid 4-oxymethyl microporous polystyrene resin, 75-150 
m (41b) 
Resin 43 (theoretical loading 1.27 mmolg', 1.26 g, 1.60 mmol) was swollen in 
THF (15 mL) for 10 mm. 48 % w/v KOH solution (5 mL) was added and stirred at 
60 °C for 7 h. The resin was filtered, washed with H 20 and CH202, swollen in 




DMF, C11202 and Et20. IR (neat) 3025 (w), 2922 (w), 1620 (m), 1589 (m), 1493 
(m), 1370 (s) cm 1 , Gel-Phase 13C NMR (75 MFIz, (CD 3)2C0) 8C 172.4 (C=O), 
165.7 (C-O), 164.8 (C-O), 132.4 (o-CH), 128 - 132 (4 CH + resin), 108.4 (m-CH), 
106.0 (C), 102.2 (m-CH), 70.7 (CH2), 41.1 (resin), 22.2 (resin). 
2-Chloro-4.oxo-benzol1g3.2jdioxaphosphinine 	7-oxymethyl 	microporous 
polystyrene resin g 75-150 urn (44) 
CI 
Resin 41a (300 mg, 0.402.mmol, theoretical loading 1.34 mmolg') was swollen in 
dry CH202 and dry THF (2 x 2 mL for 5 min each) at 60 °C. Pd3 (95 j.LL, 4 eq) 
was added to the resin in dry THF (4 mL) and the syringe was heated at 60 °C for 2 
h. The resin was drained and rinsed with dry CH202 and dry THF (2 x 2 mL for 5 
min each) and dried over P205 in a desicator. Gel Phase 31P N1\tIR (162 MIHz, 
CDCI3) Sp 148.8 ppm (82 % by integration), ICP analysis: P (%) 3.45, Loading 
obtained: 1.11 mmolg', 90 % yield. 
5'-O-(4.4'-Dirnethoxytrityl)-thvmidine (47) 





Thymidine (2.52 g, 10.4 mmol) was suspended in dry pyndine (5 mL) and DMT -
Cl (3.52 g, 10.4 mmol, 1.0 eq) in dry pyndmne (10 mL) was added via canula over 1 
mm. The reaction was stirred under N2 for 2 h, evaporated in vacuo and dissolved 
in CHC13 (20 mL) and H 20 (10 mL). The organic layer was separated, washed with 
H20 (10 mL) and brine (10 mL), dried (Na2SO4), evaporated in vacuo and purified 




foam (5.24 g, 9.63 mmol, 93 % yield). IR (neat) 2929 (w), 1678 (s), 1607 (m), 
1508 (m), 1464 (s), 1249 (s), 1032 (s) cm 1 , 1H N1IR (400 MIHz, CDC1 3 ) 8H  8.72 
(1H, s, H-3), 7.60 (1H, d, J = 1.0 Hz, H-6), 7.18 -7.43 (9H, m, 9 Ar), 6.86 (4H, d, J 
= 8.8 Hz, 4 Ph), 6.43 (1H, dd, J = 7.7, 6.1 Hz, H-i'), 4.59 (1H, m, H-4'), 4.08 (iH, 
q, J = 3.0 Hz, H-3'), 3.82 (6H, s, CH 30), 3.50 (iH, dd, H-5', J = 10.3, 3.3 Hz), 3.42 
(1H, dd, H-5', J = 10.6, 3.0 Hz), 2.84 (iH, s, OH), 2.30 - 2.46 (2H, m, H-2'), 1.51 
(3H, s, Cl3), 13C NMIR (100 MHz, CDC1 3) 8C  163.3 (C-4), 158.5 (COMe), 158.3 
(COMe), 150.0 (C-2), 144.0 (C), 135.3 (C-6), 135.1 (C), 135.1 (C), 129.8 (CH), 
128.8 (CH), 127.8 (CH), 127.7 (CH), 127.5 (CH), 127.5 (CH), 126.9 (CH), 126.8 
(CH), 113.4 (CH), 112.9 (CH), 110.9 (C-5), 86.7 (C), 85.8 (C-4'), 84.4 (C-i'), 72.2 
(C-3'), 63.3 (C-5'), 55.0 (CH 30), 40.6 (C-2'), 11.5 (CH 3), IIPLC 01282) tR 3.89 mm 
(Method 1), Rf 0.19 (4 % MeOHICH 202, ammonium molybdate). 
3'-O-Acetyl-5 ' -O-(4,4' -dimethoxytrityl)-thymidine (48) 







Nucleoside 47 (5.24 g, 9.63 mmol) dissolved in dry pyridine (50 mL) was treated 
with DMAP (283 mg, 2.31 mmol, 0.24 eq), TEA (2.70 mL, 19.2 mmol, 2.0 eq) and 
Ac20 (909 j.tL, 9.62 mmol, 1.0 eq). The mixture was stined for 45 mm, evaporated 
in vacuo, dissolved in EtOAc (100 mL), washed with 5 % NaHCO 3 solution (100 
mL), H2O (50 mL) and brine (50 mL), dried (Na2SO4), evaporated in vacuo and 
purified by column chromatography eluted with 2 % MeOWCH 2C1 2 to yield a 
white foam (5.32 g, 9.60 mmol, 99 % yield). IR (neat) 3330 (w), 3198 (m), 1687 
(s), 1599 (m), 1480 (m), 1372 (m), 1096 (m) cm', 1H NIVER (300 MHz, CDC1 3 ) oH 
9.50 (1H, s, H-3), 7.70 (1H, s, H-6), 7.28 -7.45 (9H, m, 9 Ar), 6.88 (4H, d, J = 8.8 
Hz, 4 Ph), 6.50 (11, dd, J = 8.4, 6.2 Hz, H-i'), 5.49 (1H, m, H-4'), 4.18 (1H, s, H-
3'), 3.83 (6H, s, CH30), 3.51 (2H, m, H-5'), 2.50 (2H, m, H-2'), 2.13 (3H, s, 
COCH3), 1.43 (3H, s, Cl3), 13C NMIR (75 MHz, CDC13) Oc  170.7 (C=OCH3), 
164.1 (C-4), 158.9 (COMe), 150.8 (C-2), 144.4 (C), 135.5 (C-6), 135.4 (C), 135.3 
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(C), 130.2 (CH), 128.3 (CH), 128.2 (CH), 127.4 (CH), 113.5 (CH), 111.9 (C-5), 
87.3 (C), 84.5 (C-4'), 84.2 (C-i'), 75.6 (C-3'), 63.9 (C-5'), 55.4 (CH30), 38.1 (C-
2'), 21.2 (CH30), 12.0 (CH3), HPLC (X282) tR 4.23 mm (Method 1), Rf 0.63 (10 % 






Nucleoside 48 (5.32 g, 9.60 mmol), dissolved in MeOH (50 mL), treated with TFA 
(10 mL), stirred for 1 h, evaporated in vacuo and purified by column 
chromatography eluted with 0-5 % MeOH in 1% AcOHICH202 to yield an off-
white powder (1.48 g, 5.22 mmol, 54 % yield). mp 175-176 °C (MeOH), lit.' 92 - 
174 °C, IR (neat) 3326 (w), 3187 (m), 1705 (s), 1686 (m), 1660 (s), 1480 (m), 
1232 (s), 1096 (m) cni', 1H N1\'IR (300 IvlIFIz, CD30D) oH 7.84 (1H, d, J = 1.3 Hz, 
H-6), 6.28 (iH, dd, J= 8.2, 6.2 Hz, H-i'), 5.31 (iH, dt, J= 2.9, 2.2 Hz, H-4'), 4.10 
(iH, dt, J = 2.9, 2.2 Hz, H-3'), 3.80 (2H, d, J = 2.9 Hz, H-5'), 2.33 (2H, m, H-2'), 
2.09 (3H, s, COCH3), 1.88 (3H, d, J = 1.3 Hz, CH3), 13C N1VIR (75 MIHz, CD30D) 
Oc 172.2 (C=OCH3), 166.3 (C-4), 152.4 (C-2), 137.9 (C-6), 111.9 (C-5), 86.7 (C-
4'), 86.2 (C-i'), 75.4 (C-3'), 63.0 (C-5'), 38.4 (C-2'), 20.9 (CH30), 12.4 (CH 3), 
HIPLC (X282) tR 2.13 mm (Method 1), Rf 0.26 (10 % MeOHJCH202, ammonium 
molybdate). 
2- [3'-O.Acetylthymidine]-4-oxo-benzo[1,3.2ldioxaphoSPhiflifle 	7-oxymethyl 
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Resin 41a (301 mg, 0.361 mmol, theoretical loading 1.34 mmolg') was swollen in 
dry CH202 and dry THF (2 x 2 mL for 5 min each) at 60 °C. Pd 3 (95 /LL, 4 eq) 
was added to the resin in dry THF (4 mL) and the syringe was heated at 60 °C for 2 
h. The resin was drained and rinsed with dry CH202 and dry THF (2 x 2 mL for 5 
min each). 3'OAc-T 49 (235 mg, 0.827 mmol, 2 eq) was evaporated in vacuo from 
dry THF (2 mL), dried over P 205 in a desiccator for 1 h in vacuo and dissolved in 
dry THF (3 mL). The N2 flushed resin was treated with the .nucleoside solution for 
1 h at rt, drained and rinsed with dry THF (2 x 2 mL for 5 mm), then dried over 
P205 in a desicator. Gel Phase 31P NIVIR (162 MHz, CDCI 3) op 127.7 (82 %), 6.7 
(hydrolysed P-Cl reagent), ICP analysis: P (%) 2.67, Loading obtained: 0.861 
mmolg', 91 % yield. 




NH4  OO 	I 
°\r° 
Solution phase procedure: 3'OAc-T 49 (50 mg, 180 jimol) was dissolved in dry 
pyndine (2 mL), evaporated in vacuo and stored under vacuum over P 205 for 1h. 
The residue, dissolved in dry pyridine (0.3 mL) and diluted with dry THF (0.9 mL), 
was treated with freshly prepared 1.0 M 2-chloro-benzo[1,3,2]dioxaphosphinin -4-
one 11 solution in dry THF (355 tL, 0.355 mmol), stirred for 10 mm, treated with 
H20 (1 mL) and evaporated in vacuo. The residue was separated between CH 2C1 2 
(3 mL) and 0.1 M NH4OAc (3 mL). The aqueous phase was purified by Prep 
HPLC eluted with a 0.1 M N}LOAc/MeCN gradient to yield a white hygroscopic 
solid (15 mg, 41 imol, 23 % yield). Procedure using supported reagent: Resin 
41a (207 mg, 0.277 mmol, 1 eq) was swollen in dry CH 202 and dry TIHF (2 x 2 
mL for 5 min each) at 60 °C. PC1 3 (95 tL, 4 eq) was added to the resin in dry THF 
(4 mL) and the syringe was heated at 60 °C for 2 h. 3'OAc-T 49 (27 mg, 95 Mmol, 
0.33 eq) was evaporated in vacuo from dry pyndine (1 mL), dried over P 205 in a 
desiccator for 1 h in vacuo and dissolved in dry pyndine (0.25 mL) and dry THF 
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(0.75 mL). The resin was drained and rinsed with dry CH 202 and dry THF (2 x 2 
mL for 5 min each). The N 2 flushed resin was treated with the nucleoside solution 
for 1 h at rt, drained, rinsed with dry THF (2 x 2 mL for 5 mm) and treated with 
THFJH20 (1/1, 2 mL) for 10 mm. The cleaved product was collected in an RB, 
evaporated in vacuo and separated between CH 2C12 (3 mL) and 0.1 M NH4OAc (3 
mL). The aqueous layer was washed with CH 202 (2 x 3 mL) and purified by Prep 
HPLC eluted with 0.1 M N14 4OAcIMeCN gradient to yield a white hygroscopic 
foam (20 mg, 55 jmol, 58 % yield). mp 72-74 °C, 1H NMR (250 MHz, D20) H 
7.72 (1H, d, J= 1.2 Hz, H-6), 6.35 (1H, dd, J= 8.3, 6.4 Hz, H-i'), 6.76 (1H, d, J= 
637.7 Hz, PH), 5.35 (1H, dt, J = 4.8, 2.3 Hz, H-4'), 4.32 - 4.36 (1H, m, H-3'), 
4.08 (2H, dd, J = 6.1, 2.9 Hz, H-5'), 2.34 - 2.52 (2H, m, H-2'), 2.11 (3H, s, 
COCH3), 1.70 (3H, d, J = 1.2 Hz, CH3), '3C NMR (62.5 MHz, D 20) c  173.9 
(C=OCH3), 166.9 (C-4), 152.1 (C-2), 137.4 (C-6), 112.2 (C-5), 85.4 (C-i'), 83.7 
(d, J = 8.4 Hz, C-4'), 75.7 (C-3'), 63.8 (d, Jpc = 3.9 Hz, C-5'), 36.7 (C-2'), 20.8 
(CH30), 12.0 (CH3), 31P NIVIR (101 MHz, D20) 8p 7.60, ES m/z (%) 347.2 (M-ff, 
100), HRMS (FAB) for C 12H18N208P 1 (M+H): calcd 349.08008, found 
349.08073,.HPLC (X282) tR 8.1 mm (Method 7). 







Solution phase procedure: 3'OAc-T 49 (25 mg, 88 mol) was dissolved in dry 
pyridine (1 mL), evaporated in vacuo and stored under vacuum over P 205 for 1 h. 
The residue, dissolved in dry pyridine (0.3 mL) and diluted with dry THF (0.9 mL), 
was treated with freshly prepared 1.0 M 2-chloro-benzo[1,3,2]dioxaphosphinin-4-
one 11 solution in dry THF (132 ttL, 0.132 mmol, 1.5 eq), stirred for 10 mm, 
treated with 0.5 M bis (tnbutyl ammonium) pyrophosphate in DMF (265 tL, 1.5 
eq) and B113N (85 tL, 4 eq) at rt for 10 mm, then 0.5 M 1 2/pyridine:H20 98:2 (265 




drops of a 5 % aqueous solution of NaHS03 and the reaction solution was 
evaporated in vacuo. The residue was dissolved in H20 (10 mL), stirred for 30 mm, 
washed with CH202 (3 x 5 mL) and purified by Prep HPLC eluted with 0.5 % 
MeCN in 0.1 M TEAB yield a white solid (20 mg, 21.5 j.mol, 24 % yield). 
Procedure using supported reagent: Resin 41a (205 mg, 0.275 mmol, 1 eq) was 
swollen in dry THF (2 x 2 mL for 5 mm) at 60 °C. Pd 3 (95 IiL, 4 eq) was added to 
the resin in dry THF (4 mL) and the syringe was heated at 60 °C for 2 h. 3'OAc-T 
49 (26 mg, 91 j.mol, 0.33 eq) was evaporated in vacuo from dry pyridine (1 mL), 
dried over P205 in a desiccator for 1 h in vacuo and dissolved in dry pyridine (0.25 
mL) and dry THF (0.75 mL). The resin was drained and rinsed with dry THF (2 x 2 
mL for 5 mm). The N2 flushed resin was treated with the nucleoside solution for 1 
h at rt, drained and rinsed with dry THF (2 x 2 mL for 5 mm). The N 2 flushed resin 
was treated three times with 0.5 M his (tributyl ammonium) pyrophosphate in DMIF 
(800 jL, 1.5 eq) and B113N (255 ItL, 4 eq) at rt for 10 min each. The cleaved 
product was collected in an RB with 0.5 M 1 2/pyridine:H20 98:2 (800 /LL, 1.5 eq). 
15 min after the last cleavage, excess iodine was destroyed by adding a few drops 
of a 5 % aqueous solution of NaHS03 and the reaction solution was evaporated in 
vacuo. The residue was dissolved in 0.1 M TEAB (3 mL), stirred for 30 mm, 
washed with CH202 (3 x 3 mL) and purified by Prep HPLC eluted with 0.5 % 
MeCN in 0.1 M TEAB yield a white solid (12 mg, 13 mol, 13 % yield). 1H NMR 
(250 MIHz, D20) 6H 7.78 (114, d, J = 1.1 Hz, H-6), 6.34 (1H, t, J = 7.3 Hz, H-i'), 
5.40 - 5.44 (114, m, H-4'), 4.37 (iH, dd, J = 3.4, 1.7 Hz, H-3'), 4.21 (214, dd, J = 
7.8, 4.6 Hz, H-5'), 2.42 (2H, dd, J = 7.3, 4.0 Hz, H-2'), 2.10 (314, s, COCH3), 1.90 
(314, d, J = 1.1 Hz, CH3), 13C NMIR (91 MHz, D20) 8c174.4  (C=OCH3), 167.6 (C-
4), 152.8 (C-2), 138.2 (C-6), 113.0 (C-5), 85.9 (C-i'), 84.1 (d, Jp = 9.2 Hz, C-4'), 
76.8 (C-3'), 66.9 (d, Jpc = 5.3 Hz, C-5'), 37.4 (C-2'), 21.5 (CH30), 12.6 (CH3), 31P 
N\'ffl (101 MHz, D2012 M TEAB) 8p -5.40 (d, J = 21.1 Hz, P-7), -10.52 (d, J = 
19.4 Hz, P-a), -21.52 (t, J = 19.8 Hz, P-f), ES m/z (%) 523.2 (M-ff, 100), HPLC 















Solution phase procedure: 3'OAc-T 49 (26 mg, 92 ILmol)was  dissolved in dry 
pyridine (1 mL), evaporated in vacuo and stored under vacuum over P205 for 1 h. 
The residue, dissolved in dry pyridine (0.3 mL) and diluted with dry THE (0.9 mL), 
was treated with freshly prepared 1.0 M 2-chloro-benzo[ 1,3,2] dioxaphosphinin-4-
one 11 solution in dry THF (135 tL, 0.135 mmol, 1.5 eq), stirred for 10 mm, 
treated with 0.5 M bis (tributyl ammonium) pyrophosphate in DItvlF (265 ILL,  1.5 
eq) and Bu3N (85 ILL,  4 eq) at rt for 10 mm, then 0.5 M 12/pyridine:H20 98:2 (265 
ILL, 1 . 5  eq) was added. After 15 mm, excess iodine was destroyed by adding a few 
drops of a 5 % aqueous solution of NaHS03 and the reaction solution was 
evaporated in vacuo. The residue was dissolved in H20 (10 mL), stirred for 30 mm, 
then concentrated ammonia (20 mL) was added. After 1 h the solution was 
evaporated in vacuo, the residue dissolved in 0.1 M TEAB (3 mL), extracted with 
CH202 (3 x 3 mL) and purified by Prep HPLC eluted with 0.5 % MeCN in 0.1 M 
'PEAB yield a white solid (29 mg, 32.7 mol, 36 % yield). Procedure using 
supported reagent: Resin 41a (202 mg, 0.271 mmol, 1 eq) was swollen in dry 
TFIF (2 x 2 mL for 5 mm) at 60 °C. Pd3 (95 ILL,  4 eq) was added to the resin in 
dry THE (4 mL) and the syringe was heated at 60 °C for 2 h. 3'OAc-T 49 (25 mg, 
88 jimol, 0.33 eq) was evaporated in vacuo from dry pyridine (1 mL), dried over 
P205 in a desiccator for 1 h in vacuo and dissolved in dry pyridine (0.25 mL) and 
dry THE (0.75 mL). The resin was drained and rinsed with dry THE (2 x 2 mL for 
5 mm). The N2 flushed resin was treated with the nucleoside solution for 1 h at rt, 
drained and rinsed with dry THF (2 x 2 mL for 5 mm). The N2 flushed resin was 
treated three times with 0.5 M bis (tributyl ammonium) pyrophosphate in DMF 
(800 ILL,  1.5 eq) and 13113N (255 ILL,  4 eq) at rt for 10 min each. The cleaved 
product was collected in an RB with 0.5 M 12/pyridine:H20 98:2 (800 ILL,  1.5 e4). 
15 min after the last cleavage, excess iodine was destroyed by adding a few drops 
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of a 5 % aqueous solution of NaHS03. The reaction mixture was diluted with H20 
(20 mL), stined for 30 min and evaporated in vacuo. The residue was dissolved in 
concentrated ammonia (20 mL). After 1 h the solution was evaporated in vacuo, the 
residue dissolved in 0.1 M TEAB (5 mL), washed with CH 202 (3 x 5 mL), 
lyophilised and purified by Prep HPLC eluted with 0.1 M TEAB. The fractions 
containing triphosphate were pooled and lyophilised to remove the buffer to yield a 
hygroscopic solid (42 mg, 47 jAmol, 50 % yield). 1H NMR (250 MHz, D20) oH 
7.68 (1H, d, J = 1.1 Hz, H-6), 6.31 (1H, t, J = 6.9 Hz, H-i'), 4.65 (11-1, dd, J = 8.4, 
5.0 Hz, H-4'), 4.09 - 4.25 (3H, m, H-3' + H-5'), 2.27 - 2.34 (2H, m, H-2'), 1.86 
(3H, d, J= 1.1 Hz, CH3), 13 C NI1VIR (62.5 M1Hz, D20), 0c  167.0 (C-4), 152.1 (C-2), 
137.8 (C-6), 112.1 (C-5), 85.8 (d, J = 9.4 Hz, C-4'), 85.2 (C-i'), 71.1 (C-3'), 65.8 
(d, JPC = 5.6 Hz, C-5'), 38.9 (C-2'), 12.0 (CH3) , 31P NMIR (101 MT-Iz, D20/2 M 
TEAB) Op -5.23 (d, J = 21.1 Hz, P-y), -10.32 (d, J = 20.1 Hz, P-a), -21.45 (t, J = 
20.8 Hz, P-0), ES m/z (%) 480.1 (M-ff, 80), HPLC (X282) tR 9.4 mm (Method 5). 
Methyl 2-hydroxy-4-benzyloxybenzoate macroporous polystyrene resin, 150-
350 urn (56) 
Agropore-Cl resin (5.01 g, available loading 2.0 mmolg', 10.02 mmol) suspended 
in acetone (100 mL) with KI (1.63g. 9.82 mmol, 1.0 eq), K2CO3  (4.16 g, 30.10 
mmol, 3.0 eq) and 35 (5.04 g, 29.8 mmol, 3.0 eq) was refluxed at 70 °C for 90 h. 
The resin was drained, rinsed with DMF/H20, MeOHJH20, DMF, MeOH, DIVIF, 
CH202 and Et20 (3 x 50 mL each). Anal. Found: Cl 1.99, I 1.15, Loading 
obtained: 1.20 mmolg'. 








Resin 56 (4.00 g, 1.20 mmolg 1 , 4.80 mmol) suspended in THF (20 mL) was 
treated with tetrabutylammonium hydroxide (20 mL, 40 % wlv in H20) and heated 
at 75 °C for 24 h. The resin was drained, rinsed with THF, 2 M HCIITHF (1/1), 
THF, DMF/H20, MeOHJH20, DMF, MeOH, DMF, CH 202 and Et20 (3 x 50 mL 
each) and vacuum dried. IR (neat) 2925 (w), 1738 (s), 1669 (w), 1603 (w), 1366 
(m), 1217 (s) cm 1 , Theorectical loading obtained: 1.22 mmolg 1 . 
Methyl 2-hydroxy-benzoate 4-tetraethylene2lycol-oxyrnethyl microporous 
polystyrene resin, 150-300 urn (58a) 
Quadragel resin (11.1 g, 0.894 mmolg', 9.92 mmol), swollen twice in dry THF (2 
x 150 mL), was treated with PPh 3 (11.3 g, 43.1 mmol, 4.3eq) and 35(6.97 g, 41.5 
mmol, 4.2 eq). DIAD (7.8 mL, 39.7 mmol, 4.0 eq) was added in 3 aliquots over 5 
min and was shaken for 12 h. A quantitative DMT test showed the coupling to be 
98 % complete. The resin was drained, rinsed with THF, DMF, MeOH, DMF, 
CH202 and Et20 (3 x 50 mL each) and vacuum dried. IR (neat) 3025 (w), 2970 
(w), 1739 (s), 1667 (m), 1217 (s) cm 1 , Gel-Phase 13C NIVIR (91 MIFIz, (CD 3)2C0) 
6c 172.0 (C=O), 165.6 (C-O), 165.5 (C-O), 148.1 - 147.2 (C-O-CH2), 133.0 (o-
CH), 127.3 - 129.8 (resin), 109.5 (rn-CR), 106.9 (C), 103.0 (rn-CR), 72.0 (CH2), 
70.8 (CH2), 69.5 (CH2), remainder of CH 2 signals obscured, 53.4 (CH 3), 42.0 - 40.0 
(resin), Loading obtained: 0.740 mmolg 1 . 
2-Hydroxy-benzoic acid 4-tetraethylene2lycol-oxyrnethyl microporous 
polystyrene resin, 150-300 urn (59a) 
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Resin 58a (9.45 g, 0.740 mmolg 1 , 6.99 mmol), swollen THF (150 mL) was treated 
with tetrabutylammonium hydroxide (30 mL, 40 % wlv in H20) and was heated at 
65 °C for 2 d. The resin was drained, rinsed with THF, 2 M HCIJTHF (1/1), THF, 
DMFJ17120, MeOHJH20, DMF, MeOH, DMF, CH 2C12 and Et20 (3 x 100 mL each) 
and vacuum dried. IR (neat) 3025 (w), 2918 (w), 1738 (s), 1666 (m), 1238 (s) cm 1 , 
Gel-Phase 13C NMR (91 MIHz, (CD 3)2C0) öc 173.9 (C=O), 166.9 (C-O), 166.0 
(C-O), 147.3 (C-O-CH2), 133.7 (o-CH), 127.6 - 130.7 (resin), 109.3 (m-CH), 107.0 
(C), 103.1 (m-CH), 72.3 (CH2), 71.5 (CH2), 71.3 (CH2), 71.0 (CH2), 69.7 (CH2), 
69.4 (CH2), 69.3 (CH2), 69.1 (CH2), 42.2 - 42.3 (resin), Theoretical loading 
obtained: 0.748 nimolg. 
Methyl 2-hydroxy-benzoate 4-tetraethyleneglycol-oxymethyl macroporous 
polystyrene resin. 150-300 urn (58b) 
Quadrapore resin (2.80 g, 0.756 mmolg 1 , 2.12 mmol), swollen twice in dry THF (2 
x 40 mL), was treated with PPh 3 (2.24 g, 8.53 mmol, 4.0 eq) and 35 (1.46 g, 41.5 
mmol, 4.1 eq). DIAD (1.67 mL, 8.48 mmol, 4.0 eq) was added in 3 aliquots over 5 
min and was shaken for 12 h. A quantitative DMT test showed the coupling to be 
95 % complete. The resin was drained, rinsed with THF, DMF, MeOH, DIvIF, 
CH202 and Et20 (3 x 50 mL each) and vacuum dried. IR (neat) 3024 (w), 2921 
(w), 1738 (s), 1669 (m), 1228 (s) cm, Loading obtained: 0.644 mmolg'. 
2-Hydroxy-benzoic acid 4-tetraethyleneglycol-oxyrnethyl macroporous 
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Resin 58b (1.50 g, 0.64 mmolg 1 , 0.97 mmol), swollen THF (40 mL) was treated 
with tetrabutylammonium hydroxide (8 mL, 40 % w/v in H 20) and heated at 65 °C 
for 2 d. The resin was drained, rinsed with THF, 2 M HCIJTHF (1/1), THF, 
DMFIH20, MeOHJH20, DMF, MeOH, DMF, CH 202 and Et20 (3 x 20 mL each) 
and vacuum dried. IR (neat) 3024 (w), 2920 (w), 1737 (m), 1669 (m), 1240 (s) cm 
, Theoretical loading obtained: 0.650 mmolg'. 
Allyl 24-dihydroxy benzoate (60) 
0 
HOOH 
2,4-Dihydroxy benzoic acid (21.1 g, 137 mmol) was dissolved in DMF (200 mL) at 
70 °C. Proton sponge (27.9 g, 130 mmol) dissolved in DMF (100 mL) was added, 
followed by allylbromide (1.5 eq). The mixture was heated at 70 °C for 1 h, cooled 
to rt and diluted with EtOAc (300 mL) and sat. NaHCO3 solution (500 mL). The 
aqueous phase was extracted with EtOAc (2 x 100 mL) and the combined organic 
phases were washed with 2 M HC1 (2 x 100 mL) and brine (100 mL), dried 
(MgSO4) and evaporated in vacuo to give a purple oil, which solidified upon 
standing. The residue was triturated with hexane to yield an off-white powder (19.8 
g, 102 mmol, 78 % yield). mp 41 - 42 °C, IR (neat) 3335 (w), 1666 (s), 1623 (s), 
1597 (s), 1136 (s) cm 1 , 1H NI'IR (250 MIHz, CDC1 3) 8.  10.97 (1H, s, o-OH), 7.78 
(1H, dd, J = 8.4, 0.7 Hz, o-CH), 6.36 - 6.41 (211, m, 2 m-CH), 6.02 (1H, ddt, J = 
17.2, 10.4, 5.6 Hz, CH=CH2), 5.61 (114, s, p-OH), 5.41 (1H, dq, J = 17.2, 1.4 Hz, 
CH=CH2 trans), 5.31 (1H, dq, J = 10.4, 1.4 Hz, CH=CH2 cis), 4.82 (2H, dt, J = 5.7, 
1.4 Hz, CH2-CHCH2), 13C NIVIR (62.5 MHz, CDC13) öc 169.7 (C=O), 163.4 (C-
0), 162.2 (C-0), 132.0 (CH), 131.6 (CH), 118.7 (CH 2), 108.0 (CH), 105.7 (C), 
103.1 (CH), 65.6 (CH2), ES m/z (%) 193.1 (M-H, 100), HRMS (FAB) for 
C 10H11 04 (M+H): calcd 195.0652, found 195.0660, HPLC (X254) tR 7.41 mm 




Allyl 4-(2-tert-butoxy-2-oxoethoxy)-2-hydroxybenzoate (61) 
0 
OyO)LLOH 
Phenol 60 (1.02 g, 5.23 mmol) dissolved in DMF (20 mL) was treated with NaH 
dispersion (60 % in mineral oil, 204 mg, 5.10 mmol) for 5 mm, then tbutyl 
bromoacetate (770 jiL, 5.21 mmol) was added and stirred at rt for 1 h. The reaction 
was diluted with 10 % w/v LiC1 solution (50 mL), extracted with EtOAc (2 x 50 
mL), dried (MgSO4) and evaporated in vacuo to yield a yellow oil which was 
purified by column chromatography eluted with CH202 to yield a clear oil (1.03 g, 
3.33 mmol, 64 % yield). IR (neat) 2979 (w), 1752 (s), 1732 (w), 1666 (s), 1621 (s), 
1135 (s) cm 1 , 1H NIVIR (400 M}lz, CDC13) 6H  10.92 (1H, s, o-OH), 7.80 (1H, d, J 
= 8.9 Hz, o-CH), 6.47 (114, dd, J = 8.8, 2.5 Hz, m-CH), 6.40 (114, d, J = 2.5 Hz, m-
CH), 5.97 - 6.07 (1H, m, CH=CH2), 5.41 (114, ddt, J = 17.2, 1.5, 1.5 Hz, CH=CH2 
trans), 5.31 (1H, ddt, J = 10.4, 1.5, 1.5 Hz, CH=CH2 cis), 4.82 (214, dt, J = 4.5, 1.4 
Hz, CH2-CH=CH2), 4.53 (2H, s, CH20), 1.49 (914, s, 3CH3), 13C NIVER (100 MHz, 
CDC13) 8C  169.5 (C=0), 167.1 (C=O), 163.8 (C-O), 163.8 (C-0), 132.0 (CH), 
131.8 (CH), 131.4 (CII), 118.7 (CH2), 107.7 (CH), 106.2 (C), 101.6 (CH), 82.8 (C), 
65.5 (CH2), 65.5 (CH 2), 28.0 (CH3), APCI mlz (%) 307.2 (M-ff, 100), HPLC 
01254) tR 8.33 mm (Method 3), Rf 0.74 (EtOAc, KMn04). 
Allyl 4-carboxymethoxy-2-hydroxy-benzoate (62) 
0 
HO(.. Q}L..oH 
Ester 61 (650 mg, 2.11 mmol) dissolved in CH2C12 (4 mL) was treated with Et3SiH 
(800 giL, 5.01 mmol, 2.4 eq) and TFA (2 mL, 26.0 mmol, 12.3 eq) and stirred for 
2.75 h. The reaction mixture was evaporated in vacuo to to yield an off-white 
powder which was purified by column chromatography eluted with 
hexane:EtOAc:AcOH (2:1:0.02, 1:1:0.02) to yield a white solid (360 mg, 1.43 




CH), 6.53 (111, dd, J = 8.9, 2.5 Hz, m-CH), 6.45 (111, d, J = 2.5 Hz, m-CH), 6.02 - 
6.11 (1H, m, CH=CH 2), 5.41 (1H, d, J= 17.2 Hz, CH=CH2trans), 5.29 (1H, d, J= 
10.5, Hz, CH=CH2 cis), 4.83 (21-1, d, J = 5.5 Hz, CH2-CH=CH2), 4.81 (2H, s, 
CH20), 13C NMIR (100 MHz, CDC1 3) öc 171.9 (C=O), 170.8 (C=O), 165.5 (C-O), 
164.9 (C-O), 133.4 (CH), 132.6 (CR), 118.9 (CH2), 108.6 (CR), 107.3 (C), 102.8 
(CR), 66.6 (CH2), 65.9 (CH2), ES m/z (%) 251.1 (M-ff, 100), HRMS (FAB) for 
C 12H1306 (M+H): calcd 253.07121, found 253.07119, Rf 0.51 (98:2 
EtOAc:AcOH, bromophenol blue). 
Allyl 2hydroxy4-(propylcarbamovlmethoXV)-beflZOate CPG (63) 
Trisoperl CPG (340 mg, 0.225 mmolg', 68 j.Lmol) in CH 2C12IDMF (4/1, 5 mL) was 
treated with linker 62 (169 mg, 670 tmo1), DIC (93 ItL, 633 imo1) and HOBt (106 
mg, 693 mol) and was heated at 60 °C for 3.5 h. The resin was drained, rinsed 
with CH202, DMF, MeOH and CH202 (3 x 10 mL each) and vacuum dried. 
Ninhydrin test: negative, Theoretical loading: 0.214 mmo1g. 
2-Hydroxy-4-(propylcarbamovlmethoxV)-beflZOiC acid CPG (64) 
OH 
Resin 63 (300 mg, 0.214 mmolg', 64 mol) in THE (5 mL) was treated with 
morpholine (20 tL, 0.229 mmol, 3.6 eq) and [Pd(PPh 3 )4] (2.7 mg, 2.3 jLmol, 3.7 
mol %) for 1 h at rt. The resin was drained, rinsed with CH 202 , DIvIIF, MeOH and 
CH202, then suspended in CH202, treated with CH 2C12/AcOH 4/1, then rinsed 
with CH202, DMF, MeOH and CH202 (3 x 10 mL each) and vacuum dried. 
Theoretical loading: 0.227 mmolg'. 
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5-Amino-hexanoic acid propylamide CPG (65) 
r NA( NH2 
Trisoperl CPG (515 mg, 0.225 mmolg 1 , 0.116 mmol) in CH2C12IDMIF (4/1, 10 
mL) was treated with Fmoc-Ahx-OH (408 mg, 1.15 mmol), DIC (162 ItL, 1.16 
mmol) and HOBt (202 mg, 1.16 mmol) and was heated at 60 °C. After 7 h, a 
further 10 eq of DIC were added. The resin was drained after 24 h, rinsed with 
DMF, MeOH, CH202 and Et20 (3 x 10 mL each). The resin was capped by 
shaking with Ac 20/pyridine (2 mL, 1/1) in CH 202 (3 mL) for 2 h. The resin was 
drained, rinsed with DMFIH20, MeOHJH20, DMF, MeOH, CH202 and Et20 (3 x 
10 mL each) and vacuum dried. The resin was deprotected with 20 % piperidine in 
DMF (3 x 10 mm), drained and rinsed with DMF, MeOH, CH2C12 and Et20 (3 x 10 
mL each) and vacuum dried. Loading obtained: 0.162 mmolg 1 (72 % yield) 
(Quantitative Fmoc test). 
Allyl 2-hydroxy-4- [(5-propylcarbamoyl-pentylcarbamoyl)-methoXVl-benZOate 
CPG (66) 
0 
o 	 0 
€r00  
Resin 65 (510 mg, 0.162 mmolg', 83 JLmol) in CH2C12IDMF (4/1, 5 mL) was 
treated with linker 62 (206 mg, 0.817 mmol), DIC (116 AL, 0.833 mmol) and 
HOBt (137 mg, 0.895 mmol) and was heated at 60 °C for 4 h. The resin was 
drained, rinsed with CH202, DMF, MeOH and CH2C12 (3 x 10 mL each) and 






1 Aro • OH 
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Resin 66 (532 mg, 0.156 mmolg, 83 imo1) was treated with [Pd(PPh 3 )4] (2.9 mg, 
2.5 /Lmol, 3.0 mol %), morpholine (22 jiL, 252 jimol, 3.0 eq) in THF (5 mL) and 
shaken at it for 90 mm. The resin was drained, rinsed with CH 202 , DMF, MeOH 
and CH202, then suspended in CH 202, treated with CH2C12/AcOH 4/1, then rinsed 
with CH2Cl2, DMF, MeOH and CH202 (3 x 10 mL each) and vacuum dried. 
Theoretical loading: 0.157 mmolg'. 
Allyl 2-hydroxy-4-(propyloxy)-benzoate silica (68) 
0 
0 /—N'~~O&OH
Bromopropylsilica (3.27 g, 1.43 mmolg 1 , 4.68 mmol) was suspended with linker 
60 (4.54 g, 23.4 mmol, 5 eq) and DIPEA (4 mL, 23.4 mmol, 5 eq) in THF (25 mL) 
and was heated at 40 °C for 34 h. The resin was drained, rinsed with THF, CH 202 , 
MeOH, DMF, CH202 and Et20 and vacuum dried. Anal. Found: Br 7.03, Loading 
obtained: 0.350 mmo1g. 
Allyl 2-hydroxy-4-(benzyloxv)-benzoate silica (69) 
Allyl 2,4-dihydroxybenzoate 60 (4.52 g, 23.3 mmol, 5 eq) in THF (25 mL) was 
treated with NaH (60 % in mineral oil, 946 mg, 23.7 mmol, 5.2 eq) for 5 min to 
give a green solution. Chlorobenzylsilica (3.37 g, 1.34 mmo1g, 4.52 mmol) was 
added and heated at 50 °C for 48 h. The resin was quenched with MeOH, drained, 
rinsed with DMFIH20, MeOHJH20, DMF, MeOH, CH202, and Et20 and vacuum 
dried. Anal. Found: Cl 1.98, Loading obtained: 0.550 mmo1g. 
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Allyl 4-benzyloxy-2-hydroxy benzoate (70) 
0 
Phenol 60 (1.04 g, 5.33 mmol) in acetone (20 mL), treated with K2CO3  (3.28 g, 
23.8 mmol) and BnBr (650 tiL, 5.47 mmol, 1.03 eq), was refluxed at 75 °C for 3 h 
until complete (HPLC). The reaction mixture was evaporated in vacuo, quenched 
with 2 M HC1 (75 mL) and extracted into Et 20 (75 mL). The organic layer was 
washed with sat. NaHCO 3 solution (50 mL) and brine (50 mL), dried (MgSO 4) and 
evaporated in vacuo. The oily residue was sonicated in MeOH to yield a white 
suspension which was filtered off and dried to yield a fine white powder (670 mg). 
The filtrate was evaporated and purified by colun chromatography eluted with a 0 
- 10 % Et20:hexane to yield white crystals (3L mg). (Combined yield: 1.05 g, 
3.69 mmol, 69 % yield). mp 60-61 °C, IR (neat) 3069 (w), 1652 (s), 1613 (s), 1369 
(s), 1247 (s) cm 1 , ' H NI1VIR (250 MIHz, CDC1 3) oH 10.97 (1H, s, o-OH), 7.80 (1H, 
dt, J = 8.9, 1.0 Hz, o-CH), 7.22 - 7.37 (5H, m, Ar), 6.42 - 6.46 (2H, m, 2 rn-CR), 
6.03 (1H, ddt, J = 17.2, 10.4, 5.6 Hz, CH=CH2), 5.42 (1H, ddt, J = 17.2, 1.5,1.5 
Hz, CH=CH2 trans), 5.31 (1H, ddt, J= 10.4, 1.5, 1.5 Hz, CH=CH2 cis), 5.08 (2H, s, 
CH20), 4.82 (2H, dt, J = 5.6, 1.4 Hz, CH2-CH=CH2), 13C NMR (62.5 MHz, 
CDC13 ) 0c  169.6 (C0), 164.7 (C-0), 163.8 (C-0), 136.0 (C), 131.8 (CII), 131.3 
(CH), 128.6 (CH), 128.2 (CH), 127.5 (CR), 118.6 (CH 2), 108.1 (CR), 105.6 (C), 
101.6 (CR), 70.1 (CR 2), 65.5 (CH2), APCI m/z (%) 283.2 (M-H, 100), HRMS 
(FAB) for C 17R1704 (M+H): calcd 285.1127, found 285.1138, HPLC 01254) tR 
4.57 mm (Method 1), 8.39 mm (Method 3), Rf 0.28 (5:95 Et20:hexane, PMA). 




Silica 68 (ca. 3.0 g, 0.350 mmolg', Ca. 1.0 mmol) in THF (10 mL) was treated 




mol %) in THF (1 mL) for 1 h at rt. The resin was drained, rinsed with THF, 
THF/H20, C14202 and vacuum dried. Theoretical loading: 0.355 mmolg 1 . 
2-Hydroxy-4-(benzyloxy)-benzoic acid silica (72) 
Silica 69 (ca. 3.0 g, 0.550 mmolg 1 , Ca. 1.7 mmol) in THF (10 mL) was treated 
with phenylsilane (940 IzL, 7.62 mmol, 5 eq) and [Pd(PPh 3 )4] (92 mg, 80 timol, 5 
mol %) in THF (1 mL) for 1 h at rt. The resin was drained, rinsed with TIfF, 
THFIH20, CH202 and vacuum dried. Theoretical loading: 0.560 mmolg 1 . 
Methyl 2-hydroxy-4-benzyloxybenzoate microporous polystyrene resin 38-75 
JLffl (73) 
Memfield resin (24.0 g, 1.2 mmolg 1 , 28.8 mmol) was suspended in acetone (250 
mL) with 1(1 (5.5 g, 33.1 mmol, 1.1 eq), K2CO3  (13.4 g, 97.0 mmol, 3.4 eq) and 35 
(14.8 g, 88.0 mmol, 3.0 eq) and refluxed at 70 °C for 2 days. The resin was drained, 
rinsed with acetoneI171 20, H20, MeOHJH20, DMF, MeOH, DMF, CH202 and Et20 
(3 x each). IR (neat) 3024 (w), 2918 (w), 1719 (s), 1667 (s), 1252 (s) cm 1 , Anal. 
Found: Cl 0.98, I <0.10, Loading obtained: 1.01 mmolg'. 
Methyl 2-hydroxy-4-benzyloxybenzoate microporous polystyrene resin, 150-




Merrifield resin (5.1 g, 1.7 mmolg 1 , 8.67 mmol) was suspended in acetone (50 
mL) with Ku (1.4 g, 8.4 mmol), K2CO3  (3.6 g, 26.0 mmol, 3.0 eq) and 35 (14.4 g, 
85.6 mmol, 3.0 eq) and refluxed at 70 °C for 2 days. The resin was drained, rinsed 
with acetonefll20, H20, MeOHJH20, DMF, MeOH, DMF, CH202 and IEt20 (3 x 
each). IR (neat) 3026 (w), 2920 (w), 1669 (s), 1662 (m), 1348 (m), 1254 (s) cm 1 , 
Anal. Found: Cl 1.60, I <0.10, Loading obtained: 1.39 mmolg 1 . 
2-Hydroxy-benzoic acid 4-oxymethyl microporous polystyrene resin, 38-75 Im 
Iz 
Resin 73 (ca. 24 g, 28.8 mmol) suspended in THF (250 mL) with 
tetrabutylammonium hydroxide solution (50 mL, 40 % w/v in H 20) was refluxed at 
70 °C for 2 d. The light orange resin was cooled to rt, drained, rinsed with H 20, 
THF, 2 M HC1/THF (1/1), H 20, TH1F/H20, THF, MeOH, DMF, CH202 and Et20. 
IR (neat) 3024 (w), 2919 (w), 1666 (s), 1600 (m), 1492 (m) cm 1 , Theorectical 
loading: 1.05 mmolg'. 
2-Hydroxy-4-benzyloxybenzoic acid microporous polystyrene resin, 150-300 
m (76) 
Resin 74 (ca. 5 g, 8.67 mmol) suspended in THF (50 mL) with 
tetrabutylammonium hydroxide solution (10 mL, 40 % w/v in H 20) was refluxed at 
70 °C for 2 d. The light orange resin was cooled to rt, drained, rinsed with H 20, 
THF, 2 M HC1/THF (1/1), H20, THFJH20, THF, MeOH, DMF, CH 202 and Et20. 
IR (neat) 3026 (w), 2924 (w), 1740 (m), 1666 (s), 1604 (m), 1367 (m), 1219 (s) 
cm 1 , Theorectical loading: 1.42 mmolg'. 
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6.3.3 	Phosphorylations using different resin supports 
General method: synthesis of dTTP 
Resin (0.27 mmol, 1 eq) was swollen in dry THF (2 x 2 mL for 5 mm) at 60 °C. 
PC13 (95 tiL,  4 eq) was added to the resin in dry THF (4 mL) and the syringe was 
heated at 60 °C for 2 h. 3'OAc-T 49 (90 jtmol, 0.33 eq) was evaporated in vacuo 
from dry pyridine (1 mL), dried over P 205 in a desiccator for 1 h in vacuo and 
dissolved in dry pyndine (0.25 mL) and dry THF (0.75 mL). The resin was drained 
and rinsed with dry THF (2 x 2 mL for 5 mm). The N2 flushed resin was treated 
with the nucleoside solution for 1 h at rt, drained and rinsed with dry THF (2 x 2 
mL for 5 mm). The N2 flushed resin was treated three times with 0.5 M bis (tributyl 
ammonium) pyrophosphate in DMF (800 .iL, 1.5 eq) and Bu 3N (255 tL, 4 eq) at rt 
for 10 min each. The cleaved product was collected in an RB with 0.5 M 
12/pyndine:H20 98:2 (800 iL, 1.5 eq). 15 min after the last cleavage, excess iodine 
was destroyed by adding a. few drops of a 5 % aqueous solution of NaHS0 3 . The 
reaction mixture was diluted with H 20 (20 mL), stirred for 30 min and evaporated 
in vacuo. The residue was dissolved in concentrated ammonia (20 mL). After 1 h 
the solution was evaporated in vacuo, the residue dissolved in 0.1 M TEAB (5 mL), 
washed with CH202 (3 x 5 mL), lyophilised and purified by Prep HPLC eluted 
with 0.1 M TEAB on a C18 column. The fractions containing tnphosphate were 
pooled and lyophilised to remove the buffer to yield a hygroscopic solid. 
Table 6.1 Summary of syntheses for dTTP using dWerent  resins 
Resin Type Bead size Loading Resin Yield 
(tim) (mmol g') (mg) (%) 
41a Microporous PS gel 75-150 1.34 201 50 
57 Macroporous PS rigid 150-350 0.93 289 15 
59a Quadragel gel 150-300 0.75 372 19 
59b Quadrapore rigid 150-300 0.65 413 26 
71 Silica rigid 40-63 0.35 774 8 
72 Silica rigid 40-63 0.56 435 4 
75 Microporous PS gel 38-75 1.05 290 13 




6.4 	Experimental for Chapter 3 
6.4.1 	General methods 
Triphosphate synthesis: 0.1 mmol scale 
Resin 41a (0.27 mmol, 1 eq) was swollen in dry THF (2 x 2 mL for 5 mm) at 60 
°C. Pd 3 (95 A L, 4 eq) was added to the resin in dry THF (4 mL) and the syringe 
was heated at 60 °C for 2 h. Nucleoside (90 .tmol, 0.33 eq) was evaporated in 
vacuo from dry pyridine (1 mL), dried over P 205 in a desiccator for 1 h in vacuo 
and dissolved in dry pyridine (0.25 mL) and dry THF (0.75 mL). The resin was 
drained and rinsed with dry THF (2 x 2 mL for 5 mm). The N2 flushed resin was 
treated with the nucleoside solution for 1 h at it, drained and rinsed with dry TFIF 
(2 x 2 mL for 5 mm). The N2 flushed resin was treated three times with 0.5 M bis 
(tributyl ammonium) pyrophosphate in DIVIF (800 p.L, 1.5 eq) and B113N (255 j.xL, 4 
eq) at rt for 10 min each. The cleaved product was collected in an RB with 0.5 M 
12/pyndine:H20 98:2 (800 jtL, 1.5 eq). 15 min after the last cleavage, excess iodine 
was destroyed by adding a few drops of a 5 % aqueous solution of NaHS0 3 . The 
reaction mixture was diluted with H 20 (20 mL), stined for 30 min and evaporated 
in vacuo. The residue was dissolved in concentrated ammonia (20 mL). After 1 h 
the solution was evaporated in vacuo, the residue dissolved in 0.1 M TEAB (5 mL), 
washed with CH202 (3 x 5 mL), lyophilised and purified by Prep HPLC eluted 
with 0.1 M TEAB on a C18 column. The fractions containing triphosphate were 
pooled and lyophilised to remove the buffer to yield a hygroscopic solid. 
6.4.2 	Synthesis of compounds and resins 
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Using general procedure: 3OAcCBz  77 (33 mg, 89 p.mol) and resin 41a (199 
mg, 0.270 mmol, 1 eq) were used. The nucleoside was dissolved in dry pyridine 
(0.25 mL), dry DMF (0.25 mL) and dry THF (0.50 mL) to load onto the resin. The 
final deprotection step was left for 1 h and the residue was purified twice by Prep 
IHPLC eluted with 0.1 M TEAB to yield a white hygroscopic solid (9 mg, 10 j.tmol, 
12 % yield). 1H NMR (250 MHz, D20) 6H  8.14 (1H, d, J = 7.7 Hz, H-5), 6.43 (1H, 
t, J = 6.7 Hz, H-i'), 6.29 (111, d, J = 7.5 Hz, H-4), 4.73 (iH, t, J = 5.2 Hz, H-4'), 
4.31 —4.33 (311, m, H-3' + H-5'), 2.54 (iH, ddd, J = 14.1, 6.3, 3.8 Hz, H-2'), 2.37 - 
2.48 (111, m, H-2'), 13C N1VIR (62.5 MHz, D 20) 8C  164.9 (C-4), 153.6 (C-2), 142.6 
(C-6), 96.7 (C-5), 86.0 (d, Jpc = 9.2 Hz, C-4'), 85.9 (C-i'), 71:0 (C-3'), 65.6 (d, JPC 
= 5.9 Hz, C-5'), 39.8 (C-2'), 31P NIVJIR (101 MiHz, D20) op -9.62 (d, J = 18.8 Hz, 
P-y), -10.24 (d, J = 20.2 Hz, P-ct), -22.08 (t, J = 18.1 Hz, P-13),  ES m/z (%) 466.2 
(M-Ff, 100), HPLC (?280) tR 6.29 mm (Method 5). 
Guanidine 5'-triphosphate tetraethylammonium salt (81) 
0 




Using general procedure: 3'0Ac-G'' 78 (33 mg, 87 p.mol) and resin 41a (205 
mg, 0.272 mmol, 1 eq) were used. The final deprotection step was left for 15 h and 
the residue was purified by Prep HPLC eluted with 0.1 M TEAB to yield a white 
hygroscopic solid (22 mg, 24 j.imol, 28 % yield). 'H NMR (250 MIHz, D20) 0H 
7.94 (iH, s, H-8), 6.21 (1H, dd, J = 8.1, 6.0 Hz, H-i'), 4.63 - 4.67 (1H, m, H-4'), 
4.14 (1H, t, J = 3.7 Hz, H-3'), 4.06 (2H, dd, J = 9.7, 5.2 Hz, H-5'), 2.68 (1H, ddd, J 
= 14.3, 8.1, 6.2 H, H-2'), 2.39 (iH, ddd, J = 14.1, 6.3, 3.1 Hz, H-2'), 31P NMR 
(101 MHz, D20) opO.Oi (d, J = 19.3Hz, P-y), -10.25 (d, J = 20.3 Hz, P-a), -21.66 
(t, J = 19.6 Hz, P-13),  ES m/z (%) 506.1 (M-If, 100), HPLC (X280) tR 13.89 mm 
(Method 5). 
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P, 0--~—Oj ccc 
OH 
4 HNEt3 
Using general procedure: 3OAcABz  79 (38 mg, 95 p.mol) and resin 41a (205 
mg, 0.272 mmol, 1 eq) were used. The final deprotection step was left for 15 h and 
the residue was purified by Prep HPLC eluted with 0.1 M TEAB to yield a white 
hygroscopic solid (38 mg, 42 zmol, 45 % yield). 'H NMR (250 MBz, D20) 8H 
8.31 (11-1, s, H-2), 8.06 (1H, s, H-8), 6.32 (1H, t, J= 6.5 Hz, H-i'), H-4' obscured 
by H20 peak, 3.94 - 4.12 (314, m, H-3' + H-5'), 2.61 - 2.72 (1H, m, H-2'), 2.37 - 
2.47 (1H, m, H-2'), 31P NMR (101 MIHz, D20) op -5.60 (d, J = 20.7 Hz, P-y), -9.99 
(d, J = 19.7 Hz, P-a), -21.15 (t, J = 20.5 Hz, P-13), ES mlz (%) 490.1 (M-ff, 40), 
HPLC (X280) tR 6.29 mm (Method 5). 





3'-OAc-T 49 (55 mg, 0.19 mmol) was dissolved in dry pyndine (2 mL), evaporated 
in vacuo and stored under vacuum over P205 for 1 h. The residue, dissolved in dry 
pyridine (0.25 mL) and diluted with dry THF (0.75 mL), was treated with freshly 
prepared 1.0 M 2-chloro-benzo[ 1 ,3 ,2]dioxaphosphinin-4-one 11 solution in dry 
THF (290 AL, 290 jmol, 1.5 eq). After 10 mm, 0.5 M 12  in 98:2 pyndine:H20 (580 
L, 0.290 mmol, 1.5 eq) was added. The reaction was quenched with H20 (1 mL) 
after 5 min and evaporated in vacuo. The residue was dissolved in 0.1 M TEAB 
buffer (10 mL), washed with CH202 (3 x 5 mL) and lyophilised. The residue was 
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purified by Prep HPLC eluted with 5 % MeCN in 0.1 M ammonium acetate to 
yield a white hygroscopic solid (25 mg, 50 tmol, 27 % yield). 1H NMR (250 MHz, 
D20) 6H  7.33 (1H, d, J = 1.1 Hz, H-6), 7.25 (1H, d, J = 7.7 Hz, CH), 6.99 —7.11 
(214, m, CR), 6.85 (1H, td, J = 7.2, 1.2 Hz, CR), 6.01 (1H, dd, J = 8.1, 6.4 Hz, H-
1'), 4.99 (1H, dt, J = 4.5, 2.2 Hz, H-4'), 4.04 (111, dt, J = 5.0, 2.6 Hz, H-3'), 3.91 
(1H, d, J = 3.8 Hz, H-5'), 3.88 (1H, d, J = 4.3 Hz, H-5'), 1.99 - 2.14 (211, m, H-2'), 
1.79 (3H, s, COCH3), 1.42 (3H, d, J = 1.1 Hz, CR3), '3C N1VER (62.5 MHz, D20) 
c 173.9 (C0), 173.9 (C0), 166.8 (C-4), 152.1 (C-2), 149.5 (d, Jpc = 6.5 Hz, C-
0), 137.6 (C-6), 132.1 (CR), 130.1 (CR), 124.3 (CR), 120.1 (d, Jpc = 1.9 Hz, CR), 
112.1 (C-5), 85.5 (C-i'), 83.5 (d, Jpc = 9.2 Hz, C-4'), 75.8 (C-3'), 66.2 (d, Jpc = 
4.9 Hz, C-5'), 36.6 (C-2'), 20.8 (CH 30), 11.9 (CR3), 31P NMR (101 MHz, D20) 8P  
-3.91, ES m/z (%) 483.1 (M-ff, 100), HPLC (X282) tR 13.6 mm (Method 8 
(tp5g25)). 
2-I3'-O-Acetylthymidinel-2-iodo-4-oxo-benzo[1.3,2ldioxaphosphonium iodide 
7-oxymethyl resin (90) 
0 
(@rc~ 
	9/ I 	N'ZO 
OAc 
Resin 41a (310 mg, 0.420 mmol, theoretical loading 1.34 mmolg') was swollen in 
dry THF (2 x 2 mL for 5 mm) at 60 °C. PC1 3 (142 tL, 4 eq) was added to the resin 
in dry THF (4 mL) and the syringe was heated at 60 °C for 2 h. The resin was 
drained and rinsed with dry THF (2 x 2 mL for 5 min each). 3'OAc-T 49 (225 mg, 
0.792 mmol, 2.0 eq) was evaporated in vacuo from dry THF (5 mL), dried over 
P205 in a desiccator for 1 h in vacuo and dissolved in dry THF (2.8 mL). The N 2 
flushed resin was treated with the nucleoside solution for 1 h at rt, drained and 
rinsed with dry THF (2 x 2 mL for 5 mm). The resin was swollen in dry THF (2 
mL), treated with 0.5 M 12 in pyridine (4 mL, 5 eq) for 1 h, drained, rinsed with 
C142C12 (4 x 2 mL for.5 mm) and dry THF (4 x 2 mL for 5 mm) and dried over 
P205 in a desicator. IR (neat) 3024 (w), 1738 (s), 1685 (s), 1608 (s), 1230 (s) cm', 
Gel Phase 31P NMR (162 MRz, CDC1 3) 8p46, -12. 
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2- [3'OAcety1thyniidine]-2-oxo-4-oxo-benzo[(3,2]dioxaphosphinone 	7- 




Resin 41a (315 mg, 0.422 mmol, theoretical loading 1.34 mmolg') was swollen in 
dry THF (2 x 2 mL for 5 mm) at 60 °C. Pd 3 (142 jtL, 4 eq) was added to the resin 
in dry THF (4 mL) and the syringe was heated at 60 °C for 2 h. The resin was 
drained and rinsed with dry TFIF (2 x 2 mL for 5 mm). 3'OAc-T 49 (227 mg, 0.800 
mmol, 2.0 eq) was evaporated in vacuo from dry THF (5 mL), dried over P 205 in a 
desiccator for 1 h in vacuo and dissolved in dry THF (2.8 mL). The N 2 flushed 
resin was treated with the nucleoside solution for 1 h at rt, drained and rinsed with 
dry THF (2 x 2 mL for 5 mm). The resin was swollen in dry TIHIF (6 mL), treated 
with 5.5 M tBuOOH in nonane (363 ItL, 2 mmol, 5 eq) for 1 h, drained, rinsed with 
C112C12 (4 x 2 mL for 5 mm) and dry THF (4 x 2 mL for 5 mm) and dried over 
P205 in a desicator. IR (neat) 3026 (w), 1774 (m), 1688 (s), 1615 (s), 1232 (s) cm', 
Gel Phase 31P NMIR (162 MHz, CDC1 3) 8p-ll.S, ICP analysis: P (%) 2.57, 0.829 
mmolg', 89 % yield. 
Thymidine triphosphate synthesis using on-resin oxidation 
Resin 41a (201 mg, 0.27 mmol, 1 eq) was swollen in dry TFIF (2 x 2 mL for 5 mm) 
at 60 °C. Pd 3 (95 L, 4 eq) was added to the resin in dry THF (4 mL) and the 
syringe was heated at 60 °C for 2 h. 3'-OAc-T 49 (26 mg, 92 timol, 0.33 eq) was 
evaporated in vacuo from dry pyridine (1 mL), dried over P 205 in a desiccator for 1 
h in vacuo and dissolved in dry pyndine (0.25 mL) and dry THF (0.75 mL). The 
resin was drained and rinsed with dry THF (2 x 2 mL for 5 mm). The N 2 flushed 
resin was treated with the nucleoside solution for 1 h at rt, drained and rinsed with 
dry THF (2 x 2 mL for 5 mm). The resin was swollen in dry THF (4 mL), treated 
with 5.5 M tBuOOH in nonane (245 AL, 2 mmol, 5 eq) for 1 h, drained, rinsed with 
dry THF (2 x 2 mL for 5 mm). The N 2 flushed resin was treated three times with 
0.5 M bis (tributyl ammonium) pyrophosphate in DrvlF (800 /LL, 1.5 eq) and Bu3N 
Chapter 6 	 173 
(255 /LL, 4 eq) at rt for 10 min each. The filtrate was stirred with H 20 (20 mL), 
then treated with concentrated ammonia (20 mL) for 1 h and evaporated in vacuo. 
The residue was dissolved in 0.1 M TEAB (5 mL), washed with CH 2Cl2 (3 x 5 
mL), lyophilised and purified by Prep HPLC eluted with 0.1 M TEAB. The 
fractions containing triphosphate were pooled and lyophilised to remove the buffer 
to yield a hygroscopic solid (2.0 mg, 2.3 p.mol, 3 % yield). 
2 g2.2TrifluoroNprop-2ynyI-acetaflhide (95) 
NACF3 
Propargylamine (8.84 g, 160 mmol) and TEA (45 mL, 320 mmol, 2 eq) were 
dissolved in CH2C12 (50 mL) at 0 °C. Trifluoroacetic anhydnde (25 mL, 180 mmol, 
1.13 eq) was added dropwise.over 30 mm. The reaction mixture was warmed to r.t., 
stirred for 14 h and evaporated in vacuo to a brown oil. Et 20 (200 mL) and 1 M 
NH4OAc (300 mL) were added. The organic layer was separated and washed with 
H20 (100 mL), dried (Na2SO4) and purified by column chromatography eluted 
with CH202 to yield a yellow oil (17.9 g, 118 mmol, 74 % yield). IR (neat) 3301 
(m), 3093 (w), 1705 (s), 1549 (m), 1153 (s) cm 1 , 1H NMIR (250 MIHz, CDC1 3 ) oH 
7.37 (1H, br signal, NH), 4.11 (2H, ddd, J= 5.5, 2.6, 0.4 Hz, CH2), 2.30 (1H, t, J= 
2.6 Hz, CH), 13C NMR (62.5 M}Iz, CDC1 3) Oc  157.2 (q, J = 37.9 Hz, COCF3), 
115.5 (q, J = 287.2 Hz, CF3), 77.0 (C), 72.8 (CH), 29.5 (CR 2), ES m/z (%) 150.2 
(M-H, 100), HPLC (X220) tR 4.63 mm (Method 3), Rf 0.44 (CH2C1 2 , KMn04). 
5' -O-(4,4'-Dimethoxvtrityl)-5-iodo-2'-deoxvuridine (97) 






5-Iodo-2'-deoxyundine 96 (2.98 g, 8.40 mmol), evaporated in vacuo from dry 
pyndine (10 mL), was treated with DMAP (210 mg, 1.72 mmol, 0.2 eq) and sealed 
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under a N2 atmosphere. The solids were dissolved in dry pyridine (10 mL) and 
treated dropwise with a solution of DMT-Cl (2.86 g, 8.43 mmol, 1.0 eq) in dry 
pyridine (20 mL) over 30 min via canula transfer. The reaction mixture was stirred 
for a total of 3 h until complete (tic) and evaporated in vacuo. The residue was 
dissolved in CH202 (100 mL), washed with H20 (2 x 50 mL) and brine (100 mL), 
dried (Na2SO4), evaporated in vacuo and purified by column chromatography 
eluted with 0-3 % MeOHJCH 2C12 to yield an off-white foam (4.17 g, 6.35 mmol, 
76 % yield). IR (neat) 1685 (s), 1676 (s), 1507 (m), 1210 (s) cm, 1H NIVIR (250 
MiFIz, CDC1 3) 8H  9.24 (1H, br signal, H-3), 8.15 (1H, s, H-6), 7.22 - 7.43 (9H, m, 
Ph + p-CH of DMT), 6.85 (4H, d, J = 9 Hz, 4 o-CH of DMT), 6.32 (111, dd, J = 8, 
6 Hz, H-i'), 4.55 (iH, dt, J= 5,3 Hz, H-3'), 4.11 (iH, dt, J= 3,3 Hz, H-4'), 3.78 
(6H, s, CH30), 3.41 (1H, dd, J= 11,3 Hz, H-5'), 3.35 (iH, dd, J= 11,3Hz, H-5'), 
2.51 (1H, ddd, J = 14, 6, 3 Hz, H-2'), 2.29 (iH, ddd, J = 14, 8, 6 Hz, H-2'), 1.78 
(iH, br signal, OH), ' 3C N1VIR (62.5 MIFIz, CDC1 3) 6c  160.0 (C-4), 158.6 (COMe), 
150.0 (C-2), 144.3 (C-6, C), 135.4 (C), 135.3 (C), 130.1 (CH), 128.1 (CH), 128.0 
(CH), 127.1 (CH), 113.4 (CH), 87.0 (C-Ar 3), 86.5 (C-4'), 85.6 (C-i'), 72.5 (C-3'), 
68.6 (C-5), 63.5 (C-5'), 55.3 (CH 30), 41.4 (C-2'), APCI m/z (%) 655.1 (M-I-f, 
100), IIPLC (X282) tR 2.55 mm (Method 1), 6.59 mm (Method 2), Rf 0.35 (10 % 
MeOHJCH202, ammonium molybdate). 





N A CF3 
ON 
I 	II 	OH 
Y 
o 
Nucleoside 97 (3.88 g, 5.91 mmol), [Pd (PPh 3)41 (682 mg, 0.590 mmol, 0.1 eq) and 
copper (I) iodide (226 mg, 1.187 mmol, 0.2 eq) were sealed under a N2 atmosphere. 
Trifluoroacetylpropargylamine 95 (2.24 g, 14.85 mmol, 2.5 eq) in DIvII.F (11.8 mL) 




was stirred for 2.5 h until complete (tic) and evaporated in vacuo. The residue was 
dissolved in CH202 (100 mL), washed with 5 % w/v EDTA (3 x 100 mL), 5 % w/v 
NaHS03 (100 mL) and brine (100 mL), dried (Na 2SO4), evaporated in vacuo and 
purified by column chromatography eluted with 0-3 % MeOHICH 2C12 to yield a 
yellow powder (2.77 g, 4.08 mmol, 69 % yield). mp 98-102 °C, JR (neat) 1708 (s), 
1674 (s), 1508 (m), 1462 (s), 1282 (s) cm i , 'H N1VIR (250 MIHz, CDC1 3) 8H  9.43 
(1H, br signal, H-3), 8.24 (1H, s, H-6), 7.19-7.43 (10H, m, Ph +p-CH of DMT + 
H-9), 6.84 (411, d, J = 9 Hz, 4o-CH of DMT), 6.35 (1H, dd, J = 7, 6 Hz, H-i'), 
4.60 (1H, m, H-3'), 4.13 (1H, dt, J = 3, 3 Hz, H-4'), 3.96 (1H, dd, J = 18, 5 Hz, H-
9), 3.87 (1H, dd, J = 18, 5 Hz, H-9), 3.77 (611, s, CH 30), 3.40 (1H, dd, J = 11, 3 
Hz, H-5'), 3.34 (1H, dd, J = 11, 3 Hz, H-5'), 2.98 (1H, d, J = 4.4Hz, OH), 2.56 
(1H, ddd, J = 14, 6, 3 Hz, H-2'), 2.33 (1H, m, H-2'), 13C NMR (62.5 MHz, CDC13 ) 
c 162.7 (C-4), 158.5 (COMe), 158.5 (COMe), 156.6 (q, J = 37.6 Hz, COCF3), 
149.4 (C-2), 144.4 (C), 143.5 (C-6), 135.4 (C), 135.3 (C), 129.9 (CH), 129.8 (CH), 
127.9 (CH), 127.8 (CH), 126.9 (CH), 115.5 (q, J = 289.7 Hz, CF3), 113.2 (CH); 
98.8 (C-5), 87.4 (C-Ar 3), 86.9 (C-7, C-4'), 85.9 (C-i'), 75.1 (C-8), 72.1 (C-3'), 
63.5 (C-5'), 55.1 (CH30), 41.5 (C-2'), 30.3 (C-9), APCI mlz (%) 678.2 (M-If, 





/ 	 0 
	
0 - HN )1JH 
b ON 
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0. 
Nucleoside 98 (2.56 g, 3.78 mmol) was treated with DMAP (115 mg, 0.94 mmol, 
0.25 eq) and dissolved in pyndine (25 mL). TEA (1.33 mL, 9.46 mmol, 2.5 eq) and 
Ac20 (385 jiL, 3.78 mmol, 1.0 eq) were added and the reaction mixture was stirred 
for 2 h until complete (tic) and evaporated in vacuo. The residue was dissolved in 
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EtOAc (100 mL), washed with H20 (3 x 100 mL), dried (Na 2SO4) and evaporated 
in vacuo to yield a brown foam (2.53 g, 3.51 mmol, 93 % yield). mp 108-110 °C, 
IR (neat) 3065 (w), 1692 (s), 1608 (m), 1508 (w), 1246 (s), 1174 cm 1 , 1H NI'VIR 
(250 MHz, CDC1 3) 8H  9.78 (1H, br signal, H-3), 8.25 (1H, s, H-6), 7.22 - 7.44 (911, 
m, Ph + p-CH of DMT), 7.21 (1H, br signal, H-9), 6.85 (4H, d, J = 9 Hz, 4 o-CH of 
DMT), 6.34 (1H, dd, J = 8, 6 Hz, H-i'), 5.46 (1H, d, J = 6 Hz, H-3'), 4.18 (1H, m, 
H-4'), 3.99 (1H, dd, J = 18, 5 Hz, H-9), 3.88 (1H, dd, J = 18, 5 Hz, H-9), 3.78 (6H, 
s, CH30), 3.45 (1H, dd, J= 11,3 Hz, H-5'), 3.38 (1H, dd, J= 11,3 Hz, H-5'), 2.59 
(111, m, H-2'), 2.42 (1H, ddd, J = 14, 8, 6 Hz, H-2'), 2.09 (3H, s, CH3 ), 13C NMR 
(90 MIF{z, CDC1 3) 6c  170.4 (C=OCH3), 162.2 (C-4), 158.6 (COMe), 156.6 (q, J = 
37.7 Hz, COCF3), 149.2 (C-2), 144.3 (C), 143.4 (C-6), 135.3 (C), 135.1 (C), 129.9 
(CH), 129.8 (CH), 128.1 (CH), 127.7 (CH), 127.0 (CH), 115.5 (q, J = 287.7 Hz, 
CF3), 113.3 (CH), 99.4 (C-5), 87.3 (C-Ar3), 87.3 (C-7), 85.4 (C-4'), 84.6 (C-i'), 
75.0 (C-8), 74.9 (C-3'), 63.5 (C-5'), 55.2 (CH 30), 38.8 (C-2'), 30.3 (C-9), 20.9 
(CH3), APCI mlz (%) 720.2 (M-ff, 100), HPLC 01282) tR 2.71 mm (Method 1), 
7.19 mm (Method 2), Rf 0.56 (10 % MeOHJCH 2C12, ammonium molybdate). 





Nucleoside 99 (1.62 g, 2.24 mmol) was dissolved in 3 % TCAICH2Cl2 (50 mL) to 
give a dark--red solution. MeOH (5 mL) was added after 1 min to yield a yellow-
orange solution, evaporated in vacuo and purified by column chromatography 
eluted with 0 - 3 % MeOH in CH 202 to yield a yellow powder (920 mg, 2.19 
mmol, 98 % yield). mp 145-148 °C, IR (neat) 3050 (w), 1690 (s), 1555 (m), 1288 
(s), 1239 (s), 1208 (s), 1186 (s) cm 1 , 1H NIVIR (250 MHz, CDC1 3ICD30D) 6H 9.44 
(1H, br signal, NH), 8.32 (1H, s, H-6), 6.24 (111, dd, J = 8.3, 5.7 Hz, H-i'), 5.28 
(1H, dt, J = 6.0, 1.5 Hz, H-3'), 4.20 (2H, s, H-9), 4.08 (1H, q, J = 2.2 Hz, H-4'), 
3.84 (1H, dd, J = 11.5, 1.7 Hz, H-5'), 3.79 (1H, dd, J = 11.5, 1.9 Hz, H-5'), 2.41 
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(1H, ddd, J = 14.0, 5.7, 1.7 Hz, H-2'), 2.24 (1H, m, H-2'), 2.06 (3H, s, CH 3), 13C 
NMR (90 MHz, CDC1 3/CD30D) öc 170.7 (C=OCH3), 162.9 (C-4), 157.2 (q, J = 
37 Hz, COCF3), 149.3 (C-2), 144.0 (C-6), 115.6 (q, J.  = 287 Hz, CF3), 98.7 (C-5), 
87.1 (C-7), 85.5 (C-4'), 85.4 (C-i'), 75.0 (C-3'), 74.8 (C-6), 61.5 (C-5'), 38.1 (C-
2'), 29.9 (C-9), 20.5 (CH3), ES mlz (%) 418.2 (M-H, 100), HPLC 01280) tR 5.96 






5-(3' '-Tnfluoroacetamidopropynyl)-2' -deoxycytidine 101 (295 mg, 0.784 mmol), 
evaporated in vacuo from dry pyridine (5 mL), was treated with DMAP (26 mg, 
0.213 mmol, 0.27 eq) and sealed under a N 2 atmosphere. The solids were dissolved 
in dry pyridine (3 mL) and treated with DMT-Cl (282 mg, 0.832 mmol, 1.06 eq). 
After 24 h, the reaction mixture was evaporated in vacuo. The residue was 
dissolved in EtOAc (15 mL), washed with H20 (2 x 10 mL) and brine (10 mL), 
dried (Na2SO4), evaporated in vacuo and purified by column chromatography 
eluted with 0-5 % MeOWCH2C12 to yield an off-white powder (292 mg, 0.430 
mmol, 55 % yield). mp 117-120 °C, IR (neat) 3064 (w), 1716 (m), 1642 (s), 1605 
(m), 1505 (s), 1299 (m), 1174 (s) cm 1 , 1H NIVIR (250 MHz, CDC13 ) oH 8.22 (1H, s, 
H-6), 7.49 (1H, t, J = 5.0 Hz, NHTfa), 7.21 -7.44 (9H, m, Ph + p-CH.of DMT), 
7.00 (1H, br signal, OH), 6.84 (4H, d, J = 8.9 Hz, 4 o-CH of DMT), 6.26 (1H, t, J = 
6.1 Hz, H-i'), 5.99 (2H, br signal, NH2), 4.51 (1H, dt, J = 6.9, 3.5 Hz, H-3'), 4.12 
(1H, q, J = 3.0 Hz, H-4'), 4.08 (1H, m, H-9), 3.96 (1H, dd, J = 17.9, 4.9 Hz, H-9), 
3.78 (6H, s, CH30), 3.37 (1H, dd, J = 10.8, 2.9 Hz, H-5'), 3.30 (1H, dd, J = 10.7, 
4.0 Hz, H-5'), 2.67 (1H, ddd, J = 13.8, 6.1, 3.7 Hz, H-2'), 2.19-2.27 (1H, m, H-2'), 
one H-9 signal partially obscured by H-4' signal, 13 C NTVLR (62.5 MHz, CDC1 3) &, 
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164.7 (C-4), 158.4 (COMe), 157.6 (q, J = 37.2 Hz, COCF3), 154.7 (C-2), 144.4 (C-
6), 135.8 (C), 135.7 (C), 130.1 (CH), 129.9 (CII), 128.0 (CH), 126.9 (CH), 116.3 
(q, J = 287.4 Hz, CF3), 113.3 (CII), 90.4 (C-5/C-7), 89.4 (C-5/C-7), 86.9 (C-4'), 
86.8 (C-Ar3), 86.5 (C-i'), 75.1 (C-8), 71.8 (C-3'), 63.5 (C-5'), 55.3 (CH30), 42.1 
(C-2'), 30.3 (C-9), APCI mlz (%) 677.5 (M-H, 100), HRMS (FAB) for 
C35H34N407F3 (M+H): calcd 679.23796, found 679.23751, IIPLC (X280) tR 7.90 
mm (Method 3), Rf 0.22 (10 % MeOHJCH202, ammonium molybdate), 
5 '-O-(44'-Dimethoxytrityl)-5-iodo-2'-deoxycvtidifle (104) 
1H2 
A 
5-Iodo-2'-deoxycytidine 103 (639 mg, 1.81 mmol), evaporated in vacuo from dry 
pyndine (4 mL), was treated with DMAP (50 mg, 0.409 mmol, 0.23 eq) and sealed 
under a N2 atmosphere. The solids were dissolved in dry pyridine (2 mL) and 
treated dropwise with a solution of DMT-Cl (630 mg, 1.86 mmol, 1.03 eq) in dry 
pyridine (5.4 mL) over 45 min via canula transfer. The reaction mixture was stirred 
for a total of 3 h and evaporated in vacuo. The residue was dissolved in 
CH2C12/EtOAc (1/1, 150 mL), washed with H 20 (50 mL) and brine (50 mL), dried 
(Na2SO4), evaporated in vacuo and purified by column chromatography eluted with 
0-5 % MeOWCH2C12 to yield a white flaky powder (722 mg, 1.10 mmol, 61 % 
yield). mp 176-178 °C, IR (neat) 3054 (w), 1658 (m), 1631 (s), 1605 (m), 1507 
(m), 1489 (m), 1249 (rn) cm 1 ,'H NMR (250 MHz, CDC13) oH 8.18 (1H, s, H-6), 
7.18-7.39 (9H, m, Ph +p-CH of DMT), 6.80 (4H, d, J= 9.0 Hz, 4 o-CH of DMT), 
6.18 (iH, dd, J= 7.4, 5.7 Hz, H-i'), 4.40 (1H, dt, J= 5.8, 2.9 Hz, H-3'), 4.08 (1H, 
q, J = 3.1 Hz, H-4'), 3.75 (6H, s, CH 30), 3.37 (1H, dd, J = 10.6, 3.0 Hz, H-5'), 
3.26 (1H, dd, J = 10.7, 3.4 Hz, H-5'), 2.54 (1H, ddd, J = 13.7, 5.7, 2.9 Hz, H-2'), 
2.14 (1H, ddd, J = 13.5, 7.3, 6.0 Hz, H-2'), 13C NEVIR (62.5 MHz, CDC1 3) Oc  163.6 
(C-4), 158.5 (COMe), 158.4 (COMe), 155.2 (C-2), 146.6 (C-6), 144.3 (C), 135.6 
(C), 135.5 (C), 130.0 (CH), 128.0 (CIII), 127.9 (CH), 126.9 (CH), 113.2 (CII), 86.8 
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(C-Ar3), 86.7 (C-4'), 86.6 (C-i'), 71.7 (C-3'), 63.4 (C-5'), 55.2 (CH30), 42.0 (C-
2'), C-5 signal not observed, APCI m/z (%) 654.4 (M-ff, 100), HPLC 01280) tR 
8.00 mm (Method 3), R0.15 (10% MeOWCH2C12). 
5' -O-(4.4 ' Dimethoxytrity1)-3-O-acety1-4-N,N-diacety1-5-iOdO-2'-deOXVCVtidifle 











Nucleoside 104 (50 mg, 77 mol) and DMAP (13 mg, 0.11 mmol, 1.4 eq) 
dissolved in dry CH202 (1.2 mL) were treated with TEA (110 ptL, 0.782 mmol, 10 
eq) and Ac 20 (40 jL, 0.392 mmol, 5 eq) and stirred at r.t. for 14 h. The reaction 
mixture was purified by column chromatography eluted with 0-2 % MeOHJCH 2C1 2 
to yield a yellow amorphous powder 105 (19 mg, 24 jtmol, 31 % yield) and a clear 
glass 106 (12 mg, 16 p.mol, 20 % yield). Data for 105: mp: 75-78 °C, IR (neat) 
2931 (w), 1729 (s), 1669 (s), 1606 (m), 1222 (s) cm 1 , ' H NII\'IR (250 MHz, CDC1 3) 
H 8.69 (1H, s, H-6), 7.22 - 7.41 (9H, m, Ph + p-CH of DMT), 6.84 (414, dd, J = 
9.0, 1.2 Hz, 4 o-CH of DMT), 6.26 (1H, dd, J = 8.0, 5.5 Hz, H-i'), 5.39 (1H, dt, J 
= 6.1, 1.7 Hz, H-3'), 4.29 (114, q, J = 2.7 Hz, H-4'), 3.79 (6H, s, CH30), 3.47 (114, 
dd, J = 10.9, 2.8 Hz, H-5'), 3.41 (1H, dd, J = 10.9, 3.0 Hz, H-5'), 2.92 (114, ddd, J 
= 14.2, 5.5, 1.6 Hz, H2'), 2.40 - 2.45 (1H, m, H-2'), 2.35 (611, s, Ac 2), 2.09 (3H, s, 
Ac), 13C N1VIR (62.5 MHz, CDC1 3) 8C  170.4 (C=O), 170.2 (C), 158.7 (COMe), 
153.9 (C-2), 151.0 (C-6), 144.0 (C), 135.3 (C), 135.1 (C), 130.0 (CH), 129.9 (CH), 
128.2 (CH), 128.0 (CH), 128.0 (CH), 113.5 (CH), 88.3 (C-Ar 3), 87.3 (C-4'), 85.5 
(C-i'), 74.9 (C-3'), 66.7 (C-5), 63.2 (C-5'), 55.3 (CH30), 39.6 (C-2'), 26.6 (CH3 ), 
20.9 (CH3), C-4 signal not observed, APCI m/z (%) 780.4 (M-ff, 40), HRMS 
(FAB) for C 36H37N3091 1 (M+H): calcd 782.15746, found 782.15807, IIPLC (X280) 
tR 8.25 mm (Method 3), Rf 0.68 (10 % MeOHICH2C12); Data for 106: mp: 72-75 
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°C, IR (neat) 2933 (w), 1707 (m), 1660 (s), 1607 (s), 1506 (s), 1233 (s) cm 1 , 1H 
NMR (250 MiHz, CDC1 3 ) 5H  8.40 (1H, s, H-6), 7.75 (1H, s, NH), 7.20 - 7.40 (9H, 
m, Ph + p-CH of DMT), 6.84 (4H, dd, J = 9.0, 0.6 Hz, 4 o-CH of DMT), 6.30 (1H, 
dd, J= 8.3, 5.5 Hz, H-i'), 5.39 (iH, dt, J= 6.1, 1.8 Hz, H-3'), 4.22 (iH, m, H-4'), 
3.79 (6H, s, CH30), 3.42 (2H, d, J = 2.7 Hz, H-5'), 2.80 (iH, dd, J = 13.7, 4.9 Hz, 
H-2'), 2.68 (3H, s, Ac), 2.31 - 2.40 (iH, m, H-2'), 2.09 (3H, s, Ac), 13C NMR 
(62.5 MIHz, CDC1 3 ) 6c  171.1 (C=O), 169.4 (C), 157.7 (COMe), 152.4 (C-2), 147.6 
(C-6), 143.2 (C), 134.3 (C), 134.2 (C), 129.0 (CH), 127.1 (CH), 127.0 CH), 126.2 
(CH), 112.4 (CH), 86.2 (C-Ar 3 , C-4'), 84.0 (C-i'), 74.1 (C-3'), 66.7 (C-5), 62.4 (C-
5'), 54.3 (CH30), 38.6 (C-2'), 25.1 (CH 3), 20.0 (CH3), C-4, C-5 signals not 
observed, APCI mlz (%) 738.3.4 (M-ff, 40), HPLC (X280) tR 8.28 mm (Method 
3), Rf 0.55 (10 % MeOHJCH2C12). 




Nucleoside 104 (200 mg, 0.306 mmol) and DMAP (8.4 mg, 69 .tmol, 0.22 eq) 
suspended in dry CH202 (6.1 mL) and TEA (430 iL, 3.06 mmol, 10 eq). Ac20 (31 
pL, 0.304 mmol, 1 eq) was added and stirred at r.t. for 15 mm. The reaction 
mixture was evaporated in vacuo and purified by column chromatography eluted 
with 0-2.5 % MeOHJCH2C12 to yield a clear glass 106 (7 mg, 9.5 jimol, 3 % yield) 
and a white foam 107 (190 mg, 0.273 mmol, 89 % yield). mp 115-118 °C, IR 
(neat) 2928 (w), 1739 (m), 1626 (s), 1508 (s), 1488 (m), 1235 (s) cm 1 , 'H NMIR 
(250 MIHz, CDC13) 8H  8.58 (1H, s, NH), 8.12 (iH, s, H-6), 7.15 - 7.38 (9H, m, Ph + 
p-CH of DMT), 6.80 (4H, d, J = 8.8 Hz, 4 o-CH of DMT), 6.28 (1H, dd, J = 8.4, 
5.3 Hz, H-i'), 5.60 (1H, s, NH), 5.32 (1H, d, J= 5.8 Hz, H-3'), 4.13 (iH, m, H-4'), 
3.74 (6H, s, CH30), 3.38 (iH, dd, J = 10.1, 2.8 Hz, H-5'), 3.34 (1H, dd, J = 10.0, 
3.0 Hz, H-5'), 2.60 (1H, dd, J = 13.7, 5.2 Hz, H-2'), 2.23 (iH, ddd, J = 14.4, 8.5, 




(C-4), 158.6 (COMe), 154.6 (C-2), 146.2 (C-6), 144.2 (C), 135.4 (C), 135.3 (C), 
130.0 (CH), 128.0 (CH), 127.0 (CH), 113.3 (CH), 87.0 (C-Ar 3), 86.3 (C-4'), 84.3 
(C-i'), 75.2 (C-3'), 63.4 (C-5'), 56.7 (C-5), 55.2 (CH30), 39.3 (C-2'), 20.9 (CH 3), 
APCI m/z (%) 696.4 (M-H, 100), HRMS (FAB) for C 32H33N3071 1 (M+H): calcd 
698.1358, found 698.1355, IIPLC (X280) tR 8.25 mm (Method 3), Rf 0.39 (10 % 
MeOHJCH2C12). 
5 '-O-(44'-Dimethoxytrityl)-3-O-acetvl-5-(3' '-trifluoroacetamidopropynyl)-2'-
deoxycytidine (108) and 5 1 -0-(4.4 1 -dimethoxytrityl)-3-0-acetvl-2'-
deoxycytidine (109) 
0 
F / 	 NH2 
F 
)__~ 
H O =\ 
ON 
I 	II 	0 	0 
1H 2 
Nucleoside 107 (323 mg, 0.463 mmol), [Pd (PPh 3)41 (56 mg, 48.5 p.moi, 0.1 eq) 
and copper (I) iodide (50 mg, 0.263 mmoi, 0.5 eq) were sealed under a N2 
atmosphere. Trifluoroacetyipropargylamine 95 (200 rng, 1.20 mmoi, 2.5 eq), DMF 
(925 p.L) and TEA (325 tL, 2.33 mmoi, 5 eq) were added and the reaction mixture 
was stirred for 2 h until complete (tic) and evaporated in vacuo. The reaction 
mixture was purified by column chromatography eluted with 0-5 % MeOWCH 202 
to yield a brown foam 108 (263 mg, 0.364 mmol, 79 % yield) and a brown oil 109 
(18 mg, 32 p.moi, 7 % yield). Data for 108: mp 98-101 °C, IR (neat) 1719 (m), 
1643 (s), 1504 (s), 1174 (s) cm 1 , 1H N1\'IR (250 MIHz, CDC1 3) 8H  8.13 (1H, s, H-6), 
7.84(1H, t,J= 5.0 Hz, NH), 7.18- 7.42 (9H, m, Ph +p-CH of DMT), 6.84 (414, d, 
J = 8.9 Hz, 4 o-CH of DM1'), 6.26 (1H, dd, J = 7.6, 5.8 Hz, H-i'), 6.16 (1H, s, 
NH), 5.36 (1H, d, J = 6.1 Hz, H-3'), 4.17 (1H, q, J= 2.2 Hz, H-4'), 4.12 (1H, dd, J 
= 18.1, 5.2 Hz, H-9), 4.01 (1H, dd, J= 17.7, 4.6 Hz, H-9), 3.78 (6H, s, CH30), 3.39 
(1H, dd, J = 10.5, 3.3 Hz, H-5'), 3.32 (114, dd, J = 9.3, 2.8 Hz, H-5'), 2.67 (1H, 
ddd, J = 14.0, 5.7, 1.3 Hz, H-2'), 2.23 - 2.35 (114, m, H-2'), 2.06 (3H, s, Ac), '3C 
N\'W (62.5 MIHz, CDC13) 8C  170.4 (C=O), 164.4 (C-4), 158.5 (COMe), 157.0 (q, J 
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= 37.7 Hz, COCF3), 154.3 (C-2), 144.4 (C-6), 144.2 (C), 135.6 (C), 135.5 (C), 
129.9 (CH), 129.9 (CH), 128.0 (CH), 127.9 (CH), 127.0 (CH), 116.1 (q, J = 287.3 
Hz, CF3), 113.3 (CR), 90.5 (C-5/C-7), 89.5 (C-5/C-7), 87.1 (C-Ar 3), 86.6 (C-4'), 
84.4 (C-i'), 74.9 (C-8), 74.8 (C-3'), 63.5 (C-5'), 55.3 (CH30), 39.5 (C-2'), 30.3 
(C-9), 20.9 (CH3), APCI mlz (%) 719.5 (M-H, 100), HRMS (FAB) for 
C37H36N408F3 (M+H): calcd 721.2480, found 721.2470, HIPLC (X280) tR 8.16 mm 
(Method 3), Rf 0.34 (10 % MeOWCH202); Data for 109: mp 95-98 °C, IR (neat) 
2931 (w), 1737 (s), 1645 (s), 1508 (m), 1245 (s), 1032 (m) cm 1 , 'H NII\'IR (250 
MHz, CDC1 3) 8H  7.80 (1H, d, J = 7.5 Hz, H-6), 7.22 - 7.39 (9H, m, Ph + p-CH of 
DMT), 6.83 (4H, d, J = 8.8 Hz, 4 o-CH of DMT), 6.32 (1H, dd, J = 7.4, 5.8 Hz, H-
1'), 5.55 (1H, d, J = 7.5 Hz, H-5), 5.36 (1H, d, J = 6.2 Hz, H-3'), 4.16 (1H, q, J = 
2.6 Hz, H-4'), 3.79 (6H, s, CH30), 3.43 (2H, d, J = 2.9 Hz, H-5'), 2.59 (1H, ddd, J 
= 14.1, 5.5, 2.1 Hz, H-2'), 2.20-2.31 (1H, m, H-2'), 2.05 (3H, s, Ac), 13C NMR 
(62.5 MHz, CDC13 ) 6c  170.8 (C=O), 165.4 (C-4), 159.1 (COMe), 156.1 (C-2), 
144.7 (C-6), 141.6 (C), 135.7 (C), 135.6 (C), 130.5 (CH), 128.5 (CH), 128.4 (CH), 
127.5 (CH), 113.8 (CR),  113.7 (CR), 95.1 (C-5), 87.4 (C-4'), 86.4 (C-i'), 84.4 (C-
Ar3), 75.0 (C-3'), 63.7 (C-5'), 55.7 (CH30), 39.5 (C-2'), 21.4 (CR)),  APCF m/z 
(%) 570.4 (M-ff, 100), HRMS (FAB) for C 32H34N307 (M+H): calcd 572.23968, 
found 572.23907, HPLC (X280) tR 7.37 mm (Method 3), Rf 0.33 (10 % 
MeOWCH2C12). 





Nucleoside 108 (262 mg, 0.364 mmol) was dissolved in 3 % TCA in CH 202 (10 
mL). After 5 mm, MeOH (5 mL) was added, evaporated in vacuo and purified by 
column chromatography eluted with 0-7.5 % MeOWCH 202 to yield a yellow oil, 
which was lyophilized to yield a yellow powder (145 mg, 0.347 mmol, 95 % 




1186 (s), 1157 (s) cm 1 , 1H N1\'IR (250 MHz, CD30D) 6H  8.37 (1H, s, H-6), 6.22 
(1H, dd, J = 7.9, 5.7 Hz, H-i'), 5.28 (1H, dt, J = 6.2, 1.9 Hz, H-3'), 4.33 (2H, s, H-
9), 4.15(1H, q, J = 2.8 Hz, H-4'), 3.85 (1H, dd, J = 11.9, 2.7 Hz, H-5'), 3.79 (1H, 
dd, J = 11.9, 3.0 Hz, H-5'), 2.52 (111, ddd, J = 14.0, 5.7, 1.9 Hz, H-2'), 2.26 (1H, 
ddd, J = 14.2, 7.8, 6.4 Hz, H-2'), 2.09 (3H, s, CH3), ' 3C NIVIIR (62.5 MHz, 
CD30D) 8C 172.2 (C=OCH3), 165.7 (C-4), 158.8 (q, J = 37.4 Hz, COCF3), 155.7 
(C-2), 146.5 (C-6), 117.3 (q, J = 286.3 Hz, CF3), 92.4 (C-5), 91.4 (C-7), 88.1 (C-
4'), 87.3 (C-i'), 76.3 (C-3'), 75.0 (C-6), 62.7 (C-5'), 39.7 (C-2'), 31.0 (C-9), 20.9 
(CH3), APCI m/z (%) 417.2 (M-ff, 100), IIRMS (FAB) for C 16H18N406F3 
(M+H): calcd 419.1173, found 419.1166, HPLC (X280) tR 5.72 mm (Method 3), 
Rf 0.10(10% MeOHJCH 202). 
3 1 -0-Acetyl-5-(3' 1 -trifluoroacetamidopropynyl)-2'-deoxyuridine 	5 '-H- 
phosphonate ammonium salt (112) 
0 
HN)L ' H 
ON 
NH4 	 I 
°i° 
Nucleoside 100 (40 mg, 95 imo1) was evaporated in vacuo from dry pyridine (1 
mL), dried over P 205 in a desiccator for 1 h in vacuo and dissolved in dry pyridine 
(0.25 mL) and dry THF (0.75 mL). Resin 41a (0.27 mmol, 3 eq) was swollen in dry 
THF (2 x 2 mL for 5 mm) at 60 °C. PC1 3 (95 jiL, 12 eq) was added to the resin in 
dry THF (4 mL) and the syringe was heated at 60 °C for 2 h. The resin was drained 
and rinsed with dry TRIP (2 x 2 mL for 5 mm). The N2 flushed resin was treated 
with the nucleoside solution for 1 h at rt, drained and rinsed with dry THIF (2 x 2 
mL for 5 mm). The resin was suspended with THFJH20 (1/1, 4 mL) for 10 mm, 
then drained and evaporated in vacuo. The residue was purified by Prep HPLC 
eluted with an MeCN/0.1 M ammonium acetate gradient to yield a white 
hygroscopic powder (27 mg, 54 p.mol, 57 % yield). 1H NMR (250 MHz, D 20) 8H 
8.33 (1H, s, H-6), 6.91 (iH, d, J = 638.9 Hz, PH), 6.42 (1H, dd, J = 8.0, 6.0 Hz, H- 
1'), 5.49 (1H, dt, J = 6.0, 2.0 Hz, H-3'), 4.53 - 4.58 (1H, m, H-4'), 4.46 (211, s, H- 
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9), 4.23 (1H, dd, J= 5.9, 3.1 Hz, H-5'), 2.72 (1H, ddd, J= 14.7, 6.0, 2.0 Hz, H-2'), 
2.56 (1H, ddd, J = 14.8, 8.2, 6.4 Hz, H-2'), 2.26 (3H, s, CH3), 13C NMR (90 MHz, 
D20) & 173.9 (C=OCH3), 164.9 (C-4), 150.8 (C-2), 145.3 (C-6), 99.2 (C-5), 88.4 
(C-7), 86.6 (C-i'), 84.2 (d, Jpc = 8.4 Hz, C-4'), 75.6 (C-3'), 74.7 (C-6), 63.7 (d, Jpc 
= 4.1 Hz, C-5'), 37.5 (C-2'), 30.3 (C-9), 20.8 (CH 3), COCF3 signals not visible due 
to low concentration, 31P NMR (101 MHz, D20) 8p 7.44, ES m/z (%) 482.1 (M-ff 
100), HPLC 01280) tR 5.97 mm (Method 9). 












Using general procedure: Nucleoside 100 (37 mg, 88 jimol) and resin 41a (209 
mg, 0.280 mmol, 1 eq) were used. The final deprotection step was left for 1 h and 
the residue was purified twice by Prep HPLC eluted with 0.1 M TEAB to yield a 
white solid. 1H NMR (250 MHz, D20) oH 8.49 (1H, s, H-6), 6.30 - 6.35 (1H, m, 
H-i'), 4.69 —4.70 (1H, m, H-3'), 4.31 —4.32 (1H, m, H-4'), 4.24-4.26 (2H, m, H-
9), 4.05 (2H, s, H-5'), 2.45 - 2.47 (2H, m, H-2'), 31P N1VIR (101 MHz, D20) Op - 
5.1 (m, P-T),  -10.2 (m, P-u), -21.6 (m, P-13),  ES m/z (%) 520.1 (M-H, 100), HPLC 
(X280) tR 6.92 mm (Method 5). The yield was estimated using UV/Vis spectrometry. 
93 was dissolved in 0.1 M TEAB buffer to 10 mL and the absorbance value 
measured (Table 6.3). The number of moles was calculated to give an estimated 
yield of 1 %. 
Table 62 Determination of the yield using UV-Vis 
Dilution 	A 	conc 	n 	yield 
mL M IIMOI %' 
10 	0.6134 6.82 10 	0.68 0.8 









Method 1: NaBH4 (61 mg, 1.61 mmol, 5.7 eq) and anhydrous CaC12 (161 mg, 1.45 
mmol, 5.2 eq) were flushed with N 2 . Nucleoside 99 (203 mg, 0.281 mmol, 1.0 eq) 
was evaporated from dry EtOH (5 mL), flushed with N2, dissolved in dry EtOH. 
(5.6 mL) and added dropwise onto the powders stirred over an ice-bath. The 
reaction was kept at 0 °C for 10 min until the effervescence subsided and was then 
stirred at ii for a further 20 mm. The reaction was quenched with the addition of 
0.1. M NH4OAc (20 mL),' partially evaporated in vacuo and extracted with CH 2C12 
(3 x 10 mL). The organic layer was dried (Na 2SO4), evaporated in vacuo and 
purified by column chromatography eluted with 0-3 % MeOH in 1%TEAICH 2C12 
to yield a yellow oil (40 mg, 0.064 mmol, 23 % yield). Method 2: A vessel was 
charged with nucleoside 120 (1.00 g, 1.43 mmol), [Pd (PPh 3 )41 (167 mg, 0.145 
mmol, 0.1 eq), copper (I) iodide (137 mg, 0.719 mmol, 0.5 eq), propargylamine 
(295 jiL, 4.30 mmol, 3.0 eq), Amberlite IRA-67 resin (526 mg, 5.6 meq/g, 2.96 
mmol, 2.1 eq) and DMF (7.2 mL). The reaction mixture was purged with N 2 and 
stirred for 2 h. The solution was diluted with MeOH (5 mL) and TEA (1 mL), 
filtered through a silica plug with MeOH (20 mL) and evaporated in vacuo. The 
residue was purified by column chromatography eluted with 0-6 % MeOWCH 2C12 
to yield a brown powder (778 mg, 1.24 mmol, 87 % yield). mp 132-135 °C, IR 
(neat) 2930 (w), 1682 (s), 1606 (m), 1506 (m), 1280 (s) cm, 1H NI'vIR (250 IvlIFlz, 
CD30D/CDC13) oH 8.22 (111, s, H-6), 7.19 - 7.45 (9H, m, Ph + p-CH of DMT), 
6.86 (4H, d, J= 8.7 Hz, 4 o-CH of DMT), 6.26 (1H, dd, J= 7.8, 5.9 Hz, H-i'), 5.42 
(1H, dt, J = 5.9, 2.0 Hz, H-3'), 4.17 (1H, q, J = 2.1 Hz, H-4'), 3.77 (6H, s, CH 30), 
3.67 (2H, s, H-9), 3.44 (1H, dd, J = 10.8, 3.0 Hz, H-5'), 3.38 (1H, dd, J = 11.0, 2.8 
Hz, H-5'), 2.59 (1H, ddd, J = 14.5, 5.5, 1.5 Hz, 11-2'), 2.40 - 2.51 (iH, m, H-2'), 
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2.06 (3H, s, CH3), 13C NMR (62.5 MHz, CD 30D/CDCI3) 8C  171.8 (C=0CH3), 
164.2 (C-4), 159.8 (COMe), 150.7 (C-2), 145.6 (C), 144.4 (C-6), 136.5 (C), 136.4 
(C), 130.9 (CH), 128.8 (CH), 127.8 (CH), 114.2 (CH), 99.6 (C-5), 88.1 (C-Ar3), 
87.8 (C-7), 86.7 (C-4'), 85.6 (C-i'), 77.5 (C-8), 75.9 (C-3'), 64.4 (C-5'), 55.8 
(CH30), 39.4 (C-2'), 31.1 (C-9), 21.0 (CH 3), ES mlz (%) 626.2 (M+H, 100), 
HRMS (FAB) for C 351136N308 (M+H): calcd 626.2502, found 626.2505, HPLC 
(X282) tR 2.13 mm (Method 1), 5.35 mm (Method 2), 6.16 mm (Method 3), Rf 0.32 
(10 % MeOHJCH202, Ninhydnn), 0.47 (10 % MeOH in 1%TEA/CH 2C12 , 
Ninhydrin). 
3-[5(6)-Carboxy-fluoresceinl-amido-propvne (118) 
HO 	0 	OH 
0 
0 
5(6)-Carboxyfluorescein 119 (2.00 g, 5.32 mmol) in DMF (40 mL) was treated 
with PyBOP (2.72 g, 5.22 mmol, 0.98 eq) for 1 mm, then propargylamine (365 p.L, 
5.32 mmol, 1.0 eq) and DIPEA (1.85 mL, 10.62 mmol, 2.0 eq) were added and the 
mixture was stirred for 2 h, then 2 M NaOH (10 mL) was added and stirred for 90 
mm. The reaction mixture was evaporated in vacuo, dissolved in 1120 (100 mL) 
and MeOH (200 mL). The greenish-yellow solution was acidified with 2 M HC1 
(ca. 50 mL) and partially evaporated until the solution turned cloudy. The flask was 
cooled to 4 °C for 15 h and the yellow powder was filtered off (1.69 g, 4.09 mmol, 
77 % yield). IR (neat) 3042 (w), 1716 (w), 1637 (s), 1586 (s), 1490 (s) cm 1 , 1H 
NTVIR (250 IvIiHz, (CD 3)2S0) 8H  9.36 (1H, t, J = 5.5 Hz, NH, isomer A), 9.20 (114, 
t, J = 5.5 Hz, NH, isomer B), 8.48 (1H, d, J = 0.7 Hz, CH, C4 isomer 5), 8.27 (1H, 
dd, J = 8.0, 1.5 Hz, CH, C 6 isomer 5), 8.19 (1H, dd, J = 8.0, 1.2 Hz, CH, C 5 isomer 
6), 8.09 (1H, d, J = 8.0 Hz, CH, C4 isomer 6), 7.71 (111, s, C7 isomer 6), 7.39 (1H, 
d, J = 8.0 Hz, CH, C7 isomer 5), 6.73 - 6.74 (211, m, m-CH, isomers 5 & 6), 6.53 - 
6.64 (414, m, o-CH, isomers 5 & 6), 4.11(211, dd, J = 5.4, 2.4 Hz, CH 2, isomer A), 
3.99 (211, dd, J = 5.2, 2.6 Hz, CH 2, isomer B), 3.17 (111, t, J = 2.4 Hz, H-CC, 
isomer A), 3.10 (114, t, J = 2.4 Hz, H-CC, isomer B), 13C NMIR (62 MHz, 




160.1 (C), 155.1 (C), 152.4 (C), 152.3 (C), 152.2 (C), 140.2 (C), 135.9 (C), 135.0 
(CH, C6 isomer 5), 129.9 (CH, C 5 isomer 6), 129.6 (o-CH), 129.5 (o-CH), 128.9 
(C), 127.0 (C), 125.4 (CH, C4 isomer 6), 124.8 (CH, C7 isomer 5), 123.9 (CH, C4 
isomer 5), 122.8 (CH, C7 isomer 6), 113.2 (o-CH), 113.1 (o-CH), 109.5 (C), 109.4 
(C), 102.7 (m-CH), 813 (C), 81.1 (C), 73.5 (CCH), 73.5 (CCH), 29.1 (CH2), 
29.0 (CH2), CCH signal obscured by DMSO peak, ES m/z (%) 412.1 (M-H, 95), 
HRMS (FAB) for C24H1 5N106 (M+H): calcd 413.08994, found 413.09032, 
HPLC 01254) tR 6.44, 6.56 mm (Method 3), R1 0.25 (10 % MeOH:CH2C12). 






Nucleoside 97 (2.00 g, 3.05 mmol) was dissolved in pyridine (20 mL) and treated 
with DMAP (95 mg, 0.78 mmol, 0.25 eq), TEA (1.1 mL, 7.83 mmol, 2.5 eq) and 
Ac20 (310 j.L, 3.04 mmol, 1.0 eq) and stirred for 2 h until complete (tic). The 
reaction mixture was evaporated in vacuo, dissolved in EtOAc (100 mL), washed 
with H20 (3 x 100 mL), dried (Na2SO4), evaporated in vacuo and purified by 
column chromatography eluted with 0-3 % MeOWCH 2C12 to yield a white foam 
(2.20 g, 3.10 mmol, 100 % yield). IR (neat) 3058 (w), 2834 (w), 1682 (s), 1606 
(m), 1507 (w), 1300 (s) cm i , 'H NIVIR (250 IvlIFIz, CDC1 3) oH 9.50 (1H, br signal, 
H-3), 8.17 (1H, s, 11-6), 7.23 —7.44 (9H, m, Ph +p-CH of DM1'), 6.86 (4H, d, J = 
8.5 Hz, 4 o-CH of DMT), 6.35 (1H, dd, J = 9, 5 Hz, H-i'), 5.44 (111, d, J = 6 Hz, 
H-3'), 4.15 (1H, m, H-4'), 3.79 (6H, s, CH 30), 3.47 (1H, dd, J = ii, 3 Hz, H-5'), 
3.40(111, dd, J= 11,3 Hz, H-5'), 2.56 (ill, dd, J= 14,5 Hz, H-2'), 2.39 (1H, m, 
H-2'), 2.09 (3H, s, CH 3), ' 3C NMR (90 MHz, CDC1 3) Oc  170.3 (C=OCH3), 159.9 
(C-4), 158.6 (COMe), 150.1 (C 22), 144.1 (C-6), 143.9 (C), 135.3 (C), 135.1 (C), 
130.0 (CH), 128.1 (CH), 128.0 (CII), 127.1 (CH), 113.3 (CH), 87.2 (C-Ar 3), 85.1 
(C-4'), 84.4 (C-i'), 75.1 (C-3'), 69.1 (C-5), 63.4 (C-5'), 55.2 (CH 30), 38.6 (C-2'), 
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20.9 (CH3), APCI mlz (%) 697.1 (M-ff, 100), HPLC (X282) tR 4.26 mm (Method 
1), 16.98 mm (Method 2), Rf 0.62 (10 % MeOWCH2C12, ammonium molybdãte). 
3-15(6)-Carboxy-fluoresceini-amido-hexanoic acid (123) 
HO 
IWM 
5(6)-Carboxyfluorescein 119 (201 mg, 0.535 mmol) in DMIF (4 mL) was treated 
with PyBOP (277 mg, 0.532 mmol) for 1 mm, then 6-aminohexanoic acid methyl 
ester hydrochloride (98 mg, 0.534 mmol) and DIPEA (300 ItL, 1.72 mmol, 3.2 eq) 
were added and the mixture was stirred for 2 h until complete (HPLC). The 
reaction mixture was evaporated in vacuo, dissolved in CH202 (5 mL) and 2 M 
HC1 (5 mL) was added. The brown precipitate was filtered off, washed with H 20 (5 
mL) and dried to give a brown powder. The residue was dissolved in DMF (5 mL) 
and was stirred with 2 M NaOH (1 mL) for 2 h. The reaction mixture was 
evaporated in vacuo, the residue dissolved in H 20 (5 mL), 2 M HC1 (2 mL) was 
added, the precipitate filtered off and rinsed with H 20 to yield an orange-brown 
solid (184 mg, 0.376 nimol, 70 % yield). IR (neat) 2931 (w); 1707 (m), 1587 (s), 
1538 (s), 1453 (s), 1205 (s), 1115 (s) cm 1 , 1H N1'LR (400 MiHz, (CD3)2S0) oH 9.49 
(1H, br signal, COOH, isomers 5 & 6), 8.81 (111, t, J = 5.4 Hz, NH, isomer A), 
8.67 (111, t, J = 5.4 Hz, NH, isomer B), 8.45 (1H, d, J = 1.3 Hz, CH, C 4 isomer 5), 
8.23 (1H, dd, J = 8.0, 1.3 Hz, CH, C6 isomer 5), 8.17 (1H, dd, J = 8.0, 1.2 Hz, CH, 
C5 isomer 6), 8.06 (1H, d, J = 8.0 Hz, CH, C 4 isomer 6), 7.67 (111, d, J = 1.2 Hz, 
CH, C7 isomer 6), 7.35 (1H, d, J = 8.0 Hz, CH, C7 isomer 5), 6.71 - 6.72 (2H, m, 
m-CH, isomers 5 & 6), 6.56 - 6.57 (411, m, o-CH, isomers 5 & 6), 3.28 - 3.33 (2H, 
m, CH2 , CA isomer A), 3.16-3.21 (2H, m, CH 2, CA isomer B), 2.22 (2H, t, J = 7.3 
Hz, CH2, CE isomer A), 2.16 (2H, t, J = 7.4 Hz, CH2, CE isomer B), 1.51 - 1.58 
(4H, m, CH2, CB + CD isomer A), 1.42 - 1.49 (4H, m, CH 2 , CB + CD, isomer B), 
1.30 - 1.38 (2H, m, CH2, Cc isomer A), 1.23 - 1.28 (2H, m, CF!2. Cc isomer B), 
13C NMR (100 MHz, (CD3)2S0) 0c  174.5 (CO2H), 174.4 (CO2H), 168.2 (C=O), 
168.1 (C=O), 164.5 (C=O), 164.3 (C=O), 159.7 (C), 154.6 (C), 152.7 (C), 151.9 
(C), 140.8 (C), 136.4 (C), 134.6 (CH, C6 isomer 5), 129.4 (CH, C 5 isomer 6), 129.2 
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(o-CH), 129.1 (o-CH), 128.2 (C), 126.5 (C), 124.8 (CH, C 4 isomer 6), 124.2 (CH, 
C7 isomer 5), 123.2 (CH, C 4 isomer 5), 122.2 (CH, C7 isomer 6), 112.8 (o-CH), 
112.7 (o-CH), 109.2 (C), 109.1 (C), 102.3 (m-CH), 83.4 (C), 39.3 (CH2), 39.3 
(CH2), 33.7 (CH2), 33.6 (CH2), 28.7 (CH2), 28.6 (CH2), 26.0 (2 CH2), 24.3 (CH2), 
24.2 (CH2), ES m/z (%) 490.2 (M+J{, 100), HPLC (Lo) tR 6.89 mm (Method 2), 
Rf 0.10 (5:95:2 MeOH:CH2C1 2:AcOH). 
6-Carboxvfluorescein dipivalate (131) 
5(6)-Carboxyfluorescein 119 (5.15 g, 13.7 mmol) was refluxed in Piv 20 (10 mL) 
for 2 h at 130 °C, cooled to rt, diluted with THF (10 mL) and H20 (10 mL) and 
stirred at rt for 1 h. Et 20 (50 mL) was added and the lower phase separated. The 
organic layer was washed with 1 M pH 7 sodium phosphate buffer (20 mL), brine 
(2 x 25 mL), 1 M HC1 (25 mL), brine (25 mL), dried (MgSO 4) and evaporated in 
vacuo. The yellow oil was dissolved in EtOH (50 mL), diisopropylamine (5 mL) 
was added and the solution cooled to -20 °C for 2 h. An off-white precipitate was 
filtered off, washed withice-cold EtOH and acetone and vacuum-oven dried (1.89 
g). The powder was dissolved in CH 202 (50 mL), washed with 1 M HC1 (2 x 25 
mL), dried (MgSO4) and evaporated in vacuo to yield a pale yellow foam (1.17 g, 
2.16 mmol, 16 % yield). IR (neat) 2972 (w), 1756 (m), 1733 (s), 1480 (s), 1158 (s) 
cm 1 , 1H NMR (250 MHz, CDC1 3 ) 6H  8.34 (1H, dd, J = 8.0, 1.3 Hz, CH, C5), 8.12 
(1H, dd, J = 8.0, 0.7 Hz, CH, C4), 7.86 (1H, dd, J = 1.3, 0.8 Hz, CH, C7), 7.08 (2H, 
t, J = 1.3 Hz, CU), 6.79 (4H, d, J = 1.3 Hz, CH), 1.35 (18H, s, C(CH 3)3 ), 13C NMR 
(62 MHz, CDC13) 8C  176.5 (C=O), 169.3 (C=O), 168.1 (C=O), 153.1 (C), 152.8 
(C), 151.5 (C), 135.7 (C), 131.8 (CH, C5), 130.2 (C), 128.7 (CU), 125.9 (CH, C 4), 
125.5 (CH, C7), 117.9 (CU),  115.3 (C), 110.5 (CH), 82.2 (spiroC), 39.2 (C(CH3)3), 
27.0 (CH3), APCI mlz (%) 543.3 (M-ff, 100), HPLC (X254) tR 9.45 mm (Method 









Nucleoside 122 (50 mg, 81 tmol) and 6-carboxylluorescein dipivalate 131 (45 mg, 
83 jtmol) were dissolved in dry CH 202 (0.4 mL) and treated with DIC (25 pL). 
The mixture was stirred for 2 h, evaporated in vacuo, purified by column 
chromatography eluted with 0-2 % MeOH in CH 202 to yield a white powder (43 
mg, —46 % yield, Rf 0.68 (10 % MeOWCH202)). The powder was dissolved in 3 
% TCA in CH202 (3 mL), MeOH (lmL) was added and after 5 mm, was 
evaporated in vacuo. The residue was purified by column chromatography eluted 
with 0-2 % MeOH in CH202 to yield a white powder (30 mg, 31 p.mol, 37 % over 
two steps). mp 150 °C (decomp.), IR (neat) 2977 (w), 1753 (s), 1661 (s), 1616 (m), 
1242 (m), 1113 (s) cm 1 , 'H NIVIR (250 MHz, CD30D) oH 8.13 (1H, 5; H-6), 8.07 
(1H, dd, J = 8.0, 1.3 Hz, CH, C 5), 8.01 (1H, dd, J = 8.0, 0.7 Hz, CH, C4), 7.65 (1H, 
dd, J= 1.1, 0.8 Hz, CH, C 7), 7.02-7.03 (2H, m, CH), 6.80 (2H, dd, J= 8.7, 0.6 Hz, 
CH), 6.74 (2H, ddd, J= 8.7, 2.1, 0.9 Hz, CH), 6.07 (1H, dd, J= 8.2, 5.8 Hz, H-i'), 
5.15 (1H, dt, J = 6.0, 1.9 Hz, H-3'), 4.07 (2H, s, H-9), 4.17 (1H, q, J = 2.5 Hz, H-
4'), 3.65 (2H, d, J = 2.8 Hz, H-5'), 2.28 (1H, ddd, J = 14.0, 5.8, 1.9 Hz, H-2'), 2.15 
(1H, ddd, J = 14.3, 8.3, 6.2, H-2'), 1.97 (3H, s, CH 3), 1.24 (18H, s, C(CH3 )3), 13C 
NI1VIR (62 MHz, CD30D) Oc  178.4 (C=0), 172.5 (C=OCH3), 170.3 (C=0), 167.8 
(C=O), 164.9 (C-4), 155.0 (C), 154.8 (C), 153.3 (C), 151.4 (C-2), 145.7 (C-6), 
142.5 (C), 131.5 (CH, C5), 130.8 (CH), 130.1 (C), 126.9 (CH, C 4), 124.5 (CH, C7), 
119.8 (CH), 117.5 (C), 112.0 (C), 110.5 (CR), 100.5 (C-5), 90.2 (C-7), 87.5 (C-4'), 
87.3 (C-i'), 83.8 (spiroC), 76.8 (C-3'), 76.0 (C-8), 63.2 (C-5'), 40.6 (C(CH3)3), 




HRMS (FAB) for C 45HN3014 (M+H): calcd 850.2818, found 850.2844, HPLC 
(X280) tR 8.41 mm (Method 3), Rf 0.55 (10 % MeOH/CH2C12). 






A vessel was charged with 5-iodo-2'-deoxyuridine 96 (90 mg, 0.253 mmol), [Pd 
(PPh3)41 (14 mg, 0.012 mmol, 0.047 eq), copper (I) iodide (13 mg, 0.068 mmol, 
0.26 eq), trifluoroacetamidopropargylamine 95 (76 g, 0.50 mmol, 2.0 eq), 
Amberlite IRA-67 resin (230 mg, 1.29 mmol, 5.1 eq) and DIVIF (2.5 mL). The 
reaction mixture was purged with N 2 and stirred for 14 h at 60 °C. The solution was 
cooled to rt, filtered through a silica plug with MeOH/CH 2C12 (1/2, 20 mL) and 
evaporated in vacuo. The residue was purified by column chromatography eluted 
with 0-15 % MeOH in CH202 to yield a yellow oil (73 mg, 0.20 mmol, 80 % 
yield). 1H N1VJIR (250 MHz, CD30D) oH 8.32 (1H, s, 11-6), 6.22 (1H, t, J = 6.5 Hz, 
H-i'), 4.39 (1H, dt, J = 6.8, 3.6 Hz, H-3'), 4.27 (2H, s, H-9), 3.94 (1H, q, J = 3.3 
Hz, H-4'), 3.81 (iH, dd, J = 12.1, 2.9 Hz, H-5'), 3.73 (iH, dd, J = 12.0, 3.5 Hz, H-
5'), 2.32 (111, ddd, J = 14.5, 6.6, 4.2 Hz, 11-2'), 2.21 (1H, dd, J = 13.6, 6.5 Hz, H-
2'), 13C NMR (90 MHz, CDC1 3) Oc  164.6 (C-4), 158.5 (q, J = 37.5 Hz, COCF3), 
151.1 (C-2), 145.8 (C-6), 117.4 (q, J = 286.6 Hz, CF0, 99.5 (C-5), 89.2 (C-4'), 
88.4 (C-7), 87.2 (C-i'), 76.1 (C-8), 72.0 (C-3'), 62.6 (C-5'), 41.7 (C-2'), 30.8 (C-
9), HPLC (X282) tR 2.38 mm (Method 1), 9.50 mm (Method 2), Rf 0.19 (10 % 
MeOHJCH202 , Ninhydrin). 











Method 1: A vessel was charged with 5-iodo-2'-deoxyuridine 96 (449 mg, 1.27 
mmol), [Pd (PPh 3 )41 (146 mg, 0.126 mmol, 0.10 eq), copper (I) iodide (120 mg, 
0.630 mmol, 0.50 eq), propargylamine (255 iLL, 3.72 mmol, 3.0 eq), Amberlite 
IRA-67 resin (446 mg, 2.50 mmol, 2 eq) and DMF (6.25 mL). The reaction mixture 
was purged with N2 and stirred for 2 h. The solution was diluted with NH 3 sat. 
MeOH (5 mL) filtered twice through a silica plug with NH3 sat. MeOH (20 mL) 
and evaporated in vacuo. The residue was purified by column chromatography 
eluted with 20 - 30 % NH3 sat. MeOH in CH202 to yield a white powder (152 mg, 
0.541 mmol, 43 % yield). Method 2: Nucleoside 133 (61 mg, 0.220 mmol) was 
dissolved in NIH40H (10 mL) and stirred for 80 min until complete (tic). The 
reaction was evaporated in vacuo and purified by column chromatography eluted 
with 20 - 30 % NH 3 sat. MeOH in CH202 to yield a white powder (42 mg, 0.149 
mn-iol, 68 % yield). IR (neat) 3023 (w), 2840 (w), 1709 (s), 1684 (s) cm 1 , 'H N1VIR 
(250 MiHz, (CD 3)2S0) oH 8.39 (1H, s, H-3), 8.22 (1H, s, H-6), 6.10 (1H, t, J = 6.6 
Hz, H-i'), 4.21- 4.26 (1H, m, H-3'), 3.80 (iH, q, J= 3.1 Hz, H-4'), 3.64 (2H, s, H-
9), 3.56 (1H, dd, J= 12.0, 3.5 Hz, H-5'), 2.08 -2.13 (2H, m, H-2'), one.H-5' signal 
obscured by H-9 signal, '3C NMIR (90 IvliHz, (CD 3 )2S0) 0c  161.6 (C-4), 149.4 (C-
2), 143.7 (C-6), 98.0 (C-5), 90.8 (C-7), 87.6 (C-4'), 84.7 (C-i'), 75.8 (C-8), 70.2 
(C-3'), 60.9 (C-5'), 41.2 (C-2'), 30.4 (C-9), ES m/z (%) 563.4 (2M+H, 100), 
HR1\'IS (FAB) for C 12H 15N305 (M): calcd 281.10117, found 281.10198, HPLC 
(X282) CR 0.75 mm (Method 1), 3.80 mm (Method 2), 1.34 mm (Method 3), Rf 0.09 
(20 % NH3 sat. MeOHJCH202, Ninhydrin). 
543' '-trifluoroacetamidopropynyl)-2'3'-dideoxvuridine (136) 
0 
HN 	 H )I) 
ON 
HO 	 I 
A vessel was charged with 5-iodo-2',3'-dideoxyuridine (30 mg, 87.5 p.mol), [Pd 
(PPh3)41 (4.5 mg, 3.9 imol, 0.045 eq), copper (I) iodide (3.6 mg, 18.9 gmol, 0.22 
eq), trifluoroacetamidopropargylamine 95 (27 mg, 0.178 mmol, 2.0 eq), Amberlite 




mixture was purged with N2 and stirred for 22 h at ii. The solution was filtered 
through a silica plug with MeOWCH 2C12 (1/2, 20 mL) and evaporated in vacuo. 
The residue was purified by column chromatography eluted with 0-2 % MeOH in 
CH2Cl2  to yield starting material (15 mg, 44 .tmol, 51 % yield) and 136 as a clear 
oil (9 mg, 25 j.tmol, 28 % yield). 'H NMR (250 MHz, CD30D) oH 8.47 (1H, s, H-
6), 6.00 (1H, dd, J = 6.6, 3.0 Hz, H-i'), 4.27 (2H, s, H-9), 4.12 - 4.20 (1H, m, H-
4'), 3.91 (1H, dd, J = 12.2, 2.8 Hz, H-5'), 3.68 (1H, dd, J = 12.3, 3.6 Hz, H-5'), 
2.33 - 2.49 (1H, m, H-2'), 2.06 - 2.17 (1H, m, H-2'), 1.96 (1H, dd, J = 12.1, 4.5 
Hz, H-3'), 1.93 (1H, dd, J = 14.1, 1.5 Hz, H-3'), 13C NMIR (90 MiHz, 
CDC13/CD30D) 0c 163.8 (C-4), 149.9 (C-2), 144.9 (C-6), 98.0 (C-5), 87.4 (C-4'IC-
1'), 87.3 (C-7), 82.9 (C-1'/C-4'), 75.7 (C-6), 62.4 (C-5'), 33.6 (C-2'/C-3'), 30.5 
(C-9), 24.4 (C-2'/C-3'), COCF 3 signals not visible due to low concentration, APCI 
mlz (%) 360.2 (M-ff, 100), HPLC (X280) tR 5.54 mm (Method 3), Rf 0.18 (10 % 
MeOHJCH2C12, KMn0 4). 




Nucleoside 136 (9 mg, 25 p.mol) was dissolved in NH40H (10 mL) and stirred for 
lh 45 min and evaporated in vacuo. 6-Carboxyfluorescein dipivalate 131 (15 mg, 
27 Itmol) was dissolved in dry DMF/CH 2C12 (1/2, 0.4 mL) and treated with DIC (4 
p.L) for 5 mm, added to the dried nucleoside and stirred for 3 h. The mixture was 
evaporated in vacuo, purified by column chromatography eluted with 0-2 % MeOH 
in CH202  to yield a white powder (6 mg, -30 % yield). Compound contained 
diisopropylurea, which co-purified. 'H NTv[R (250 MHz, CD 30D) 0H  7.94 (111, s, 
H-6), 7.73 (1H, dd, J = 8.0, 1.4 Hz, CH, C5), 7.67 (111, dd, J = 8.1, 0.8 Hz, CH, 
C4), 7.25 (1H, dd, J = 1.3, 0.8 Hz, CH, C 7), 6.69 (2H, d, J = 2.1 Hz, CR), 6.45 (2H, 
d, J = 8.6 Hz, CR), 6.40 (2H, dd, J = 8.7, 2.1 Hz, CII), 5.50 (1H, dd, J = 6.7, 3.0 
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Hz, H-i'), 3.78 (2H, s, H-9), 3.61 - 3.70 (1H, m, H-4'), 3.16 (iH, dd, J = 12.2, 3.5 
Hz, H-5'), 1.83 - 1.98 (1H, m, H-2'), 1.54 - 1.65 (1H, m, H-2'), 1.39 -1.48 (2H, m, 
H-3'), 0.98 (18H, s, C(CH3)3), one H-5' signal obscured by CD 30D signal. 
5-propargylamido-(6-carboxvfluorescein) 5 '-triphosphate ethylaminonium 
salt (141) 
TNO 
-0,c? 0j 0...c?0 
P P P 




Using general procedure: Nucleoside 132 (38 mg, 44 tmol) and resin 41a (199 
mg, 0.270 mmol, 1 eq) were used. The nucleoside was dissolved in dry pyridine/ 
dry THF (1/3, 0.25 mL) to load onto the resin. The loading was performed for 2 h. 
The final deprotection step was left for 1 h and the residue was purified by Prep 
HPLC eluted with 0.1 M TEAB to yield an orange solid. 31P NMR (101 MIHz, 
D20/2 M TEAB) 6p-6.40 (m, P-y), -11.00 (m, P-a), -21.63 (m, P - 13 ) ,  MALDI m/z 
(%) 878.31 (M-H, 80), HPLC 01 280) tR 9.52 mm (Method 5). The yield was 
estimated using UV/Vis spectrometry. 141 was dissolved in 0.1 M TEAB buffer to 
25 mL. Two further dilutions were performed and the absorbance values tabulated 
below (Table 6.3). The number of moles was calculated to give an estimated yield 
of 1 %. 
Table 63 Determination of the yield using UV-Vis 
Dilution A cone n yield 
mL imol %" 
25 1.5156 1.89 10 5 0.47 1.1 
62.5 0.6134 7.67 10 0.48 1.1 
125 0.3409 4.26 106 0.53 1.2 




6.5 	Experimental for Chapter 4 
3' -O-Acetyl-5'-O-benzyloxy-thymidine 5 '-H-phosphonate (154) 
0 
c 	NHO L-0 N . L 
0 
"'r 0 
Resin 41a (207 mg, 0.277 mmol, 1 eq) was swollen in dry THF (2 x 2 mL for 5 
min each) at 60 °C. PC13 (95 jL, 4 eq) was added to the resin in dry THF (4 mL) 
and the syringe was heated at 60 °C for 2 h. 3'OAc-T 49 (25 mg, 88 11mol, 0.33 eq) 
was evaporated in vacuo from dry pyridine (1 mL), dried over P 205 in a desiccator 
for 1 h in vacuo and dissolved in dry pyridine (0.25 mL) and dry THF (0.75 mL). 
The resin was drained and rinsed with dry TFIF (2 x 2 mL for 5 min each). The N 2 
flushed resin was treated with the nucleoside solution for 1 h at rt, drained, rinsed 
with dry THF (2 x 2 mL for 5 mm) and treated with anhydrous BnOH (1 mL) for 
10 mm. The cleaved product was collected in an RB, stined at rt for 30 mm, 
evaporated in vacuo and purified by column chromatography eluted with 0 - 4 % 
MeOH in CH202 to yield a clear oil 154(3 mg, 7 j.mol, 8 % yield) and recovered 
starting material 49 (6 mg, 21 itmol, 24 % yield). JR (neat) 2927 (m), 1739 (s), 
1686 (s), 1469 (s), 1235 (s) cm 1 , 1H N1VIR (250 Ivll{z, CDC1 3 ) oH 8.51 (1H, br 
signal, H-3), 7.44 (1H, d, J = 1.1 Hz, H-6), 7.39 (5H, m, Ph), 6.96 (1H, d, J = 
708.5Hz, PH), 6.34 (1H, dd, J = 9.1, 5.3 Hz, H-i'), 5.18 (2H, s, CH 2), 5.14 (114, s, 
H-3'), 4.21 —4.37 (214, m, H-5'), 4.14 (iH, dd, J = 4.3, 2.1, H-4'), 2.37 (1H, dtd, J 
= 10.4, 5.4, 1.5 Hz, H-2'), 2.10 (3H, s, COCH3), 2.01 - 2.14 (114, m, H-2'), 1.91 
(3H, d, J = 1.2 Hz, CH3), 13 C NTVIR (62.5 MIHz, D20) Oc  170.5 (C=OCH3), 164.4 
(C-4), 152.7 (C-2), 134.9 (d, J= 6.8 Hz, i-C), 135.0 (C-6), 129.0 (CH), 128.8 (CH), 
128.2 (CH), 111.8 (C-5), 84.5 (C-i'), 82.6 (d, J= 7.0 Hz, C-4'), 74.1 (C-3'), 69.8 
(d, J = 11.7 Hz, Ph-CH2), 65.1 (d, Jpc = 4.7 Hz, C-5'), 37.0 (C-2'), 20.8 (CH 30), 
12.3 (CH3) , 31P NMR (101 MHz, CDC1 3) Op 10.25, 9.05, ES m/z (%) 439.2 




698.1355, HPLC (X280) tR 6.28 mm (Method 3), Rf 0.26 (10 % MeOHICH2Cl2 , 
ammonium molybdate). 
Dibenzyl phosphite (155) 
oo-oo 
Ill 
Resin 41a (205 mg, 0.275 mmol, 1 eq) was swollen in dry THF (2 x 2 mL for 5 
mm) at 60 °C. Pd 3 (95 jL, 4 eq) was added to the resin in dry TFIF (4 mL) and the 
syringe was heated at 60 °C for 2 h. 3'OAc-T 49 (25 mg, 88 timol, 0.33 eq) was 
evaporated in vacuo from dry pyridine (1 mL), dried over P 205 in a desiccator for 1 
h in vacuo and dissolved in dry pyridine (0.25 mL) and dry THF (0.75 mL). The 
resin was drained and rinsed with dry THF (2 x 2 mL for 5 mm). The N2 flushed 
resin was treated with the nucleoside solution for 1 h at rt, drained, rinsed with dry 
THF (2 x 2 mL for 5 mm) and treated with anhydrous BnOH: tBuOH (1:1, 1 mL) 
for 10 mm. The cleaved product was collected in an RB, stirred at rt for 30 mm, 
evaporated in vacuo and purified by column chromatography eluted with 0 - 4 % 
MeOH in CH202 to yield dibenzylphosphite 155 as a clear oil (7 mg, 27 jimol, 30 
% yield), a clear oil 154 (3 mg, 7 jimol, 7 % yield) and recovered starting material 
49 (12 mg, 42 j.mol, 48 % yield). 'H NMR (250 IvIHz, CDC1 3 ) 8H  7.52 (10H, m, 
Ph), 6.94 (1H, d, J = 706.7 Hz, PH), 5.10 (2H, dd, J = 11.9 , 9.8 Hz, CH2), 5.03 
(2H, dd, J = 11.8, 9.4 Hz, CH2), 13C NIVIR (62.5 MIHz, CDC1 3) 6c  146.3 (CH), 
128.6 (CH), 128.0 (CH), 67.3 (d, J = 5.7 Hz, Ph-CH2), ipso-C not visible, 31P 









Resin 41a (204 mg, 0.272 rnmol, 1 eq) was swollen in dry TITF (2 x 2 mL for 5 
min each) at 60 °c. Pc13 (95 j.tL, 4 eq) was added to the resin in dry THF (4 mL) 
and the syringe was heated at 60 °C for 2 h. 3'OAc-T 49 (25 mg, 89 /Lmoi, 0.33 eq) 
was evaporated in vacuo from dry pyridine (1 mL), dried over P205 in a desiccator 
for 1 h in vacuo and dissolved in dry pyridine (0.25 mL) and dry THF (0.75 mL). 
The resin was drained and rinsed with dry THF (2 x 2 mL for 5 min each). The N 2 
flushed resin was treated with the nucleoside solution for 1 h at rt, drained, rinsed 
with dry THF (2 x 2 mL for 5 mm) and treated with dry EtOH (1 mL) for 10 mm. 
The cleaved product was collected in an RB with 0.5 M 12  in pyridine (800 jL). 
After 15 mm, excess iodine was quenched with a few drops of 5 % NaHS03 
solution. The reaction mixture was extracted with CH 2C1 2 (3 x 3 mL), dried 
(Na2SO4) and purified by column chromatography eluted with 0-20 % acetone in 
Et20 to yield recovered starting material (3 mg, 9 itmol, 10 % yield) and 157 as a 
clear oil (6 mg, 14 itmol, 15 % yield). 'H NIIVIR (250 MHz, cDC13) oH 8.92 (1H, s, 
H-3), 7.51 (1H, d, J = 1.3 Hz, H-6), 6.40 (1H, dd, J = 9.2, 5.5 Hz, H-i'), 5.28 (111, 
dt, J = 6.4, 1.3 Hz, H-4'), 4.32 (1H, ddd, J = 11.1, 5.1, 2.6 Hz, H-5'), 4.25 (1H, 
ddd, J = 111.0, 5.1, 2.3 Hz, H-5'), 4.10 (4H, dqd, J = 8.1, 7.1, 1.0 Hz, cH2cH3), 
4.05 - 4.15 (1H, m, H-3'), 2.40 (iH, ddd, J = 14.0, 5.5, 1.3 Hz, H-2'), 2.16 (1H, 
ddd, J = 11.7, 7.9, 5.1, H-2'), 2.10 (3H, s, COCH3), 1.94 (3H, d, J = 1.2 Hz, cH3), 
1.35 (3H, td, J= 7.1, 2.1 Hz, c112cH3), 1.34 (3H, td, J= 7.1, 2.1 Hz, cH2cH3), 31P 
NMR (101 IvlHz, cDc13) Op 0.20, ES m/z (%) 421.2 (M+H, 100), HPLC (X280) tR 









Resin 41a (205 mg, 0.275 mmol, 1 eq) was swollen in dry THF (2 x 2 mL for 5 
mm) at 60 °c. pc13 (95 tL, 4 eq) was added to the resin in dry THF (4 mL) and the 
syringe was heated at 60 °c for 2 h. 3'OAc-T 49 (25 mg, 88 jimol, 0.33 eq) was 
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evaporated in vacuo from dry pyridine (1 mL), dried over P 205 in a desiccator for 1 
h in vacuo and dissolved in dry pyridine (0.25 mL) and dry THF (0.75 mL). The 
resin was drained and nnsed with dry THF (2 x 2 mL for 5 mm). The N2 flushed 
resin was treated with the nucleoside solution for 1 h at rt, drained, rinsed with dry 
TUF (2 x 2 mL for 5 mm) and treated with dry BnOH (1 mL) for 10 mm. The 
cleaved product was collected in an RB with 0.5 M 12  in 98:2 pyridine:H 20 (800 
L, 1.5 eq). After 15 mm, excess iodine was quenched with a few drops of 5 % 
NaHS03 solution. The reaction mixture was evaporated in vacuo, dissolved in 
CH202, washed with H20 (3 x 3 mL), dried (Na 2SO4) and purified by column 
chromatography eluted with 0 - 30 % acetone in Et 20 to yield a clear film (13 mg, 
24 Amol, 27 % yield). IR (neat) 2957 (w), 1738 (m), 1686 (s), 1497 (w), 1236 (s) 
cm 1 , 1 H N1VIR (250 MHz, CDC1 3 ) oH 8.44 (1H, s, H-3), 7.50 (1H, d, J= 1.1 Hz, H-
6), 7.34 (10H, d, J = 1.2 Hz, Ph), 6.33 (1H, dd, J = 9.3, 5.4 Hz, H-i'), 4.99 —5.14 
(5H, m, CH2 + H-4'), 4.23 (1H, ddd, J = 11.1, 5.0, 2.5 Hz, H-5'), 4.16 (1H, ddd, J 
11.1,5.2,23Hz, H-5'), 4.08 (iH, td, J= 4.1, 2.3, H-3'), 2.27 (iH, ddd, J= 14.0, 
5.4, 1.0 Hz, H-2'), 2.09 (3H, s, COCH3), 1.88-1.93 (1H, m, H-2'), 1.84 (3H, d, J = 
1.2 Hz, CH3), 13C NMR (62.5 MHz, D 20) 0c  170.4 (C=OCH3), 163.3 (C-4), 150.2 
(C-2), 135.3 (d, J= 5.9 Hz, i-C), 135.0 (C-6), 128.9 (CH), 128.7 (CH), 128.1 (CH), 
111.7 (C-5), 84.4 (C-i'), 83.7 (d, J = 8.4 Hz, C-4'), 74.6 (C-3'), 69.8 (d, J = 4.9 
Hz, Ph-CH2), 67.1 (d, Jpc = 5.8 Hz, C-5'), 37.1 (C-2'), 20.9 (CH 30), 12.3 (CH3), 
31p NMR (101 MHz, D20) Op 0.59, ES m/z (%) 545.3 (M+H, 100), HPLC (X280) 






Resin 41a (201 mg, 0.269 mmol, 1 eq) was swollen in dry THF (2 x 2 mL for 5 
mm) at 60 °C. PCI 3 (95 AL, 4 eq) was added to the resin in dry THF (4 mL) and the 




evaporated in vacuo from dry pyridine (1 mL), dried over P 205 in a desiccator for 1 
h in vacuo and dissolved in dry pyndine (0.25 mL) and dry THF (0.75 mL). The 
resin was drained and rinsed with dry THF (2 x 2 mL for 5 mm). The N 2 flushed 
resin was treated with the nucleoside solution for 1 h at rt, drained, rinsed with dry 
THF (2 x 2 mL for 5 mm) and treated with dry iso-propanol (1 mL) for 10 mm. 
The cleaved product was collected in an RB with 0.5 M 12  in 98:2 pyridine:H20 
(800 ItL, 1.5 eq). After 15 mm, excess iodine was quenched with a few drops of 5 
% NaHS03  solution. The reaction mixture was evaporated in vacuo, dissolved in 
CH202, washed with H20 (3 x 3 mL), dried (Na 2SO4) and purified by column 
chromatography eluted with 0 - 20 % acetone in Et20 to yield a clear film (7 mg, 
16 jimol, 18 % yield). IR (neat) 2925 (w), 1740 (m), 1692 (s), 1467 (s), 1239 (s) 
cm 1 , 1H NMR (360 MFIz, CDC1 3) oH 8.21 (1H, s, H-3), 7.55 (1H, d, J = 1.3 Hz, H-
6), 6.42 (1H, dd, J = 9.3, 5.4 Hz, H-i'), 5.31 (1H, dt, J = 6.2, 2.3 Hz, H-3'), 4.64 - 
4.74 (2H, m, CH), 4.30 (iH, ddd, J = 11.1, 4.9, 2.4 Hz, H-5'), 4.21 (1H, ddd, J = 
11.1, 4.9, 2.4 Hz, H-5'), 4.17 (1H, td, J = 4.1, 2.2, H-4'), 2.40 (1H, ddd, J = 14.0, 
5.4, 1.2 Hz, H-2'), 2.18 (1H, ddd, J = 13.5, 9.3, 6.3 Hz, H-2'), 2.11 (3H, s, 
COCH3), 1.97 (3H, d, J = 1.2 Hz, CH3), 1.33 - 1.36 (12H, m, 4 CH3), 13C NMR 
(90 MHz, CDC13) 8C  170.4 (C=OCH3), 163.2 (C-4), 150.1 (C-2), .135.0 (C-6), 
111.7 (C-5), 84.4 (C-i'), 83.0 (d, Jpc = 8.4 Hz, C-4'), 74.8 (C-3'), 73.1 (d, JPC = 
5.4 Hz, CH), 66.7 (d, Jpc = 5.9 Hz, C-5'), 37.2 (C-2'), 29.6 (CH 3), 20.8 (CH30), 
12.3 (CH3), 31P NMR (101 MHz, D 20) Op -1.67, ES m/z (%) 449.2 (M+W, 100), 
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Supported phosphorylation reagents - synthesis of nupleoside triphosphates 
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The importance of triphosphates and their analogues in DNA sequencing and enzyme and 
inhibition studies has led to various approaches for their synthesis, none of them wholly 
satisfactory for a wide range of alcohols and none of them suitable for use in a library 
synthesis. To address this issue, a supported phosphorylation reagent has been developed. The 
use of polystyrene based supports allows direct access to phosphonate mono and diesters, 
which could be oxidized to their phosphate esters. The effect of the nature of the solid support 
on the chemistry was studied and is discussed with respect to the synthesis of nucleoside 
triphosphates. 
